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ABSTRACT
 Genomic imprinting is a specialized transcriptional mechanism resulting in the 
unequal expression of alleles based on their parent-of-origin.  Imprinted genes are critical 
for embryonic and fetal development and their dysregulation is linked to a group of 
human diseases called imprinting disorders, including Beckwith-Wiedemann Syndrome, 
Angelman Syndrome and Silver-Russell Syndrome.  Two critical phases of genomic 
imprinting exist.  The acquisition phase occurs in developing germ cells, asynchronously 
for different  imprinted loci, while the maintenance phase takes place during 
preimplantation development, while the rest of the genome is undergoing demethylation. 
Increased frequencies of human imprinting disorders are observed in children following 
the use of assisted reproductive technologies (ARTs).  The timing of ARTs during the 
critical periods of imprint acquisition and maintenance provides a mechanism for their 
disruption.  At the onset  of this project, I hypothesized that superovulation alone, and 
embryo culture alone, disrupt  imprinting acquisition and maintenance mechanisms, 
respectively, and that  disruption of genomic imprinting correlates with rates of 
preimplantation embryo development.  I have determined the effects of superovulation, 
and embryo culture using five commercially available media, on the key imprinted loci 
H19, Snrpn, Peg3, Kcnq1ot1 and Peg1/Mest, and correlated rates of preimplantation 
development with loss of genomic imprinting.  Superovulation alone disrupted genomic 
imprinting, in a dose-dependent manner.  Embryo culture in all media was sub-optimal in 
maintaining genomic imprints.  Embryos developing at a moderate pace showed levels of 
imprinted methylation most similar to in vivo-derived controls.  In addition, these studies 
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suggest that superovulation does not affect the acquisition of imprinted methylation, but 
rather maintenance throughout preimplantation development.  Data presented in this 
thesis suggests that superovulation disrupts one or more key  maternal-effects genes 
necessary  for imprint maintenance, and that superovulation and embryo culture disrupt 
the same pathway.  Future studies delineating the mechanisms mediating embryonic 
adaptation to the environmental insult caused by  ARTs, and improving current techniques 
to minimize the amount of adaptation required for embryo growth and survival outside 
the female reproductive tract, will lead to a decreased incidence of disease and improve 
the long term health of children born following ARTs. 
KEYWORDS:
Genomic Imprinting, H19, Snrpn, Peg3, Peg1/Mest, Kcnq1ot1, Assisted Reproductive 
Technologies, Superovulation, Embryo Culture
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Chapter 1: Introduction
1.1 - Epigenetics
1.1.1 Early Epigenetics
 While the concept of genes and their role in development is well known, the 
concept of epigenetics is a relatively  recent idea, and as such, much remains to be 
discovered in the field.  The term “epigenetics” was originally  coined by  C. H. 
Waddington in the 1940s, resulting from a combination of the words “epigenesis”, 
referring to the theory of animal development whereby development occurs in a step-wise 
manner resulting from successive differentiation rather than enlargement of preformed 
structures, and “genetics”, the theories and information originally derived from 
Mendelian ideology (Van Speybroeck, 2002).  Waddington’s ideas brought the concepts 
of genetics into the study of embryology, suggesting that genes interact in a number of 
ways, which are not static in every individual, to create unique organisms (Waddington, 
1939).  The frequency of discordance between genotype, the genetic makeup  of the 
individual, and phenotype, the observed physical characteristics, began to demand an 
addendum to Mendel’s laws of inheritance, which could account for these disagreements. 
Waddington suggested that the genotype of an individual did not dictate the phenotype, 
but simply provided a range of possible phenotypes, governed by  some other processes 
(Waddington, 1939).  In addition, Waddington postulated that these other processes not 
only played a role in inter-individual variation, but were also responsible for regulating 
the development of different tissues within the same individual (Waddington, 1939). 
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Essentially, the phenotype was a result of interactions between genetic processes and their 
cytoplasmic and external environments (Waddington, 1939).  
1.1.2 Modern Epigenetics
 Today, this concept has evolved, and we understand the term epigenetics as a 
combination of the word “genetics” and the prefix “epi”, meaning “on top of”.  In 
essence, epigenetics encompasses the study of heritable and reversible modifications of 
chromatin that influence the accessibility of genes and regulate gene transcription 
(Rodenhiser and Mann, 2006).  The plastic nature of epigenetics recapitulates 
Waddington’s ideas of cytoplasmic and external environments modulating the genetics of 
an organism.  Over the course of the last 50 years, as our understanding of the nuclear 
microenvironment and the composition and organization of the genome rapidly expanded, 
many advancements have been made that elucidated the core epigenetic mechanisms 
modulating these nuclear components resulting in modulation of gene expression.
1.1.3 Mechanisms of Epigenetic Regulation 
   
 Epigenetic mechanisms can modulate every aspect of the genetic material, from 
the ionic microenvironment of chromatin to the sub-nuclear localization of entire 
chromosomes.  Known mechanisms include histone modifications, DNA methylation and 
long non-coding RNAs, which, along with chromatin looping and the formation of 
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chromatin territories (CT), result in changes to chromatin structure and localization within 
the nucleus (Figure 1.1).    
1.1.3.1 Histone Modifications 
 The basic unit of DNA is the nucleosome which consists of double-stranded DNA 
wrapped around octamers of histone proteins (Kornberg, 1974), two each of H2A, H2B, 
H3, and H4, with H1 linker histones establishing spacing between nucleosomes (Figure 
1.1, 1.2). These histone proteins contain specific amino acid residues that can undergo 
post-translational modifications that modulate their charge and hydrophobicity 
(Lehninger et al., 2005).  Modulation of these two factors can change the local, or the 
global structure of chromatin organization resulting in local areas of open or closed 
chromatin, or silencing of entire chromosomes.  A number of histone modifications have 
been extensively studied and are consistently associated with either open (active), or 
closed (repressed) chromatin conformations.  Acetylation of lysine tails, such as H3K9, 
and H3K14, (Turner and Fellows, 1989; Schiltz et al., 1999; Vaquero et al., 2004), and 
phosphorylation of serine and threonine residues such as H3S10 (Sassone-Corsi et  al., 
1999; Anest et al., 2003), result in a more active chromatin state.  Other modifications 
such as methylation, sumoylation, and ubiquitination have more diverse functions in 
chromatin organization, and depending on their location, can act as either repressive or 
activating marks.  Histone methylation can occur on either lysine or arginine residues, and 
can be mono-, di-, or tri-methylated.  For example, tri-methylation of H3K4 results in an 
active chromatin conformation, while tri-methylation of H3K9 and H3K27 are repressive
3
Figure 1.1:  Mechanisms of Epigenetic Regulation
Epigenetic modifications include chromatin looping, histone modifications and DNA
methylation.  Chromatin looping allows binding of transcription factors (TF) to active 
regions of chromatin, while inactive regions are more likely located in the core of the 
chromosome territories.  DNA is made up of a series of nucleosomes, which contains 
histones and DNA.  Histone can be post-translationally modified in a number of ways, a 
few of which are methylation (Me), acetylation (Ac) and phosphorylation (P).  These 
marks can be activating or repressive depending on their nature and location.  DNA can 
be methylated on the 5’ carbon of cytosine residues by DNA methyl transferase enzymes 
(DNMTs), which is most often a repressive mark.  Long non-coding RNAs mediate 
epigenetic modifications in cis and trans through interactions with chromatin complexes 
and transcription factors.  Figure adapted from: Rodenhiser and Mann, 2006, Epigenetics 
and human disease: translating basic biology into clinical applications. CMAJ; 174(3):
341-348, Luong, P. 2009. Basic Principles of Genetics., http://web.me.com/marschalf/
classes-taught/apbiology/Spry-resources.htm, and Fraser, P., and Bickmore, W., 2007, 
Nuclear organization of the genome and the potential for gene regulation, Nature 447, 
413-417
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Figure 1.2: The Nucleosome and Histone Modifications
The nucleosome consists of an octamer of dimers of H2A, H2B, H3, and H4, with the H1 
linker protein establishing the space between nucleosomes.  DNA is wrapped around each 
nucleosome twice, resulting in approximately  147 bp of DNA per nucleosome.  This 
figure indicates the most common modifications of the H3 protein resulting in activation 
or repression of gene expression.  Ac: acetylation, Me: methylation, P: phosphorylation
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(Lehninger et  al., 2005).  Importantly, all of the above histone modifications are 
reversible, and therefore allow for temporal as well as spatial control of chromatin 
structure.  It is evident that control of chromatin state by  histone modifications is a 
complex process, involves a large network of proteins and has the capacity to finely 
modulate gene expression throughout the life cycle. 
 In early embryos, the paternal genome also acquires repressive histone 
modifications, including histone 3 lysine 9 and lysine 27 methylation (H3K9me2, 
H3K27me2, and H3K27me3). By comparison, the maternal genome possesses both active 
(H4Ac, H3K4me1) and repressive histone modifications (H3K9me2, H3K9me3, and 
H4K20me3) (Adenot et al., 1997; Cowell et al., 2002; Lepikhov and Walter, 2004). 
These covalent modifications are proposed to initiate the transcriptionally repressed state 
that coincides with embryonic genomic activation.  This potential for chromatin 
bivalency, where both activating and repressive marks occupy the same stretch of 
chromatin, is likely  a major factor in establishing the correct  gene expression profile for 
embryonic development (Schultz, 2002). 
1.1.3.2 DNA Methylation
 DNA methylation is another important epigenetic mechanism regulating gene 
expression and consists of the covalent addition of a methyl group to the C5 position of 
cytosine residues within CpG dinucleotides (Figure 1.1).  DNA methylation is most often 
associated with repression of gene expression (Lehninger et al., 2005).  A family of 
7
enzymes known as the DNA methyltransferases (DNMTs) is responsible for the addition 
of these methyl groups (Figure 1.3), while the mechanism of de-methylation is less clear. 
De novo DNA methyltransferases that add methyl groups to unmethylated CpGs are 
DNMT3A and DNMT3B (Okano et al., 1998; Okano et al., 1999).  As such, these 
enzymes are responsible for the establishment of DNA methylation during early 
development and differentiation, in conjunction with other enzymes such as DNMT3L, 
and other regulatory  complexes (Lehninger et al., 2005).  DNA methylation is heritable 
throughout successive rounds of DNA replication due to the action of DNMT1, the 
maintenance methyltransferase, which recognizes hemi-methylated DNA and adds a 
methyl group to the daughter strand (Figure 1.3).  With regards to DNA demethylation, 
our current understanding suggests that passive demethylation occurs through the absence 
of maintenance methylation (DNMT1) (Morgan et al., 2005), while active demethylation 
either utilized a multistep DNA repair mechanism, or converts methylated cytosines to 
different compounds to facilitate direct removal.  These modifications include DNA 
glycosylation or 5‘hydroxy  methylation through the Tet family of enzymes (Morgan et al., 
2005; Schar and Fritsch, 2011).    
 Acquisition of DNA methylation occurs in the developing gametes and is acquired 
differentially between the two parental genomes (Hajkova et al., 2002; Kageyama et al., 
2007) (Figure 1.4).  Following fertilization, there is a wave of demethylation that erases 
gamete-specific methylation patterns and ensures the totipotency of the early embryo 
(Mayer et al., 2000; Dean et al., 2001; Santos et al., 2002; Beaujean et al., 2004). The
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Figure 1.3: DNA Methylation by DNMTs
DNA methylation is performed by DNA methyltransferases. CpG dinucleotides are 
methylated de novo by DNMT3A/B in conjunction with DNMT3L.  Hemi-methylated 
DNA is fully methylated by DNMT1 following DNA replication. Me: methyl group. 
Adapted from http://images.yourdictionary.com/DNA.
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Figure 1.4: DNA Methylation Throughout Germ Cell and Preimplantation Embryo 
Development.
Acquisition of DNA methylation begins in the developing oocyte and spermatocytes, and 
is complete prior to fertilization.  At fertilization, the paternal pronucleus undergoes 
active demethylation, while the maternal pronucleus undergoes passive demethylation 
throughout the early  stages of preimplantation development.  Imprinted methylation is 
maintained throughout preimplantation development, despite the demethylation occurring 
in the rest  of the genome.  Superovulation occurs during the time of imprint acquisition, 
and embryo culture takes place during maintenance of genomic imprinting.  Figure 
adapted from Mann, M.R.W. and Bartolomei, M.S., Genome Biology. 3(2) 1003.1-1003.4 
2002.
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paternal genome is actively  demethylated within hours after fertilization, while the 
maternal genome is passively demethylated during early cleavage divisions in a 
replication-dependent manner through a lack of maintenance methylation (Rougier et al., 
1998; Oswald et al., 2000).  The end result  is that the two parental genomes undergo 
extensive changes in global methylation during preimplantation development.  Post-
implantation, de novo methylation gradually increases in accordance with cellular 
differentiation (Monk et al., 1987).
1.1.3.3 Long Non-Coding RNA
 Studies of the human genome have revealed that only  1-2% of the DNA sequences 
carry  protein-coding information, leading scientists to question the function of the other 
98% (Lee, 2010).  Recently, a class of RNAs have been discovered that are not 
transcribed into protein products, but instead play  an important  role in epigenetic 
regulation (Guttman et al., 2009; Khalil et  al., 2009).  Transcription of these long non-
coding RNAs occurs throughout the genome, overlapping with, and between other 
protein-coding genes (Carninci et al., 2005; Kapranov et al., 2007). Many long non-
coding RNAs have been identified which show significant  evolutionary conservation 
(Guttman et al., 2009) and differences in expression across tissue types indicating a 
functional role in genomic regulation (Dinger et al., 2008; Guttman et al., 2009).  Long-
non coding RNAs can affect the expression of other protein-coding genes using both cis- 
and trans-acting mechanisms.  They can associate with chromatin modifying complexes, 
resulting in the addition of activating or repressive histone marks to these areas (Bracken 
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et al., 2006; Dinger et al., 2008; Ku et al., 2008; Nagano et al., 2008; Pandey et al., 2008), 
or RNA-binding proteins and transcription factors, resulting in recruitment to specific 
areas of the genome in cis or trans (Feng et al., 2006; Rinn et al., 2007; Wang et al., 2008; 
Zhao et al., 2008; Khalil et al., 2009).  Additional evidence suggests that elongation of the 
transcript, or the act of transcription through the domain itself is important for domain 
regulation.  While the exact mechanism is unknown, silencing may occur though the 
interaction of RNA polymerase and the tethered non-coding RNA, leading to recruitment 
of repressive chromatin complexes to areas of elongation in cis (Mancini-Dinardo et  al., 
2006), or through the interaction of the transcript with mRNAs in the domain generating 
double-stranded RNA, thereby  activating RNA interference mechanisms (Dykxhoorn et 
al., 2003).  
1.1.3.4 Nuclear Territories and Chromatin Looping
 Both histone modifications and DNA methylation can result in local alterations of 
chromatin structure, but also alter gene expression on a larger scale.  Within the nucleus, 
chromosomes are organized into a number of chromosome territories (CTs) and it was 
initially postulated that active regions (euchromatin) lie in chromatin loops at the surface 
and inactive regions are located deep within the territories (heterochromatin) (Zirbel et 
al., 1993) (Figure 1.1).  This sequestration of inactive regions to the core of the territory 
presumably prevents access to the transcriptional machinery, and these heterochromatic 
regions replicated later in S phase than their euchromatin counterparts (Gilbert, 2002). 
We now know that gene-poor regions tend to localize to the core of CTs, while gene-rich 
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regions tend to cluster at the surface (Shopland et al., 2006).  Studies also suggest that 
“looping out” of specific chromatin regions is associated with activation of transcription, 
and that these active regions, on the same or on different chromosomes, interact with one 
another (Chambeyron and Bickmore, 2004; Wurtele and Chartrand, 2006).  In addition, 
regions of constitutively high activity are often found “looped out”, in regions outside 
their normal CT (Mahy et al., 2002; Brown et al., 2006).  However, not all “looped out” 
regions of chromatin are active, but  instead represent regions poised for transcription, 
with additional chromatin modifications necessary  for active transcription to occur (Heard 
and Bickmore, 2007).  
1.2 - Genomic Imprinting
1.2.1 Brief History of Genomic Imprinting
 Genomic imprinting is an epigenetic phenomenon whose investigation is still in 
its infancy.  The term “imprint” was originally coined by H. V. Crouse from experiments 
on the insect Sciara. During sperm, but not oocyte development, Sciara selectively 
eliminate the paternal X chromosome (Crouse, 1960).  After fertilization, one or both 
remaining X chromosomes are eliminated, depending on the sex of the offspring.  This 
was the first description of the ability  of a cell to distinguish between maternal and 
paternal chromosomes, and Crouse used the term “imprint” to describe the phenomenon 
that marked a given chromosome “based solely  on the sex of the germline through which 
the chromosome had been inherited” (Crouse, 1960).   
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 The field of genomic imprinting follows from experiments on mammalian 
parthenogenotes, embryos possessing maternal but not paternal genomes.  Activation of 
oocytes in non-mammalian species resulted in the production of viable offspring 
(Engelstadter, 2008).  However, mammalian parthenotes are unable to complete 
development and die (Kaufman et al., 1977), suggesting an unequal contribution of 
maternal and paternal alleles.  This was confirmed by  further experiments constructing 
uniparental embryos, either from exclusively maternal or exclusively paternal DNA. 
Work by McGrath and Solter demonstrated that mammalian embryos generated from 
either two female pronuclei (gynogenotes) or two male pronuclei (androgenotes) fail to 
complete normal embryogenesis, dying shortly after implantation, confirming that 
contributions from both maternal and paternal chromosomes are necessary to support 
mammalian development (Markert, 1982; McGrath and Solter, 1984; Surani et al., 1984). 
Since then, many imprinted genes have been identified, and while general mechanisms 
regulating this phenomenon have been elucidated, much remains to be discovered about 
the control of imprinted gene expression.
 
1.2.2 Overview of Genomic Imprinting
 Genomic imprinting is a phenomenon whereby certain genes are expressed 
exclusively  from one parental allele (Figure 1.5).  To date, there are approximately 150 
known imprinted genes ((http://www.mousebook.org/catalog.php?catalog=imprinting;
(Morison et  al., 2005)).  Imprinted genes are often found clustered together in regions 
known as imprinting domains, where multiple imprinted genes are under the control of
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Figure 1.5:  Genomic Imprinting
Expression from both the maternal and paternal alleles is characteristic of the majority of 
the genes in the genome.  A subset of genes are expressed in a parent-of-origin specific 
manner.  Some are expressed from the paternal allele, and methylated on the maternal 
allele, while other are expressed from the maternal allele and methylated on the paternal 
allele.
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one or a few regulatory  elements (Reinhart and Chaillet, 2005).  Within imprinted 
domains, genes may  be expressed from either the maternal or paternal allele, and, 
paradoxically, non-imprinted genes may be interspersed within these domains.  In 
addition, some genes within a given imprinted domain may display imprinted expression 
in certain tissues, but not in others.  Many imprinted genes play critical roles in the 
development of the embryo, or influence behaviour after birth (Varrault et al., 2006; 
Wilkinson et al., 2007; Champagne et al., 2009), and their dysregulation is linked to a 
group of human diseases called imprinting disorders.  
 The acquisition and maintenance of genomic imprinting is controlled through 
various epigenetic mechanisms.  DNA methylation, histone modifications and chromatin 
looping all play a role in imprinted gene regulation.  Imprinted domains are coordinately 
regulated in cis by  DNA elements known as imprinting centers, or imprinting control 
regions (ICR) (Rodenhiser and Mann, 2006).  These ICRs are often rich in CpG 
dinucleotides, which can be methylated on the 5’ carbon, providing binding sites for 
various proteins involved in imprinting regulation (Wan and Bartolomei, 2008) and are 
differentially methylated depending on their parent-of-origin (Reinhart and Chaillet, 
2005).
 Although the specific mechanisms controlling the acquisition and maintenance of 
genomic imprinting at each imprinting domain is not known, research into a few key 
domains has led to the discovery of two key  regulatory models, the insulator/enhancer 
model and long non-coding RNA-mediated silencing model (Wan and Bartolomei, 2008; 
Koerner et al., 2009) (Figure 1.6, Table 1.1).
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Figure 1.6:  Models of Epigenetic Regulation
(A) The H19 imprinted domain is an example of the insulator/enhancer model of genomic 
imprint regulation.  The maternal allele is unmethylated at the imprinting control center 
(ICR), allowing insulator (Ins) proteins, such as CTCF to bind.  Binding of these insulator 
proteins prevents the interaction of the enhancer elements (E) with the upstream Igf2 gene 
promoter, allowing interaction with the H19 promoter.  H19 is expressed and Igf2 is 
repressed.  On the paternal allele, methylation (Me) of the ICR represses H19 expression 
and prevents binding of insulator proteins.  This allows the downstream enhancer 
elements to interact with the Igf2 promoter, resulting in expression at this locus. 
Methylation spreads to the H19 promoter, preventing interaction with the enhancers.
(B) The Kcnq1ot1 imprinted domain is an example of the long non-coding RNA-
mediated silencing model.  On the maternal allele, the ICR is methylated, preventing 
expression of Kcnq1ot1 non-coding RNA.  Lack of expression of the long non-coding 
RNA results in an active domain, and expression of Kcnq1, Cdkn1c and other genes.  The 
paternal allele is unmethylated at the ICR, allowing expression of Kcnq1ot1, which in 
turn represses of the domain.
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Table 1.1:  Imprinted Genes, their Imprinted Domains and Associated Human 
Disorders
Gene Expression Regulatory 
Model
Imprinted 
Domain
(Human)
Human 
Syndrome
H19 Maternal Insulator/
Enhancer
11p15.5 Beckwith-
Wiedemann 
Syndrome, 
Silver-Russell 
Syndrome
Peg1/Mest Paternal Unknown 7q32 Silver-Russell 
Syndrome
Snrpn Paternal Long non-
coding RNA-
mediated 
silencing
15q11-13 Angelman 
Syndrome, 
Prader-Willi 
Syndrome
Kcnq1ot1 Paternal Long non-
coding RNA-
mediated 
silencing
11p15.5 Beckwith-
Wiedemann 
Syndrome
Peg3 Paternal Unknown 19q13.4 None
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1.2.3 Imprinted Domains of Interest, their Regulation and Associated Syndromes
1.2.3.1 H19 Imprinted Domain 1.2.3.1.1 Structure and Regulation of the Domain
 One of the first imprinting domains to be discovered, and one of the most well 
understood, is the H19 imprinted domain, which is regulated through an enhancer/ 
insulator model.  This domain contains an imprinting control region (ICR), located 2 kb 
upstream of the H19 transcription start  site, and enhancer elements located downstream of 
the H19 gene, all of which are necessary  for genomic imprinting in this domain (Figure 
1.6) (Srivastava et al., 2000).  Differential methylation is observed at the H19 ICR, as 
well as at the Igf2 DMRs on the maternal and paternal alleles.  However, only the H19 
ICR acquires gamete-derived DNA methylation.  On the maternal allele, the ICR is 
unmethylated, allowing for binding of the insulator protein CTCF (Figure 1.6).  CTCF 
binding forms a long-range intrachromosomal loop and recruits chromatin modifying 
complexes that result  in repressive histone modifications at the Igf2 promoter, 
suppressing gene expression (Li et al., 2008).  Essentially, CTCF binding acts as an 
insulator, preventing the interaction between downstream enhancer elements and the 
upstream Igf2 gene promoter, resulting in silencing of Igf2, and expression of H19 on the 
maternal allele (Hark et al., 2000).  On the paternal allele, DNA methylation of the 
upstream ICR prevents CTCF binding, allowing enhancer elements to interact with the 
Igf2 gene promoter, resulting in expression of Igf2 (Figure 1.6).  Methylation at the ICR 
also directs methylation at  the H19 promoter, resulting in silencing of the H19 gene 
(Srivastava et al., 2000; Kaffer et al., 2001).  
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 In the mouse, four CTCF binding sites exist in the H19 ICR.  Mutation of one of 
these four sites results in biallelic expression of Igf2 (Pant et al., 2004).  Abolishing all 
four sites results in a dramatic shift in histone modifications (Han et al., 2008).  On the 
maternal allele, there is loss of the activating modifications H3K9 acetylation and H3K4 
methylation at the H19 ICR and promoter, and loss of repressive H3K27 trimethylation at 
the Igf2 promoter and DMRs.  In addition, the maternal allele acquires a paternal histone 
configuration, with activating H3K9 acetylation and H3K4 methylation at the Igf2 
promoter and DMRs, and repressive H3K27 trimethylation at the H19 promoter (Han et 
al., 2008).  
 Targeted deletion of the H19 ICR results in activation of H19 and reduced 
expression of Igf2 when inherited paternally, while maternal deletion reduces H19 
expression and activates Igf2 expression (Thorvaldsen et al., 1998). Deletion of the H19 
ICR and transcription unit of the H19 gene (Leighton et al., 1995), or of the transcription 
unit alone (Ripoche et al., 1997) results in biallelic expression of Igf2.  Phenotypic 
consequences of these dysregulations result in embryonic growth restriction, or an 
overgrowth phenotype.
1.2.3.1.2 Beckwith-Wiedemann Syndrome and the H19 Domain
 The similarity of the overgrowth phenotype noted above to the human overgrowth 
disorder Beckwith-Wiedemann Syndrome (BWS; OMIM  #130650) led to the 
identification of a causative relationship  between the H19 domain and BWS.  Clinically, 
BWS is an overgrowth disorder characterized by  macroglossia, abdominal wall defects, 
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postnatal growth above the 90th percentile, neonatal hypoglycemia (Elliott et al., 1994) 
and an increased incidence of Wilm’s tumour (DeBaun and Tucker, 1998; Rump et al., 
2005), and is estimated to affect  1 in 13 700 children (Shuman et al., 1993).  A number of 
studies have linked perturbations of the H19 domain with clinical BWS in human patients 
(Gicquel et al., 2003; Arnaud and Feil, 2005; Chang et al., 2005; Doornbos et al., 2007). 
Hypermethylation of the maternal allele, microdeletions of the CTCF binding sites and 
resulting overexpression of IGF2 has been shown in BWS patients, (Brown et al., 1996; 
Sparago et al., 2004; Prawitt et  al., 2005; Cerrato et al., 2008; Riccio et al., 2009). 
Overall, 5% of BWS patients possess imprinting defects at the maternal H19 imprinting 
center (Choufani et al., 2010).
 The H19 domain has also been implicated in the development of another 
imprinting disorder, Silver-Russell syndrome, discussed below (Chou et al., 2004; 
Kagami et al., 2007; Eggermann et al., 2010).
1.2.3.2 Kcnq1ot1 Imprinted Domain
1.2.3.2.1 Structure and Regulation of the Domain
 The Kcnq1ot1 imprinted domain is regulated by long non-coding RNA-mediated 
silencing, through the non-coding RNA Kcnq1ot1.  The imprinting control region for this 
domain is located in intron 11 of the Kcnq1 gene and is oriented in the antisense direction 
(Figure 1.6).  The promoter region of Kcnq1ot1 non-coding RNA is embedded in the ICR 
(Mancini-DiNardo et al., 2003; Pandey et al., 2004).  The ICR is unmethylated on the 
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paternal allele, resulting in transcription of Kcnq1ot1 through the imprinted domain. 
Recent studies from our lab have suggested that this transcript may extend up  to 470 kb in 
length (unpublished data).  It is currently  unclear if the act of Kcnq1ot1 RNA 
transcription through the domain results in recruitment of protein complexes that then 
silence the domain, or if the non-coding RNA itself plays a role in silencing of the 
domain, similar to the mechanism of X-inactivation through Xist.  However, recent 
studies show that Kcnq1ot1 helps to move the silenced allele into a nuclear compartment 
characterized by repressive histone marks (Pandey et al., 2008; Terranova et al., 2008).  
 Methylation at the Kcnq1 ICR on the maternal allele results in repression of 
Kcnq1ot1 transcription, allowing expression of Kcnq1, Cdkn1c and other maternally 
expressed genes. Further complexity exists at this domain as a number of genes display 
differential imprinted expression between embryonic and extraembryonic tissues (Lewis 
et al., 2004).  
1.2.3.2.2 Beckwith Wiedemann Syndrome and the Kcnq1ot1 Domain
 Mutations of the KCNQ1OT1 imprinted domain are thought to account for ~50% 
of molecular defects in patients with BWS (Weksberg et  al., 2001; Cooper et al., 2005), 
most of which are epigenetic, and not genetic, in nature.  In these cases, BWS results 
from loss of methylation at the KCNQ1OT1 ICR on the maternal allele, causing biallelic 
expression of KCNQ1OT1 and biallelic repression of KCNQ1 and CDKN1C (Horike et 
al., 2000).  CDKN1C is a cyclin-dependent kinase inhibitor, and is a negative regulator of 
the cell cycle (Matsuoka et al., 1996; Tsugu et al., 2000).  Although the exact molecular 
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etiology of BWS has not yet been confirmed, CDKN1C is an attractive candidate gene, as 
~10% of patients with BWS harbour mutations of this gene (Choufani et al., 2010).  
1.2.3.3 Peg1/Mest Imprinted Domain
1.2.3.3.1 Structure and Regulation of the Domain
 The Peg1/Mest imprinted domain is located on mouse chromosome 6 and human 
chromosome 7.  A CpG island spanning from the putative promoter region to exon 1 is 
methylated in a parent-of-origin specific manner: the maternal allele is methylated, while 
the paternal allele remained unmethylated (Riesewijk et al., 1997; Nishita et al., 1999). 
The Peg1/Mest imprinted domain contains three confirmed imprinted genes, two maternal 
(Klf14 and Copg2) and one paternally expressed gene (Peg1/Mest). 
 Mechanisms regulating the Peg1/Mest imprinted domain remain largely  unknown, 
however neither YY1 nor CTCF are known to play a role.  The only study  to date 
investigating regulation specifically  at this locus showed that TIF1beta and its interaction 
with the chromatin modifier HP1 is essential for maintaining the repressed state of the 
silenced allele, characterized by DNA methylation, H4K20 trimethylation, and H3K9 
trimethylation.  Interestingly, this was only necessary at the repressed allele, and a loss of 
this interaction resulted in the silenced allele acquiring an active phenotype characterized 
by DNA hypomethylation, and loss of H3K9 trimethylation with gain of H3K27 
trimethylation (Riclet et al., 2009).
24
1.2.3.3.2 Silver-Russell Syndrome and the Peg1/Mest Domain
 Misregulation of the PEG1/MEST domain has been proposed as one of the 
causative agents of Silver-Russell Syndrome (SRS) (Hannula et al., 2001; Chou et al., 
2004; Kagami et al., 2007).  SRS is a growth retardation syndrome characterized by 
intrauterine and postnatal growth restriction, low birth weight, triangular shaped face, 
pointed chin and body asymmetry (Silver et al., 1953; Russell, 1954).  Up to 44% of SRS 
cases are associated with hypomethylation of the 11p15 region (Eggermann et al., 2010), 
which harbours imprinted genes such as H19 and IGF2, while maternal uniparental 
disomy of chromosome 7 is implicated in approximately 5% of cases of SRS (Kotzot  et 
al., 1995; Eggermann et al., 2010), which harbours the PEG1/MEST gene.  Paternal 
inheritance of a null Peg1/Mest allele results in severe IUGR in the offspring, while 
maternal inheritance of the null allele does not (Lefebvre et al., 1998).  On the other hand, 
high levels of Peg1/Mest expression has been found in adipocytes from obese mice, and 
transgenic overexpression of Peg1/Mest results in enlargement of adipocytes (Takahashi 
et al., 2005).  This suggests a key role for Peg1/Mest in regulating fetal growth.
1.2.3.4 Snrpn Imprinted Domain
1.2.3.4.1 Structure and Regulation of the Domain
 The Snrpn imprinted domain contains both maternally and paternally  expressed 
genes, and is regulated by a bipartite imprinting center located within the Snrpn gene. 
The primary imprinting center (IC) for this domain, the Snrpn ICR, consists of an ~35kb 
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region within the Snrpn promoter and exon 1.  The Snrpn ICR is differentially methylated 
in oocytes and sperm, with maternal specific methylation maintained into adulthood 
(Shemer et al., 1997).  Two distinct  regions have been identified within this IC, PWS-IC 
and AS-IC, giving it a bipartite structure.  Mutations in the AS-IC result in Angelman 
Syndrome (AS; OMIM #105830), while mutations in the PWS-IC result in Prader-Willi 
Syndrome (PWS; OMIM  #176279).  The PWS-IC is necessary for a paternal epigenetic 
pattern (El-Maarri et  al., 2001), resulting in expression of MKRN3, MAGEL2, NDN, and 
SNRPN.  A maternal epigenetic pattern with expression of UBE3A and ATP10A requires 
the AS-IC, however in the absence of both PWS- and AS-ICs a maternal epigenotype is 
observed (Horsthemke and Wagstaff, 2008), indicating that a maternal epigenetic pattern 
is the default state of this domain.  The current model of regulation at the Snrpn imprinted 
domain indicates that in spermatocytes, the PWS-IC and AS-IC are unmethylated, while 
in oocytes, methylation at the PWS-IC is directed by protein complex (yet to be 
identified) binding at the AS-IC.  Following fertilization, maternal methylation of the 
PWS-IC is maintained, while the paternal allele remains unmethylated.  On the 
unmethylated paternal allele, Snrpn generates a long non-coding RNA (Snrpn-long-
transcript [Snrpnlt] also known as Ube3a-as) that  harbours a number of snoRNAs, and 
directs expression of the other paternally expressed genes (Mkrn3, Magel2, Ndn) through 
an unknown mechanism.  Expression of the Snrpnlt transcript results in silencing of the 
Ube3a gene in the brain.  Methylation at the PWS-IC on the maternal allele prevents 
activation of paternally expressed genes including the Snrpnlt transcript, allowing 
expression of Ube3a from the maternal allele (Horsthemke and Wagstaff, 2008).
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1.2.3.3.2 PWS, AS and the Snrpn Domain
 The SNRPN imprinted domain was initially discovered from studies mapping the 
chromosomal regions implicated in Prader-Willi and Angelman Syndromes to the 
15q11-13 region.  It is estimated that approximately  70% of patients harbour a deletion in 
this region (Horsthemke, 1997).  Maternally  inherited deletions of the AS-IC result in the 
AS, and paternally inherited deletions of the PWS-IC result in PWS (Knoll et al., 1989). 
Maternal and paternal uniparental disomy (Nicholls et al., 1989; Mascari et al., 1992), or 
uniparental methylation patterns (Buiting et al., 1990; Buiting et al., 1994) have also been 
reported in patients that do not harbour deletions.
 PWS is a neurological disorder characterized by  hypotonia and failure to thrive in 
the neonatal period, hyperphagia in early  childhood leading to obesity  as well as 
hypogonadism, short stature, behavioural problems and varying levels of mental 
retardation (Goldstone, 2004).  AS is a neurological disorder characterized by 
microcephaly, ataxia, severe mental retardation, absence of speech, sleep disorders, and 
seizure disorders (Williams et  al., 2006).  While no single gene has been found solely 
responsible for the development of PWS, biallelic repression of the UBE3A gene in the 
brain has been identified as the causative disruption in AS (Horsthemke and Wagstaff, 
2008).    
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1.2.3.5 Peg3 Imprinted Domain
 The Peg3 imprinted domain consists of a 500 kb region, and contains three 
maternally expressed (Zim1, Zim2, and Zim3) and 3 paternally expressed genes (Peg3, 
Usp29, and Zfp264).  The transcriptional start sites of Peg3 and Usp29 lie very  close to 
one another, with a bidirectional promoter in the intervening region, directing expression. 
A 3.8 kb region surrounding both transcriptional start sites contains a CpG island that is 
differentially methylated in sperm and oocytes, and is maintained into adulthood (Li et 
al., 2000; Huang and Kim, 2009).  Methylation of the CpG island located within the Peg3 
promoter and exon 1 on the maternal allele results in repression of Peg3 and the other 
paternally expressed genes, while the unmethylated paternal allele expresses these genes 
(Huang and Kim, 2009).  Two conserved sequence elements have been identified within 
this 3.8 kb region and have been shown to act as binding sites for the chromatin modifier 
YY1 (Kim et al., 2007; Kim and Kim, 2008).  Expression of YY1 is necessary for 
establishment of maternal methylation patterns and binding of YY1 to the maternal allele 
has been suggested to target the region for de novo methylation (Kim et al., 2009). 
 The Peg3 gene is involved in modulating growth and behaviour.  Loss of Peg3 
expression in mice results in growth retardation, an increase in total body fat, lower 
metabolic rate and lower core body temperature, and overall delayed development 
(Curley  et al., 2005).  In addition, an increase in apoptosis in the developing brain through 
p53-mediated pathways (Broad et al., 2009) and aberrant maternal behaviour 
(Champagne et al., 2009) is observed with loss of Peg3 expression.  No human imprinting 
disorders have been associated with aberrant imprinting of the Peg3 locus to date.
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1.2.4 Acquisition of Genomic Imprinting in Germ Cells
 Genomic imprints are established at different stages of development in male and 
female germ cells, and each imprinted domain acquires its mark at slightly different times 
(Figure 1.4).  In primordial germ cells, a wave of DNA demethylation occurs, and 
imprinted methylation marks on the maternal and paternal alleles are erased (Hajkova et 
al., 2002; Lee et  al., 2002; Yamazaki et al., 2003).  Parent-of-origin specific methylation 
patterns are then re-established, leading to the presence of maternal-specific methylation 
patterns in oocytes, and paternal-specific methylation patterns in spermatocytes. 
Although the exact imprinting mark is unknown, thus far, DNA methylation is the most 
well examined, and the most likely candidate, and its pattern of acquisition in developing 
germ cell is well known for a number of imprinted loci (Lucifero et al., 2002).
1.2.4.1 Acquisition in Oocytes
 Parent-of-origin specific genomic imprints must be erased in the developing fetus 
in order to establish maternal genomic imprints in the developing oocyte.  This erasure 
occurs between day 10.5 and day 11.5 in mouse primordial germ cells (Lee et al., 2002). 
Reestablishment of maternal DNA methylation occurs during the postnatal growth phase 
of oogenesis, and is complete by the MII stage (Lucifero et  al., 2002).  Maternally 
methylated ICRs acquire de novo methylation, while paternally methylated ICRs must be 
protected from methylation.  In the former case, the de novo methyltransferase DNMT3A 
functions in conjunction with DNMT3L to methylate ICRs in the developing oocyte 
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(Hata et al., 2002; Lucifero et al., 2004).  Acquisition of methylation occurs 
asynchronously for different imprinted loci (Lucifero et al., 2004), and this acquisition is 
correlated with increasing oocyte diameter (Hiura et al., 2006).  The latter process is 
thought to occur by binding of transcription factors and other unknown proteins to the 
ICRs, blocking the action of the de novo methyltransferases at these ICRs, thereby 
protecting them from DNA methylation (Brandeis et al., 1994).
1.2.4.2 Acquisition in Spermatocytes
 Acquisition of methylation imprints in the male germ line occurs during pre-natal 
development, between 15.5 and 18.5 days of gestation.  Acquisition begins in 
prospermatogonia and is completed before the end of the pachytene phase of meiosis. 
(Kafri et al., 1992; Walsh et al., 1998; Davis et al., 1999; Davis et al., 2000; Ueda et al., 
2000; Lees-Murdock et al., 2003).  De novo methylation is mediated by DNMT3A and 
3B, in conjunction with DNMT3L, similar to what is observed in oocytes (Kelly and 
Trasler, 2004).  While some overlap  in the function of DNMT3A and 3B has been 
suggested, both are required for proper imprint acquisition in the developing male germ 
cells (Okano et al., 1999).   
1.2.5 Maintenance of Genomic Imprinting
 Following fertilization, dramatic epigenetic remodeling occurs on both the 
maternal and paternal chromosomes, which is critical to the establishment of totipotency, 
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the ability of an individual embryonic cell to generate all cell types in an organism 
(Edwards and Beard, 1997) (Figure 1.4).  Immediately after fertilization, remodeling of 
the sperm chromatin begins and consists of the replacement  of protamines by acetylated 
histones, and active, genome-wide demethylation (Oswald et al., 2000).  On the other 
hand, the maternally inherited genome is passively demethylated over the course of the 
next several rounds of cell division, which is thought to be due to a lack of maintenance 
methylation (Carlson et al., 1992).  During this early stage of preimplantation 
development, methylation is lost from all areas of the genome except imprinted genes and 
retroviral sequences (Lucifero et al., 2004).  
 Maintenance of DNA methylation at imprinted loci relies on DNMT1, which 
recognized and methylates hemi-methylated DNA (Fatemi et al., 2001).  A number of 
isoforms of DNMT1 have been identified (Pradhan et al., 1997).  The longer isoform, 
DNMT1s is most predominant in somatic cells (Hermann et al., 2004), while the shorter 
DNMT1o is present in growing oocytes and during preimplantation development (Howell 
et al., 2001).  The majority of the time, DNMT1s is localized within the nucleus, 
associated with the DNA replication machinery  at replication foci during S-phase (Szyf, 
2001).  During preimplantation development, DNMT1s is excluded from the nucleus, 
allowing for passive demethylation of the maternal genome (Carlson et al., 1992).  The 
oocyte-specific isoform localizes to the nucleus at the 8-cell stage, and along with 
DNMT1s activity, is thought to be responsible for maintaining methylation at imprinted 
loci throughout preimplantation development (Ding and Chaillet, 2002).  In addition, 
disruption of number of maternal-effect genes, that are transcribed and stored in the 
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developing oocyte and are required for preimplantation development, have been shown to 
result in loss of methylation at a number of imprinted loci including Snrpn, Peg3, Peg1/
Mest and H19 (Nakamura et al., 2007; .Li et al., 2008).
 As preimplantation development proceeds, different cell lineages begin to emerge. 
As such, de novo methylation begins around the time of implantation to allow for 
differentiation of embryonic and extraembryonic lineages, and further differentiation into 
the numerous tissue types of the adult organism (Monk et al., 1987).  
1.3 - Assisted Reproductive Technologies 
1.3.1 Prevalence of ARTs and Their Sequelae
 Since the first reported birth through the use of assisted reproductive technologies 
(ART) in 1978, the use of these technologies has dramatically increased.  It is estimated 
that 1-3% of total births in developed countries result from some form of ART (Klemetti 
et al., 2002; Wright et al., 2008).  The field of assisted reproduction is broad and consists 
of a variety of techniques, from non-invasive procedures such as ovarian 
hyperstimulation, to highly  invasive interventions such as intracytoplasmic sperm 
injection (ICSI) of retrieved oocytes.  However, all involve the manipulation of human 
gametes and preimplantation embryos, and many involve embryo culture during 
preimplantation development.  As described above, germ cell and preimplantation 
development are critical periods in the erasure and maintenance of proper imprinted 
methylation patterns (Santos and Dean, 2004).  As such, the timing of ARTs during these 
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critical periods provides a mechanism for the disruption of imprinting establishment and 
maintenance through the environmental insult caused by the use of these procedures. 
 In addition to epigenetic consequences of ARTs, a number of other sequelae have 
been observed.  Couples who undergo ART carry  intrinsic subfertility, which itself is a 
risk factor for early pregnancy loss (Gray  and Wu, 2000), and are on average 5 years 
older than those who conceive naturally  (Katalinic et al., 2004).  In addition, ART carries 
a higher risk of multiple births, which itself is associated with higher rates of prematurity, 
low birth weight, neonatal mortality, congenital malformations and disability  (Koivisto et 
al., 1975; Fauser et al., 2005).  However, all of the risk associated with ARTs cannot be 
attributed to intrinsic subfertility of the couples and risk of multiple births.  Singleton 
pregnancies occurring through the use of ARTs have an increased risk of prematurity, low 
birth weight, neonatal mortality, and neonatal intensive care unit admission (Helmerhorst 
et al., 2004; Jackson et al., 2004; McDonald et al., 2005), as well as an increased risk of 
congenital malformations (Lancaster, 1985; Rimm et al., 2004; Bonduelle et  al., 2005; 
Hansen et  al., 2005; Klemetti et al., 2005; Olson et al., 2005), and cerebral palsy (Ericson 
et al., 2002; Lidegaard et al., 2005; Hvidtjorn et al., 2006) and epilepsy  (Ericson et al., 
2002; Sun et al., 2007).  Most important for the studies contained in this thesis is the 
increase in the incidence of the human imprinting disorders Angelman Syndrome (AS) 
(Cox et al., 2002; Orstavik et al., 2003) and Beckwith-Wiedemann Syndrome (BWS) 
(DeBaun et al., 2003; Gicquel et al., 2003; Maher et al., 2003) with the use of ARTs. 
 The incidence of AS in the general population is approximately  one case per 
16,000 births, with only 5% of these cases related to imprinting abnormalities (Cox et al., 
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2002; Williams, 2007).  As the prevalence of AS is low, large-scale studies containing 
sufficient numbers of patients have been difficult  to achieve.  However, seven cases of AS 
following the use of ARTs have been reported to date, 5 of which displayed imprinting 
abnormalities (71%) (Cox et al., 2002; Orstavik et al., 2003; Ludwig et al., 2005; Sutcliffe 
et al., 2006).  This is a significantly higher proportion than in the non-ART population.  
 Beckwith-Wiedemann Syndrome is a second imprinting disorder that is 
associated with ARTs and is estimated to affect  1 in 13 700 children (Shuman et al., 
1993).  As with AS, in a number of studies, parents of children with BWS were more 
likely to have undergone fertility  treatments than the general population (Chang et al., 
2005; Doornbos et al., 2007) and a higher incidence of BWS was seen in ART children 
than in the general population (Gicquel et al., 2003; Arnaud and Feil, 2005).  The link 
between BWS and ARTs has been strongly  established, and the relative risk of ART use is 
4-9 times greater for BWS patients.  Silver-Russell Syndrome has also been associated 
with the use of ARTs (Hitchins et al., 2001; Svensson et  al., 2005; Bliek et al., 2006; 
Kagami et  al., 2007; Galli-Tsinopoulou et al., 2008; Chopra et al., 2010).  Taken all 
together, ARTs may impose inherent risk for normal development.  
 Attributing any of these risks to specific forms of ART has proven difficult, and as 
procedures vary from clinic to clinic, and protocols vary  between patients, most studies 
simply  group the observed effects under the umbrella of “ARTs”.  The remainder of this 
work will focus specifically on the effects of superovulation and embryo culture on 
genomic imprinting.
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1.3.2 Superovulation and Effects on Genomic Imprinting
Superovulation, or ovarian stimulation, is the administration of exogenous 
hormones resulting in the concurrent maturation of a large number of ovarian follicles to 
produce an increased number of ovulated oocytes when compared to spontaneous 
ovulation (Hrometz and Gates, 2009)  It is commonly  used in both the treatment of 
human infertility  (Jewelewicz, 1976; Lonergan, 2007), and in the production of livestock 
(Seidel, 1981) and laboratory animals (Ozgunen et al., 2001) to obtain large numbers of 
offspring.  Ovarian stimulation regiments differ between clinics, and within clinics 
between patients, with varying doses and types of hormones (Reid et al., 1988; Edwards, 
2007).
It has been speculated that ovarian stimulation may prevent atresia of sub-optimal 
follicles, leading to ovulation of low-quality oocytes (Van der Auwera and D'Hooghe, 
2001), or may accelerate the growth rate of ovarian follicles (Baerwald et al., 2009). 
Global perturbations in DNA methylation have been observed following superovulation 
(Shi and Haaf, 2002).  In the case of genomic imprinting, shortened oocyte maturation 
time may lead to improper or incomplete acquisition of imprinting marks on the maternal 
alleles.  Loss of maternal methylation following superovulation has been observed in 
individual human oocytes (Sato et  al., 2007; Khoueiry et  al., 2008).  In addition, it has 
been suggested that both maternal and paternal alleles may be affected by  superovulation 
(Sato et al., 2007; Stouder et al., 2009), however, the frequency and severity of this 
disruption remains unknown.  Regardless, for both human imprinting disorders BWS and 
AS, children have been identified where the only form of ARTs used in the treatment of 
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their parents’ infertility was ovarian stimulation (Young et al., 1998; Chang et al., 2005; 
Ludwig et al., 2005).
1.3.3 Embryo Culture and Effects on Genomic Imprinting
 The suggestion that culture of the early embryo may lead to epigenetic 
perturbations, specifically with respect to genomic imprinting, was discovered in the 
mouse model.  A subset of cultured embryos (analyzed in pools) displayed biallelic 
expression of H19, which was maintained in extraembryonic tissues post-implantation 
(Sasaki et al., 1995).  Since then, it has been determined that preimplantation culture of 
mouse embryos results in biallelic expression of the H19 gene and loss of imprinted 
methylation at the H19, Snrpn, and Peg3 genes in blastocyst stage embryo (Doherty et al., 
2000; Khosla et al., 2001; Fernandez-Gonzalez et  al., 2004; Mann et al., 2004; Fauque et 
al., 2007).  However, the extent of this effect, measured by the percent of embryos 
affected, varied with the type of culture medium used.  This lead to the hypothesis that 
embryo culture media vary in their ability to maintain the correct epigenetic landscape of 
the early embryo (Doherty et al., 2000).  However, as with the previous study, the authors 
noted that not all embryos were affected by  culture - some differences existed between 
embryos in their ability  to compensate for the sub-optimal preimplantation environment 
to which they were subjected.  Subsequent observations of post-implantation embryos 
indicated that epigenetic alterations induced by embryo culture persist.  At day  9.5, 
following embryo culture and embryo transfer, loss of methylation and biallelic 
expression was observed for H19, Snrpn, Peg3 and Kcnq1ot1 in extraembryonic tissues, 
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indicating that imprinting perturbations are inherited through to midgestation, long after 
embryos have been removed from the culture medium (Mann et al., 2004).  It is now well 
understood that embryo culture, the act of maintaining pre-implantation embryos outside 
the female reproductive tract, as well as the components of the embryo culture medium, 
affect genomic imprinting at multiple loci. 
 Significant advancements have been made in the culture of preimplantation 
embryos to date (Bolton et al., 1991; Fischer and Bavister, 1993; Li and Foote, 1993; 
Gardner, 1994; Bavister, 1995; Gardner and Lane, 1996; Bavister, 2004; Rinaudo and 
Schultz, 2004), and many different media are currently available.  The majority  of embryo 
culture media are based on physiological saline solutions (Quinn, 1998; Summers and 
Biggers, 2003).  Early development of chemically-defined culture media was based on 
classic formulations for somatic cell culture.  For example, Whitten’s medium is a saline 
solution based on Krebs-Ringer’s solution supplemented with a carbohydrate energy 
source.  More recent formulations have adjusted concentrations of various components 
based either on optimized response by the embryo or to approximate values of known 
constituents present in the oviductal/uterine environment (Summers and Biggers, 2003). 
One example is KSOM (for K+ modified, simplex optimized medium); identification of 
amino acids in oviducts led to supplementation of culture media with amino acids (AA). 
To date, various media types are used to culture preimplantation embryos, including in 
ART clinics (Gardner, 1994; Bavister, 1995; Summers and Biggers, 2003; Pool, 2004). 
What needs to be emphasized is that preimplantation embryos survive embryo culture by 
adapting to the environment (Summers and Biggers, 2003).  The full consequences of 
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these adaptations are unknown.  The fact remains that oviductal fluid is more complex 
and subsequently  better than culture medium currently used for human and mouse 
embryos (Roberts, 2005).  Further development of culture media was based on the idea 
that media components should be altered during culture to reflect the in vivo environment 
and led to the development of  “sequential media systems”.  Culture formulations mimic 
the changing environment as embryos transverse the oviduct to the uterus/uteri.  Thus, a 
switch from high pyruvate, low glucose to high glucose, low pyruvate was implemented 
in these media systems to meet the temporal nutritional needs of the developing 
preimplantation embryo (Gardner and Lane, 1998; Cooke et al., 2002).
 Many studies have attempted to show superiority of one media or another, with 
respect to various measures of developmental competence (Leese and Barton, 1984; 
Quinn et al., 1985; Ho et al., 1995; Gardner and Lane, 1998; Roberts, 2005; Lane and 
Gardner, 2007; Biggers and Summers, 2008).  The effects of various culture media on 
genomic imprinting have been evaluated by many groups, however it  is nearly impossible 
to compare between studies due to differences in other aspects of their embryo 
manipulation techniques.  In the mouse model, M16 medium was shown to cause greater 
perturbation of H19 imprinting than G1.2/G2.2 (Fauque et al., 2007).  Human tubal fluid 
(HTF) caused loss of H19 imprinting, including aberrant histone modifications with an 
increase in H3K4 dimethylation on the paternal allele and an increase in H3K9 
trimethylation on the maternal allele (Li et al., 2005).  KSOMaa was better able to 
maintain genomic imprinting than Whitten’s medium (Doherty  et al., 2000; Mann et al., 
2004) although culture in KSOMaa also resulted in disruptions of genomic imprinting 
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(Rivera et al., 2008).  In the bovine, alterations in imprinting of Snrpn have been 
associated with the non-sequential SOF medium (Suzuki et al., 2005) as well as Sgce and 
Ata3 in the sequential Vitro Cleave/Vitro Blast medium (Tveden-Nyborg et al., 2008).  In 
humans, a recent study reported loss of methylation at the H19 locus in ~19% of a cohort 
of human embryos cultured in Cleavage Medium (Chen et al., 2010), supporting the 
translation of aberrant imprinting noted in animal models as a caution to human embryo 
culture.  However, all of the above studies employed ovarian stimulation to retrieve 
embryos prior to culture.  As such, as noted above, it is not possible to tease out the 
effects of one type of ART from another based on the current  literature.  My thesis aims to 
provide the necessary experimental protocols and analyses to begin to elucidate the 
individual effects of different forms of ART.   
 
1.5 - Rationale
As described above, germ cell and preimplantation development are critical 
periods in the erasure, establishment  and maintenance of proper imprinted methylation 
patterns (Santos and Dean, 2004).  As such, the timing of ARTs during these critical 
periods provides a mechanism for the disruption of imprinting establishment and 
maintenance through the environmental insult caused by the use of these procedures.  It is 
of critical importance to evaluate the effects of these techniques on genomic imprinting, 
and assess the safety and risks associated with each technique (Mann et al., 2004).  In 
addition, due to the stochastic nature of environmental effects on genomic imprinting, 
analysis at the individual embryo levels is necessary to gain a clear understanding of the 
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prevalence and frequency  of disruption.  Multiple analyses in the same individual embryo 
conducted in these studies also allows for correlation of multiple characteristics with the 
environmental effects of genomic imprinting.
1.6 - Hypothesis
 I hypothesize that multiple imprinted loci are disrupted by  superovulation alone or 
embryo culture alone, and that this disruption results from perturbations in the 
mechanisms regulating the acquisition and maintenance of genomic imprinting 
throughout preimplantation development.  In addition, I hypothesize that rates of 
preimplantation development correlate with loss of genomic imprinting.  
1.7 - Objectives
This thesis addresses the following objectives:
(1) To evaluate the effects of superovulation on genomic imprinting in the mouse 
embryo
(2) To determine the differential effects of embryo culture media on genomic imprinting.
(3) To determine the relationship between rates of preimplantation development and 
maintenance of genomic imprinting
All studies were performed using a technique developed during the course of my graduate 
work with which I was able to analyze multiple parameters in individual preimplantation 
embryos.
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Chapter 2: The Effects of Superovulation on Genomic Imprinting
The work in this chapter originates from the following peer-reviewed article:
Market-Velker, B.A., Zhang, L., Magri, L.S., Bonvissuto, A.C. & Mann, M.R. Dual 
effects of superovulation: loss of maternal and paternal imprinted methylation in a dose-
dependent manner. Hum Mol Genet 19, 36-51 (2010).
 
2.1 Introduction
 The use of assisted reproductive technologies (ARTs) for the treatment of human 
subfertility  / infertility contributes 1-2% of all children born in developed countries 
(Gosden et al., 2003; Roberts, 2005). However, the safety  of these technologies has yet to 
be fully evaluated.  Children conceived through various forms of ART are at an increased 
risk of low birth weight, intrauterine growth restriction, premature birth, and have a 
higher incidence of genetic and epigenetic disorders, including genomic imprinting 
disorders such as Beckwith-Wiedemann Syndrome and Angelman Syndrome (Cox et al., 
2002; DeBaun et al., 2003; Gicquel et al., 2003; Maher et al., 2003; Orstavik et al., 2003; 
Sunderam et al., 2009).  While the absolute risk of developing a genomic imprinting 
disorder in children born through ART as a result of an epigenetic defect is low, the 
relative risk when compared to non-ART children is significantly higher (Maher, 2005; 
Bowdin et al., 2007).
 Genomic imprinting is a mechanism of transcriptional regulation that restricts 
expression to either the maternally- or paternally-inherited copy of the gene; the opposite 
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parental copy is silent (Verona et al., 2003).  Imprinting may be envisaged as a multi-
generational process that begins in parental gametes, where previous DNA modifications 
are erased, and sex-specific modifications that differentially  mark the parental alleles are 
acquired (Szabo and Mann, 1995; Kato et al., 1999; Lee et al., 2002).  Maternal imprints 
are established in the oocyte, during maturation from primordial to antral follicles. 
Imprinting marks are then stably inherited and maintained in the developing embryo, 
amidst genome-wide changes in DNA methylation, where they  are translated into 
parental-specific monoallelic expression (Pfeifer, 2000).  Disruptions in any  of these steps 
may lead to loss of parental-specific expression and the development of imprinting 
disorders.
 DNA methylation of CpG dinucleotides is the most widely  investigated epigenetic 
"mark" associated with genomic imprinting.  It has generally been linked to 
transcriptional repression, is both heritable and reversible, and has been shown to interact 
with, and recruit, chromatin-modifying complexes to silence or activate specific genes 
(Razin and Riggs, 1980; Berger, 2007; Cedar and Bergman, 2009).  DNA methylation 
occurs at regions called differentially methylated regions (DMRs) that display differential 
methylation of maternal and paternal alleles, or imprinting control regions (ICRs), if it 
has been ascertained that differential methylation is acquired during gametogenesis and 
maintained during preimplantation development.  Although the exact mechanisms of 
imprinted gene regulation have yet to be elucidated, DNA methylation at DMR/ICRs has 
been correlated with allelic expression of many imprinted genes (Verona et al., 2003).
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 Superovulation, or ovarian stimulation, is an assisted reproductive technology 
commonly used to treat subfertility in women, for basic research in animal models, and in 
the production of livestock to obtain large numbers of offspring.  Increased frequencies of 
imprinting disorders have been correlated with ARTs, and loss of imprinting is more often 
the cause of imprinting disorders in affected ART populations than in non-ART children. 
Significantly, for both Angelman and Beckwith-Wiedemann Syndromes, patients have 
been identified where the only ART procedure used was ovarian stimulation (Young et al., 
1998; Chang et al., 2005; Ludwig et al., 2005).  
 To distinguish between the effects of superovulation and other contributing factors 
on genomic imprinting, carefully controlled experiments are required on spontaneously-
ovulated, in vivo-fertilized oocytes, and their induced-ovulated counterparts, thereby 
minimizing effects of in vitro manipulations.  Additionally, effects of superovulation on 
genomic imprinting need to be evaluated in an animal model system, where subfertility is 
not a confounding issue.  
 We propose that superovulation alone increases the risk of developing imprinting 
disorders. To address this, we evaluated imprinted methylation of multiple genes from 
individual mouse preimplantation embryos.  This work represents the first comprehensive 
examination of the overall effect of ovarian stimulation on genomic DNA methylation 
imprints at four imprinted loci, Snrpn, Peg3, Kcnq1ot1 and H19, in individual blastocyst 
stage embryos, and is the first to utilize low and high doses of hormones to assess their 
effects on genomic imprinting.  We report that superovulation resulted in a loss of Snrpn, 
Peg3 and Kcnq1ot1 imprinted methylation, and a gain of imprinted H19 methylation in 
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preimplantation embryos, and that this perturbation was dose-dependent; dysregulation of 
imprinted methylation was more frequent at  the high hormone dosage.  Additionally, we 
show that maternal- as well as paternal-specific H19 methylation imprints were perturbed 
by superovulation, suggesting that superovulation disrupts acquisition of imprints in 
growing oocytes, as well as maternal-effect gene products subsequently  required for 
imprint maintenance during preimplantation development.  
 
2.2 Methods
2.2.1 Ovarian Stimulation and Embryo Collection
 Embryos were obtained from crosses of C57BL/6 (CAST7) females and C57BL/6 
(B6) males (Jackson Laboratory or Charles River).  B6(CAST7) mice contain Mus 
musculus castaneus chromosome 7 on a B6 background (Mann et al., 2003).  Two 
hormone regimens were used for ovarian stimulation, 6.25 IU (low dose) and 10 IU (high 
dose).  Low or high doses of PMSG (Pregnant Mare’s Serum Gonadotropin, Intervet 
Canada) were administered to female B6(CAST7) mice, followed by  the same dose of 
hCG (Human Serum Chorionic Gonadotropin, Intervet Canada) 40-44 hours later. 
Females were mated with B6 males, and pregnancy  was determined by the presence of a 
vaginal plug the following morning (day 0.5).  F1 hybrid embryos were flushed from the 
genital tract of females ~96 hours post-hCG to recover blastocyst stage embryos. 
Additionally, females were set up in timed-matings that allow for spontaneous ovulation 
cycles (untreated controls). B6(CAST7) females were crossed with B6 stud males.  As 
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well, B6 females were mated with Mus musculus castaneus (CAST) males (spontaneous 
ovulation).  Embryos were recovered at day 3.5 postcoitum; all analyzed embryos were 
blastocysts, except for B6(CAST7) X B6 E6 (spontaneous ovulation group), E29 (6.25 IU 
group) and E23 (10 IU group) which were late stage morulae.  Embryos were flushed in 
pre-warmed M2 media (Sigma), washed 3x in 30 µL, and individually  snap frozen in 1-5 
µL of M2.  Individual embryos were stored at -80˚C.  For each control and experimental 
group, embryo collections were performed multiple times, and embryos analyzed were 
recovered from multiple litters.  Experiments were performed in compliance with the 
guidelines set by the Canadian Council for Animal Care, and the policies and procedures 
approved by the University of Western Ontario Council on Animal Care.  
2.2.2 DNA Isolation and Bisulfite Mutagenesis for Individual Embryos
 Bisulfite Mutagenesis with agarose embedding was conducted on single embryos 
as described (58,59), with modification.  Individual embryos were lysed with 0.1% 
IGEPAL (Biochemika), and 2 mg/mL Proteinase K (Sigma) in 10 µL of lysis buffer [100 
mM Tris-HCl pH 7.5 (Bioshop), 500 mM LiCl (Sigma), 10 mM EDTA pH 8.0 (Sigma), 
1% LiDS (Bioshop), 5 mM  DTT (Sigma)] for 1 hour at  50˚C.  Lysed embryos were 
embedded in 2% low melting point agarose (Sigma) under mineral oil at 95˚C.  DNA/
agarose beads were allowed to solidify for 10 minutes on ice.  Oil was removed and 
denaturation of DNA was performed in 0.1 M NaOH (Sigma) at 37˚C for 15 minutes with 
shaking.  Agarose beads were placed in 2.5 M bisulfite solution [0.125 M hydroquinone 
(Sigma), 3.8 g sodium hydrogensulfite (Sigma), 5.5 mL water, 1 mL 3 M  NaOH] at 50˚C 
61
for 3.5 hours to allow bisulfite mutagenesis to occur.  Following incubation, agarose 
beads were washed once in TE pH 7.5, and desulphonated with 0.3 M  NaOH at 37˚C for 
15 minutes with shaking.  Agarose beads were washed twice with TE pH 7.5, and twice 
with water.  Beads were incubated under oil at 65˚C and ~60 µL of pre-warmed water was 
added.  Agarose beads were mixed by pipetting and 20 µL of diluted agarose was added 
to one Ready-to-go PCR Bead (GE) containing gene-specific primers and 1 µL of 240 ng/
mL tRNA as a carrier.  PCRs were split  in half allowing two independent PCR reactions 
to be completed for each gene analyzed.  Nested primer sequences and associated 
information for each gene can be found in Table 2.1.  Negative controls (no embryo) were 
processed alongside each bisulfite reaction.
2.2.3 Allele-Specific DNA Methylation Analysis of Individual Embryos for Snrpn, 
Peg3, Kcnq1ot1, and H19
 Gene-specific primers used for nested PCR amplification of Snrpn, Peg3, 
Kcnq1ot1 and H19 as well as melting temperatures for each primer set can be found in 
Table 2.1.  Five µL of first  round product was seeded into each second round PCR 
reaction.  Second round products were digested with restriction enzymes that cleave 
methylated bisulfite converted DNA to ensure no bias in the amplification of methylated/
unmethylated products, or with restriction enzymes that cleave species-specific SNPs to 
ensure no allelic bias was introduced during PCR amplification.  PCR amplified products 
were directly cloned without intervening gel extraction steps, as we observed that column 
purification drastically decreases the variability of DNA strands recovered (data not 
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Table 2.1. Regions and Conditions for PCR Analysis Following Bisulfite 
Mutagenesis.
Gene Accession Position Primer 
Type
Primer Sequence (5'-3') Annealing 
Temp
Reference
Snrpn AF081460 2151 OF TAT GTA ATA TGA TAT AGT TTA GAA ATT 
AG
52 24; 25
-2570 OR AAT AAA CCC AAA TCT AAA ATA TTT TAA 
TC
IF AAT TTG TGT GAT GTT TGT AAT TAT TTG G 54
IR ATA AAA TAC ACT TTC ACT ACT AAA ATC 
C
Peg3 NT_039413.7 3683033 OF TTT TGA TAA GGA GGT GTT T 50 This study;
-3682588 OR ACT CTA ATA TCC ACT ATA ATA A 15
IF AGT GTG GGT GTA TTA GAT T 53
IR TAA CAA AAC TTC TAC ATC ATC
Kcnq1ot1 AJ271885 141392 OF GTG TGA TTT TAT TTG GAG AG 52 This study;
-141598 OR CCA CTC ACT ACC TTA ATA CTA ACC AC 26
IF GGT TAG AAG TAG AGG TGA TT 52
IR CAA AAC CAC CCC TAC TTC TAT
H19 U19619 1304 OF GAG TAT TTA GGA GGT ATA AGA ATT 55 25; 27 
-1726 OR ATC AAA AAC TAA CAT AAA CCT CT
IF GTA AGG AGA TTA TGT TTA TTT TTG G 50
IR CCT CAT TAA TCC CAT AAC TAT
OF Outer Forward, OR Outer Reverse, IF Inner Forward, IR Inner Reverse.
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shown).  One µL of second round PCR product was used for ligation with the pGEMT-
EASY DNA ligation kit (Promega).  Ligation was performed overnight at 4˚C and 
transformed into competent E. coli cells (Invitrogen or Zymo Research).  Blue/white 
selection (100 mg/mL IPTG, 50 mg/mL X-gal) was used to select bacterial colonies with 
ligated products.  Individual sequences were obtained by colony PCR of individual 
bacterial colonies.  The pGEMT-EASY vector contains M13 primer sites flanking the 
multiple cloning site, which were used for amplification of inserted DNA fragments. 
Approximately  2 µL of PCR product was used for agarose gel electrophoresis to verify 
amplicon size, and the remainder of the PCR reaction was sent to the Nanuq Sequencing 
Facility  located at McGill University (Montreal, QC) or BioBasic Inc (Markham, ON) for 
sequencing.  As Kcnq1ot1 was the last gene in each set to be analyzed, a proportion of 
embryos did not produce a sufficient number of DNA strands to be included in the 
analysis. 
2.2.4 Sequence Analysis
 For each sample and gene analyzed, 40-50 clones were sequenced to obtain a 
representative number of DNA strands.  Chromatograms from each sequence were 
visualized using FinchTV.  Ambiguous base pairs were manually reviewed and assigned a 
designation (where possible).  Each sequence was analyzed for total number and location 
of CpG associated cytosines, as well as location and number of converted and 
unconverted non-CpG associated cytosines to obtain conversion rates (number of 
converted non-CpG cytosines/total number of non-CpG cytosines).  Sequences with less 
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than 85% conversion rates were not included.  Identical clones (identical location and 
number of unconverted CpG associated cytosines, and identical location and number of 
unconverted non-CpG associated cytosines) were not included.  Multiple polymorphisms 
are present between B6 and CAST sequences at each gene analyzed, allowing parental 
alleles to be discriminated.  Clones possessing both B6 and CAST polymorphisms were 
determined to be due to crossover during PCR amplification, and were not included. 
Methylation levels across the region of analysis were determined by calculating the 
number of methylated CpG / total number of CpG for each individual CpG site as a 
percentage.  Total DNA methylation for each gene was calculated as a percentage of the 
total number of methylated CpG / the total number of CpG dinucleotides.
2.2.5 Statistical Analysis
 To compute the significance of nonrandom association between groups of 
embryos, we used the Fisher's exact test.  As changes in methylation status were 
anticipated to be in only  one direction (increase or decrease), a one-sided test was 
utilized.  P-values were calculated using software provided online (http://
www.langsrud.com/fisher.htm), and were considered to be significant at p < 0.05. 
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2.3 Results
2.3.1 Methylation levels of Snrpn, Peg3, Kcnq1ot1, and H19 in spontaneously 
ovulated embryos
 Prior to examining the effects of superovulation on genomic imprinting, the 
methylation status of the Snrpn, Kcnq1ot1, and H19 ICRs, and the Peg3 DMR was first 
determined in individual blastocysts derived from spontaneously ovulating females. The 
regions analyzed included 16 CpGs located in the Snrpn ICR (Lucifero et al., 2004; Mann 
et al., 2004), 24 CpGs located in the Peg3 DMR (Lucifero et al., 2004), 20 CpGs located 
in the Kcnq1ot1 ICR (26), and 17 CpGs located in the H19 ICR (25,27) (Figure 2.1). 
Methylation analyses using bisulfite mutagenesis and sequencing were performed on 
B6(CAST7) X B6 F1 individual blastocysts.  Ten individual embryos were analyzed at the 
four loci.  The Kcnq1ot1 and Snrpn ICRs, and the Peg3 DMR acquire maternal-specific 
methylation during oogenesis, while the H19 ICR acquires paternal-specific methylation 
during spermatogenesis; oocytes are unmethylated at the H19 ICR in mice (Davis et  al., 
2000; Lucifero et al., 2004).  Similar DNA methylation patterns are observed for the 
human SNRPN and H19 genes (Geuns et al., 2003; Borghol et al., 2006).  Therefore, in 
B6(CAST7) X B6 blastocyst stage embryos, the maternal (CAST) alleles of Kcnq1ot1, 
Snrpn, and Peg3 should be methylated, while the paternal (B6) allele of H19 should be 
methylated.  As anticipated from previous reports of pools of blastocysts (Tremblay et al., 
1995; Tremblay  et al., 1997; Mann et  al., 2003; Mann et al., 2004; Reese et al., 2007), the 
maternal DNA strands of Snrpn, Peg3, and Kcnq1ot1 were hypermethylated 
(Supplementary Figure 2.1-2.3), while the maternal H19 DNA strands were
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 Figure 2.1. Schematic Diagram of Regions Analyzed by Bisulfite Mutagenesis and 
Sequencing Assay.  
Maternal methylated Snrpn, Peg3, and Kcnq1ot1 alleles, and the paternal methylated H19 
allele are indicated.  ICR, Imprinted Control Region. DMR, Differentially Methylated 
Region. Open circles, CpGs. Blunt arrow designates transcription start site of non-
transcribed allele.  Regions analyzed are as follows: Snrpn ICR, 16 CpGs (15 CpGs in 
CAST) located in the promoter and first exon of the Snrpn gene; Peg3 DMR, 24 CpGs 
(23 CpGs in B6) located in the promoter and first exon of the Peg3 gene; Kcnq1ot1 ICR, 
20 CpGs located in the Kcnq1ot1 ICR; and H19 ICR, 17 CpGs (16 CpGs in B6) in the 
ICR located 2-4 kb upstream of the transcriptional start site of H19.
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hypomethylated (Supplementary  Figure 2.4).  Only maternal strands are shown as 
superovulation is thought to affect genomic imprinting during oocyte development, hence 
only affecting the maternal allele (Supplementary Figures 2.1-2.4).  From the analysis of 
embryos derived from spontaneously ovulated females, baseline total CpG methylation 
levels were determined to be greater than 65%, 70% and 85% for Snrpn, Peg3 and 
Kcnq1ot1, respectively, and less than 25% for H19.
 The reciprocal B6 X CAST cross was also performed to ensure that B6(CAST7) X 
B6 F1 embryos from spontaneously ovulated females were representative of normal 
imprinted methylation.  Maternal Snrpn strands displayed baseline total CpG methylation 
levels of 65% (Supplementary  Figure 2.5).  Levels of baseline total CpG methylation on 
maternal Peg3 and Kcnq1ot1 DNA strands in B6 X CAST F1 embryos were 75% and 
75%, respectively (Supplementary  Figures 2.6, 2.7).  The maternal H19 DNA strands 
were hypomethylated (Supplementary  Figure 2.8), with less than 15% total CpG 
methylation.  As no statistical difference was observed between embryos displaying 
aberrant methylation from the two crosses as determined by the Fisher’s Exact test, these 
two spontaneously  ovulating groups were combined for statistical calculations.  We 
conservatively set the baseline total CpG methylation level to greater than 65%, 70%, and 
75% for Snrpn, Peg3, and Kcnq1ot1, respectively, and less than 25% for H19.  These 
values were used to determine loss or gain of methylation in embryos from superovulated 
females.  
 Interestingly, for all imprinted genes investigated, at least one embryo displayed a 
drastic loss of methylation at the normally methylated maternal allele.  For the 
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B6(CAST7) X B6 F1 embryos, one embryo displayed loss of methylation at the normally 
methylated maternal allele for Snrpn (E5, 60% methylation), Peg3 (E114, 55%), and 
Kcnq1ot1 (E112, 23%) (Supplementary Figures 2.1-2.3). For B6 X CAST F1 embryos, 
spontaneous loss of methylation was observed at one embryo at the Snrpn ICR (E80, 50% 
methylation), the Peg3 DMR (E79, 34%), and at the Kcnq1ot1 ICR (E74, 58%) 
(Supplementary  Figure 2.5-2.7).  None of the F1 embryos displayed spontaneous gain of 
methylation at the H19 ICR.  One embryo (E83) was observed to have reversed Kcnq1ot1 
methylation; the maternal B6 strand had acquired a paternal imprinted methylation 
pattern, while the paternal CAST strand had acquired a maternal imprinted pattern 
(Supplementary  Figure 2.7).  This is a rare event that  has been observed previously for 
H19 imprinted expression (Mann et al., 2004).
2.3.2 Superovulation results in loss of maternal Snrpn, Peg3, and Kcnq1ot1 
methylation in a dose-dependent manner
 To determine the effects of superovulation on imprinted methylation, we 
examined embryos derived following both low and high dosages of hormonal stimulation. 
Hormone dosages typically employed for superovulation in the mouse range from 2.5 to 
10 IU, with 5 IU being the recommended dose for most mouse strains (Nagy et al, 2003). 
We chose 6.25 IU to represent to the low hormone dose, as lower concentrations were not 
as ineffective at inducing superovulation in the B6(CAST7) mice, and 10 IU for the high 
hormone dose (Nagy et al, 2003).  Snrpn, Peg3 and Kcnq1ot1 are normally paternally 
expressed and maternally  methylated.  Data were obtained from 10 embryos each in the 
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6.25 and 10 IU hormone treatment groups for Snrpn, and from 9 embryos in each 
hormone treatment group for Peg3, while 5 embryos from the 6.25 IU group, and 9 
embryos from the 10 IU group were analyzed for Kcnq1ot1 imprinted methylation. 
Forty-50 clones were sequenced and analyzed for each gene.  Methylation levels were 
analyzed at individual CpG dinucleotide across each ICR/DMR, as well as for the total 
number of methylated CpGs for each gene per embryo.
 Snrpn displayed a loss of maternal methylation at both hormone dosages 
(Supplementary  Figure 2.9), with the loss more frequent at the high hormone dosage 
(Figure 2.2 and 2.3). Analysis of total CpG methylation revealed that Snrpn exhibited a 
loss of methylation at the low hormone dosage on the maternal allele for four embryos 
(E29 31%, E13 63%, E13 45%, and E33 54% total CpG methylation of DNA strands) 
(Figure 2.2), and a loss of methylation at the high hormone dosage on the maternal allele 
for nine embryos (E10 57%, E8 55%, E1 42%, E4 63%, E23 53%, E5 59%, E6 49%, E13 
63%, and E11 61% total CpG methylation) (Figure 2.3), when compared to embryos from 
spontaneously  ovulated females (baseline of 65% methylation).  This loss of methylation 
at the high dosage was significantly different from control embryos (p = 0.001) as 
calculated by the Fisher's exact test.  
 A similar pattern of loss of methylation was observed for Peg3 when compared to 
Snrpn; both hormone dosages displayed a loss of methylation on maternal DNA strands 
(Supplementary  Figure 2.10), with a greater frequency of loss in the high hormone dosage 
group (Figure 2.4 and 2.5).  Peg3 displayed a loss of maternal methylation for four 
embryos (E14 67%, E29 49%, E18 67%, and E33 66% total CpG methylation) at the low
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Figure 2.2. Methylation of the Maternal Snrpn ICR in B6(CAST7) X B6 F1 Embryos 
Derived from Low Dosage Superovulated Females. 
Methylation status of individual DNA strands in the Snrpn ICR (maternal, CAST strands 
shown) in blastocysts derived from females superovulated with a 6.25 IU hormone 
dosage.  Unmethylated CpGs are represented as empty circles while methylated CpGs are 
depicted as filled circles.  Each line denotes an individual strand of DNA.  Clones with 
identical methylation patterns and non-CpG conversion rates representing the same DNA 
strand were included once.  Each group of DNA strands represents data from a single 
embryo, with the embryo designation indicated at the top left.  Percent methylation is 
indicated above each set of DNA strands, and was calculated as the number of methylated 
CpGs / total number of CpG dinucleotides.  The region analyzed contains 15 CpGs; a 
base pair change in the maternal CAST allele eliminates CpG dinucleotide 1.
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Figure 2.3: Methylation of the Maternal Snrpn ICR in B6(CAST7) X B6 F1 Embryos 
Derived from High Dosage Superovulated Females.  
Methylation status of individual DNA strands in the Snrpn ICR (maternal, CAST strands 
shown) in blastocysts derived from females superovulated with a 10 IU hormone dosage. 
The region analyzed contains 15 CpGs; a base pair change in the maternal CAST allele 
eliminates CpG dinucleotide 1. Details are as described in Figure 2.2.
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Figure 2.4. Methylation of the Maternal Peg3 DMR in B6(CAST7) X B6 F1 Embryos 
Derived from Low Dosage Superovulated Females.  
Methylation status of individual DNA strands in the Peg3 DMR (maternal, CAST strands 
shown) in blastocysts derived from females superovulated with a 6.25 IU hormone 
dosage. The region analyzed contains 24 CpGs. Details are as described in Figure 2.2.
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Figure 2.5. Methylation of the Maternal Peg3 DMR in B6(CAST7) X B6 F1 Embryos 
Derived from High Dosage Superovulated Females.  
Methylation status of individual DNA strands in the Peg3 DMR (maternal, CAST strands 
shown) in blastocysts derived from females superovulated with a 10 IU hormone dosage. 
The region analyzed contains 24 CpGs. Details are as described in Figure 2.2.
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hormone dosage (Figure 2.4), and a loss of methylation for five embryos (E10 50%, E8 
67%, E1 64%, E4 47%, and E11 42% CpG methylation) at the high hormone dosage 
(Figure 2.5), when compared to embryos from spontaneously ovulated females (baseline 
of 70% total CpG methylation).  This loss of imprinted methylation was statistically 
significant in the higher hormone treatment group  when compared to the spontaneous 
ovulation group (p = 0.03). 
 Kcnq1ot1, a third paternally expressed gene, also exhibited a similar loss of 
methylation on maternal DNA strands at both hormone dosages (Supplementary  Figure 
2.11), with a greater frequency of loss in the high hormone dosage group (Figure 2.6 and 
2.7). Kcnq1ot1 exhibited a loss of maternal methylation for two embryos (E5 54%, and 
E33 52% CpG methylation) at the low hormone dosage (Figure 2.6), and five embryos 
(E2 64%, E8 56%, E4 43%, E5 62%, and E13 53% total CpG methylation) at the high 
hormone dosage (Figure 2.7), when compared to embryos from spontaneously ovulated 
females (baseline of 75% CpG methylation).  Loss of Kcnq1ot1 imprinted methylation 
was not statistically  significant for either hormone treatment group when compared to 
controls (p = 0.4 for the 6.25 IU treatment group and p = 0.08 for the high hormone 
dosage), although the high hormone dosage group approached statistical significance. 
Analysis of additional embryos may be required to achieve significance. 
2.3.3 Superovulation results in gain of maternal H19 methylation in a dose-
dependent manner
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 Figure 2.6. Methylation of the Maternal Kcnq1ot1 ICR in B6(CAST7) X B6 F1 
Embryos Derived from Low Dosage Superovulated Females.  
Methylation status of individual DNA strands in the Kcnq1ot1 ICR (maternal, CAST 
strands shown) in blastocysts derived from females superovulated with a 6.25 IU 
hormone dosage.  Details are as described in Figure 2.2.
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Figure 2.7. Methylation of the Maternal Kcnq1ot1 ICR in B6(CAST7) X B6 F1 
Embryos Derived from High Dosage Superovulated Females.  
Methylation status of individual DNA strands in the Kcnq1ot1 ICR (maternal, CAST 
strands shown) in blastocysts derived from females superovulated with a 10 IU hormone 
dosage. Details are as described in Figure 2.2.
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The same ten embryos analyzed for imprinted methylation of the Snrpn, Peg3 and 
Kcnq1ot1 ICR/DMRs were also used for analysis of the H19 ICR.  H19 displayed a gain 
of maternal methylation at both hormone dosages, particularly for CpG dinucleotides 
8-17 (Supplementary Figure 2.12), with the loss more frequent at the high hormone 
dosage(Figure 2.8 and 2.9).  At the low hormone dose, one of ten embryos displayed a 
gain of maternal methylation, as seen by the presence of greater than 25% baseline CpG 
methylation of DNA strands (E14 32% methylation) (Figure 2.8).  At the higher hormone 
dosage (10 IU), 4 of 10 embryos displayed a gain of maternal methylation (E8 66%, E4 
43%, E13 67%, and E11 53% CpG methylation) (Figure 2.9).  This gain of methylation at 
the higher dosage was significantly different  from control embryos (p = 0.003).  These 
embryos acquired a more paternal-like pattern of methylation at the H19 ICR. 
2.3.4 Superovulation results in loss of paternal H19 methylation in a dose-dependent 
manner
 Studies of the effects of superovulation on genomic imprinting focused on the 
maternal allele, as superovulation is thought to affect  genomic imprinting during oocyte 
development.  Using our protocol, methylation data was obtained for both maternal and 
paternal of the four imprinted genes from individual preimplantation embryos. 
Surprisingly, not only  did we observe significant effects of superovulation on imprinted 
methylation of maternal alleles as described above, we also observed a loss of 
methylation on the normally methylated paternal H19 allele at both hormone dosages, 
especially for CpG dinucleotides 1-7 (Supplementary Figure 2.13), with more frequent
79
Figure 2.8. Methylation of the Maternal H19 ICR in B6(CAST7) X B6 F1 Embryos 
Derived from Low Dosage Superovulated Females.  
Methylation status of individual DNA strands in the H19 upstream ICR (maternal, CAST 
strands shown) in blastocysts derived from females superovulated with a 6.25 IU 
hormone dosage.  The region of the maternal CAST H19 allele analyzed contains 17 
CpGs. Details are as described in Figure 2.2.
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Figure 2.9. Methylation of the Maternal H19 ICR in B6(CAST7) X B6 F1 Embryos 
Derived from High Dosage Superovulated Females.  
Methylation status of individual DNA strands in the H19 upstream ICR (maternal, CAST 
strands shown) in blastocysts derived from females superovulated with a 10 IU hormone 
dosage.  The region of the maternal CAST H19 allele analyzed contains 17 CpGs. Details 
are as described in Figure 2.2.
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Figure 2.10. Methylation of the Paternal H19 ICR in B6(CAST7) X B6 F1 Embryos 
Derived from Low Dosage Superovulated Females.  
Methylation status of individual DNA strands in the H19 upstream ICR (paternal, B6 
strands shown) in blastocysts derived from females superovulated with a 6.25 IU 
hormone dosage.  The region of the paternal B6 H19 allele analyzed contains 16 CpGs 
due to a polymorphism that eliminates CpG8.  Details are as described in Figure 2.2.
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Figure 2.11. Methylation of the Paternal H19 ICR in B6(CAST7) X B6 F1 Embryos 
Derived from High Dosage Superovulated Females.  
Methylation status of individual DNA strands in the H19 upstream ICR (paternal, B6 
strands shown) in blastocysts derived from females superovulated with a 10 IU hormone 
dosage.  The region of the paternal B6 H19 allele analyzed contains 16 CpGs due to a 
polymorphism that eliminates CpG8.  Details are as described in Figure 2.2.
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loss of methylation at the high hormone dosage (Figure 2.10 and 2.11).  For both 
B6(CAST7) X B6 (Supplementary  Figure 2.14), and B6 X CAST F1 embryos 
(Supplementary  Figure 2.15) from spontaneously ovulated females, H19 displayed 79% 
and 77% total CpG methylation on paternal DNA strands.  Thus, the baseline level of 
total CpG methylation on the paternal H19 allele was set at 75%. Of the above embryos 
derived from spontaneously ovulating females, two B6(CAST7) X B6 F1 embryo and two 
B6 X CAST F1 embryo displayed loss of CpG methylation on paternal DNA strands (E10 
71%, E113 50%, and E73 61%, E74 56% methylation).  By  comparison, embryos from 
induced ovulations exhibited a loss of paternal H19 methylation.  At the low hormone 
dosage, three embryos (E18 54%, E20 69%, and E33 58% methylation) displayed a loss 
of methylation on paternal DNA strands (Figure 2.10), while at the high hormone dosage, 
seven embryos (E10 71%, E2 63%, E8 57%, E23 68%, E5 61%, E6 73%, and E11 47% 
CpG methylation) showed a loss of paternal methylation (Figure 2.11).  This loss of 
imprinted methylation on the paternal H19 strand was statistically significant  in the high 
hormone treatment group (p = 0.02).
 For the other imprinted genes analyzed, low levels of total CpG methylation were 
present on the paternal alleles Snrpn, Peg3 and Kcnq1ot1 following spontaneous and 
induced ovulation (Supplementary Figures 2.16-2.27).  After taking baseline levels of 
total CpG methylation, one embryo from each dosage group  showed a gain of paternal-
specific Snrpn methylation (6.25 IU treatment E14 35%; and 10 IU treatment group E8 
36%), one embryo from each hormone treatment group displayed a gain of paternal-
specific Peg3 methylation (6.25 IU treatment E31 51%; and 10 IU treatment groups E11 
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36%), and one embryo had a gain in paternal-specific Kcnq1ot1 methylation in the 6.25 
IU treatment (E33 23%).  In contrast to paternal H19 methylation, these results were not 
statistically significant, and no effect of dosage was observed.
2.3.5 Perturbation of Imprinted Methylation for Multiple Genes
 To determine the incidence of aberrant methylation (gain or loss) in the various 
treatment groups, the number of embryos with perturbation in methylation of the maternal 
Snrpn, Peg3, Kcnq1ot1 and H19 ICR/DMRs, and the paternal H19 ICR were assessed by 
the Fisher’s exact test (Table 2.2).  At the low hormone dosage, 4 of 10 embryos (E14, 
E29, F18, and E33) showed aberrant methylation of 2 or more genes, which was 
significantly different than embryos derived from spontaneously ovulated females where 
only a single embryo (E74) displayed aberrant methylation of more than one gene (p = 
0.05).  At the high dose, 10 of 10 embryos displayed aberrant methylation for 2 or more 
genes.  When compared to control embryos, this difference was highly significant (p = 
0.00002).  When all four genes were examined, no embryos exhibited aberrant 
methylation patterns at all loci at the low hormone concentration.  However at the high 
hormone dosage, one embryo (E8) displayed perturbed methylation at the maternal allele 
of all four genes, as well as at the paternal H19 allele.  These data clearly  demonstrate the 
dose-dependent effect of superovulation on perturbation of imprinted methylation.
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Table 2.2. Comparison of Hormone Dosage and Aberrant Imprinted Methylation
Dosage
Genotype
Embryo Snrpn Mat 
Loss 
(>65%)
Peg3 Mat 
Loss
(>70%)
Kcnq1ot1 
Mat Loss
(>75%)
H19
Mat Gain
(<25%)
H19
Pat Loss
(>75%)
E2 ND
E5 60 ND
E10 71
E112 23
0 IU E114 55
CAST7XB6 E113 ND 63
E115
E400 ND
E414 ND
E6
E73 61
E74 58 56
0 IU E79 34
B6XCAST E80 60
E83 R
E84
E85
E15 ND
E14 67 32
E29 31 49
E18 63 67 54
6.25 IU E13 45
CAST7XB6 E5 54
E7 ND
E20 ND 69
E33 54 66 52 58
E6 ND ND
E10 57 50 71
E2 64 63
E8 55 67 56 66 57
E1 42 64
10 IU E4 63 47 43 43
CAST7XB6 E23 53 68
E5 59 62 61
E6 49 ND ND 73
E13 63 53 67
E11 61 42 53 47
ND Not determined; R reversal of imprinted DNA methylation. 
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2.4 Discussion
 In this study, we utilized a mouse model system to investigate the effects of 
superovulation on genomic imprinting in blastocyst stage embryos.  Blastocysts were 
examined for parental-specific methylation changes to circumvent the chance of cumulus 
cell contamination that otherwise could be an issue when analyzing oocytes and early 
cleavage stage embryos.  Furthermore, by studying embryos instead of oocytes, we 
minimized the effects of in vitro manipulations, as well as limited our analysis to those 
oocytes that  were capable of being fertilized and producing embryos.  We have 
demonstrated that superovulation perturbed genomic imprinting of both maternally and 
paternally expressed genes, and that this perturbation was dose-dependent.  Previously, 
superovulation had been postulated to function by affecting oocyte development, and 
therefore effects were expected to be restricted to the maternal allele.  In our study, we 
have demonstrated that maternal-specific methylation imprints as well as paternal-
specific methylation imprints were disrupted by superovulation.  Furthermore, we 
observed that  superovulation results in perturbation of genomic imprinting for multiple 
genes within the same embryo.  
2.4.1 Superovulation Perturbs Genomic Imprinting
 Assisted reproduction has been linked to the generation of epigenetic errors that 
result in the development of the human imprinting disorders Angelman Syndrome and 
Beckwith-Wiedemann Syndrome (Cox et al., 2002; DeBaun et al., 2003; Gicquel et al., 
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2003; Maher et al., 2003; Orstavik et al., 2003; Halliday  et al., 2004).  Commonality 
between ART-associated BWS and AS is loss of maternal-specific methylation at the 
imprinting control regions at 11p15 and 15q11-13, respectively (Cox et al., 2002; DeBaun 
et al., 2003; Gicquel et al., 2003; Maher et al., 2003; Orstavik et al., 2003).  
 Multiple studies have examined the association of ARTs and imprinting, and in all 
cases examined some type of ovarian stimulation regime was consistently  employed to 
facilitate conception (Young et al., 1998; Van der Auwera and D'Hooghe, 2001; Gicquel 
et al., 2003; Chang et al., 2005; Ludwig et al., 2005).  Significantly, in both Angelman 
and Beckwith-Wiedemann Syndrome studies, patients were identified where the only 
ART procedure used was ovarian stimulation. 
 In the current study, we assessed the effects of superovulation on the ICRs of 
Snrpn, Kcnq1ot1 and H19 genes that have a causal role in the etiology of BWS and AS. 
Following superovulation, we observed a loss of maternal methylation in blastocyst stage 
embryos at the ICRs of the paternally expressed Snrpn and Kcnq1ot1 genes in individual 
mouse preimplantation embryos. While the effects of superovulation have not previously 
been examined at the blastocyst stage for Snrpn, no effect on Snrpn imprinted 
methylation was observed following superovulation in midgestation mouse embryo and 
placentas (Fortier et al., 2008).  The effects of superovulation on Kcnq1ot1 have not been 
previously  examined at the blastocyst stage, however a decrease in hypermethylated 
Kcnq1ot1 alleles from stimulated human oocytes compared to unstimulated controls has 
been observed (Khoueiry et  al., 2008).  Together these observations show that 
superovulation is associated with loss of DNA methylation at imprinted loci known to be 
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linked to the development of AS and BWS.  This study further provides a mechanistic 
link between ARTs and imprinting disorders.
The effect of superovulation on maternal methylation of the Peg3 DMR has not 
been previously  evaluated at any stage of development.  Similar to the other paternally 
expressed genes examined, we observed a loss of maternal Peg3 methylation following 
superovulation.  Our results constitute a novel finding, and suggest that the effects of 
ARTs may not be limited to a subset  of imprinted genes but may affect multiple imprinted 
loci.  Peg3 is a zinc finger protein thought to interact with p53 and Bax to regulate 
neuronal apoptosis in response to hypoxia or DNA damage (Deng and Wu, 2000; Relaix 
et al., 2000; Johnson et al., 2002).  Loss of Peg3 expression is associated with aberrant 
maternal nurturing behaviour and an offspring’s ability to thrive (Li et al., 1999; Murphy 
et al., 2001; Curley et al., 2004), phenotypes that have been linked to increased neuronal 
apoptosis during neonatal brain development (Broad et al., 2009).  Furthermore, loss of 
methylation at the Peg3 DMR has been linked to spontaneous abortion (Liu et al., 2008). 
Our data is of interest, in light of the fact that children born through ART are at an 
increased risk of neonatal mortality and intensive care unit admission (Basatemur and 
Sutcliffe, 2008) and increased risk of low birth weight and premature delivery (Sunderam 
et al., 2009).  Our observation that superovulation results in a loss of imprinted 
methylation at the Peg3 DMR may suggest an additional mechanism contributing to the 
risks of ART.
In addition to loss of maternal methylation, we observed a gain of maternal 
methylation for the normally unmethylated maternally H19 allele in blastocyst  stage 
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embryos.  This is consistent with the report by Sato et al. (Sato et al., 2007), who 
observed a gain of maternal H19 methylation following superovulation in mouse and 
human oocytes, and by  Borghol et al. (Borghol et al., 2006) who observed methylated 
H19 alleles in oocytes obtained from women undergoing ovarian stimulation followed by 
in vitro maturation.  In contrast, our data differ from those reported by Fortier et al. 
(Fortier et al., 2008), who observed that H19 methylation in midgestation mouse embryos 
and placentas derived from superovulated mothers did not reveal a gain of maternal H19 
methylation.  This discrepancy may be explained by smaller sample size, single low 
hormone dosage, or technical difficulties with the bisulfite protocol discussed by the 
authors (Fortier et  al., 2008).  Another report cited no difference in H19 methylation 
following superovulation in individual blastocysts, however, methylation analyses were 
not done allelically; therefore, methylated maternal alleles would not  have been 
discriminated from appropriately methylated paternal alleles (Fauque et al., 2007). 
2.4.2 Superovulation Perturbs Genomic Imprinting for Multiple Genes in the Same 
Embryo
 Analysis of the incidence of imprinted methylation defects following superovulation 
revealed that many embryos harboured aberrant methylation for 2 or more genes, which 
was significantly different from embryos from spontaneously ovulated females where 
only a single embryo displayed aberrant methylation for more than one gene.  Similar 
observation were recently reported in ART-conceived children with BWS (Lim et al., 
2009); imprinting defects at multiple imprinted loci other than the Kcnq1ot1 ICR were 
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more frequently observed in BWS patients whose parents had undergone some form of 
ART than in non-ART BWS patients.  These data suggest that developmental defects or 
abnormal growth in ART children might be caused by  variable combinations of epigenetic 
perturbations at imprinted genes, perhaps offering an explanation for a postulated new 
syndrome characterized by overgrowth and severe developmental delay (Shah et  al., 
2006).  Developmental and growth abnormalities could also plausibly  result from 
combinations of ART-induced epigenetic perturbations at imprinted and non-imprinted 
genes, indicative of broad effects of ART on DNA methylation  (Katari et al., 2009).
2.4.3 Superovulation may lead to perturbation in imprint acquisition as well  as 
imprint maintenance
 Loss of imprinted methylation in embryos derived from superovulated mothers, 
but not  in control females, indicates that superovulation disrupts mechanisms that 
establish imprinting during oogenesis.  There are a number of possible explanations for 
the loss of imprinting following superovulation.  Hormonal stimulation may result in the 
“rescue” of subordinate follicles which may have entered the follicular atresia pathway 
and that otherwise would not have been ovulated resulting in ovulation of lower quality 
oocytes (Van der Auwera and D'Hooghe, 2001), it  may lead to rapid oocyte maturation 
that perturbs genomic imprints, or it may induce ovulation of immature oocytes that have 
not completely acquired their imprints (Paoloni-Giacobino and Chaillet, 2004; Ludwig et 
al., 2005).  In humans, ovarian stimulation has been shown to accelerate the growth rate 
of ovarian follicles when compared to non-stimulated controls (Baerwald et al., 2009).  In 
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the case of genomic imprinting, this shortened maturation time may lead to improper or 
incomplete acquisition of imprinting marks on the maternal alleles.  However, no change 
in the activity  or localization of DNMT1 has been noted in embryos following 
superovulation (Doherty et al., 2000). Further investigations are required to distinguish 
between these possibilities.
 As the use of exogenous hormones occurs during oogenesis, effects of 
superovulation were expected to be restricted to the maternal allele.  Surprisingly, we 
report that H19 displayed a loss of methylation on the paternal, sperm-contributed allele, 
indicating that events that occur during oocyte maturation regulate imprinting on both the 
maternal and paternal alleles.  At this point, it is not known whether this effect extends to 
other ICR that are unmethylated on the maternal allele, or if it is limited to the H19 ICR. 
However, our data support  a recent study that observed activated expression of the 
normally silent, paternal H19 allele following superovulation (Fortier et al., 2008), as well 
as, a second study that showed aberrant H19 imprinted methylation in F1 and F2 male 
offspring of superovulated female mice (Stouder et al., 2009).  Thus, we postulate that 
superovulation has dual effects during oogenesis, acting to disrupt the acquisition of 
imprints in the growing oocyte, as well as causing molecular changes that disrupt 
maternal-effect gene products subsequently  required for genomic imprint maintenance 
during preimplantation development.  
2.4.4 Dose-Dependent Effects of Superovulation
92
 Dose-dependent effects of ovarian stimulation on genomic imprinting have not 
been previously reported.  To evaluate this, we performed experiments using two different 
dosages of hormones, 6.25 IU (low) and 10 IU (high).  All four imprinted genes 
investigated displayed a dose-dependent response to superovulation.  A greater number of 
embryos displayed perturbed imprinted methylation on the maternal alleles of Snrpn, 
Peg3, and Kcnq1ot1, and on both the maternal and paternal allele of H19, at  the high 
hormone dosage compared to the low hormone dosage.  Various hormone types and 
regimens are currently used for the treatment of subfertility.  A mild stimulation regimen 
was shown to decrease the incidence of aneuploidy  in resulting embryos when compared 
to the standard higher dose regimen (Baart et al., 2007), and high dosages of exogenous 
gonadotropins are associated with lower pregnancy rates (Stadtmauer et al., 1994).  Our 
study suggests that increasing hormone dosages in an effort to increase the number of 
oocytes recovered may have detrimental effects on embryo development.  These 
observations are particularly  important in light of the movement in the field towards 
single embryo transfers, where a natural cycling regime would not be detrimental to 
pregnancy outcome.
 A significant finding from these studies is that superovulation results in 
dysregulation of genomic imprinting in the absence of other confounding factors.  This is 
relevant at the clinical and community-wide level, as ovarian stimulation is currently an 
indispensable component of the ART protocol to treat human subfertility  / infertility.  As 
the genes investigated in this study play  an important role in early  development, and 
genetic and epigenetic perturbations lead to imprinting disorders, we propose that 
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superovulation may increase the risk of developing these disorders in the ART population. 
Our studies and others like it  argue for a more conservative use of assisted reproductive 
technologies, as well as more in-depth investigations of the effects of these technologies 
on human populations.
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Chapter 3: The Effects of Embryo Culture on Genomic Imprinting: Comparing 5 
Commercially Available Media
The work in this chapter originates from the following peer-reviewed article:
Market-Velker, B. A., Fernandes, A. D. and Mann, M. R. Side-by-side comparison of five 
commercial media systems in a mouse model: sub-optimal in vitro culture interferes with 
imprint maintenance. Biol Reprod 83(6): 938-50 (2010)
3.1 Introduction
Generally, assisted reproductive technologies (ARTs) are considered safe medical 
treatments.  There has been little concern that children conceived by ARTs are less 
healthy than naturally-conceived children.  However, while absolute risks remain low, 
evidence indicates that children conceived by ARTs are at  an increased risk of intrauterine 
growth restriction, premature birth, low birth weight (Schieve et al., 2002; Sunderam et 
al., 2009), as well as genomic imprinting disorders (Cox et  al., 2002; DeBaun et al., 2003; 
Gicquel et  al., 2003; Orstavik et  al., 2003; Halliday et  al., 2004; Chang et  al., 2005; 
Ludwig et al., 2005).  Thus, it  is important to monitor the consequences of manipulating 
embryos especially with the rapid evolution and increased use of ARTs.
An important protocol employed in assisted reproduction is in vitro culture. 
While steady progress in developing improved culture conditions for mammalian 
embryos has occurred over the past 50 years (Gardner, 1994; Edwards et al., 1997; Kaffer 
et al., 2001), current culture media remain suboptimal.  Cultured embryos from all species 
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have reduced pregnancy rates, reduced viability and growth, increased developmental 
abnormalities, behavioural deviations, are prone to metabolic and growth disorders, and 
display  aberrant expression patterns when compared to in vivo counterparts (Bowman and 
McLaren, 1970; Ho et al., 1995; Sasaki et al., 1995; Walker et al., 1996; Young et al., 
1998; Sinclair et  al., 1999; Barker, 2000; Doherty  et al., 2000; Khosla et  al., 2001; 
Bertolini et al., 2002; Ecker et al., 2004; Fernandez-Gonzalez et al., 2004; Rinaudo and 
Schultz, 2004).  Simply  stated, oviductal fluid is more complex than any culture medium 
currently used, containing key metabolites and/or growth factors that are either lacking or 
are present  at different concentrations in commercial media systems.  In addition, 
oviductal fluid is dynamic, changing along the length of the female reproductive tract to 
reflect altered metabolic preferences in the embryo (Roberts, 2005). 
One of the leading explanations for these culture-induced abnormalities is 
epigenetic alterations in gene expression that originate from embryo manipulation.  As 
preimplantation development is a critical period of developmental programming (Santos 
and Dean, 2004), the ability to maintain imprinting during in vitro development has been 
questioned.  Results demonstrate that  imprinting can be disrupted during mouse 
preimplantation development, pinpointing a critical period of susceptibility  to 
environmental conditions (Sasaki et al., 1995; Doherty et al., 2000; Mann et al., 2004).  In 
humans, assisted reproduction has been linked to epigenetic errors that produce the 
human imprinting disorders Angelman and Beckwith-Wiedemann Syndromes (AS and 
BWS), with loss of imprinting more often the cause of imprinting disorders in ART- 
compared to non-ART children (Cox et al., 2002; DeBaun et al., 2003; Gicquel et al., 
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2003; Orstavik et al., 2003; Halliday et al., 2004; Chang et al., 2005; Ludwig et al., 2005). 
Thus, the adverse influence of assisted reproductive technologies has significant clinical 
ramifications.
Multiple media formulations are used for culture in animal research models as 
well as human clinics (Gardner, 1994; Bavister, 1995; Gardner and Lane, 1998; Biggers 
and Summers, 2008).  Early  development of chemically-defined culture media was based 
on classic formulations for somatic cells.  For example, Whitten’s medium is a 
physiological saline based on Krebs-Ringer’s solution supplemented with a carbohydrate 
energy source (Whitten et al., 1971).  Here, we consider Whitten’s media as a “worst case 
scenario” as it produces more aberrant  non-imprinted gene expression, imprinted gene 
expression, and imprinted DNA methylation at the blastocyst stage (Doherty et al., 2000; 
Weksberg et al., 2001; Mann et al., 2004; Rinaudo and Schultz, 2004).  More recent 
formulations have adjusted concentrations of various components based on optimized-
response by embryos or approximate values of known constituents in the oviductal/
uterine environment (Leese and Barton, 1984).  Examples are potassium modified, 
simplex optimized medium (KSOM) (Lawitts and Biggers, 1993) and Human Tubal Fluid 
(Quinn et al., 1985).  Identification of amino acids in oviducts led to supplementation of 
culture media with amino acids (Ho et al., 1995; Roberts, 2005). Further development 
was based on the premise that media should be altered during culture to better represent 
the changing in vivo environment.  This resulted in development and implementation of 
“sequential media systems” (Gardner and Lane, 1998), where high pyruvate, low glucose 
medium is switched to high glucose, low pyruvate medium to reflect the embryo’s 
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changing carbohydrate preference during preimplantation development (Leese and 
Barton, 1984).  Many sequential media systems have been developed, including growth 
media, G1 and G2, and Preimplantation 1 and Multiblast media.  While two-step culture 
systems now predominate in human ART, it is unclear whether they are “superior” or 
necessary  (Leese and Barton, 1984; Quinn et al., 1985; Lawitts and Biggers, 2003; 
Biggers and Summers, 2008).
We hypothesize that imprinting maintenance mechanisms are disrupted by in vitro 
culture during mouse and human ARTs and that  media systems better able to maintain 
genomic imprinting will produce embryos that exhibit imprinting patterns more similar to 
in vivo-derived than Whitten’s cultured embryos.  In this study, we used a mouse model 
system because few studies are performed on human preimplantation embryos due to 
ethical restrictions; the effects of embryo culture need to be evaluated in a system where 
subfertility  is not  a confounding issue; and because the mouse embryo has been and is 
currently used to optimize culture conditions for human preimplantation embryos (Quinn 
and Horstman, 1998; Summers and Biggers, 2003).  We compared five commercial 
culture systems against a classic medium formulation, Whitten’s (“worst case scenario”), 
as well as in vivo-derived embryos (“best case scenario”), to determine their effects on 
genomic imprinting.  Imprinted methylation and expression were examined at H19, small 
nuclear ribonucleoprotein N (Snrpn) and paternally-expressed gene 3 (Peg3). 
3.2 Materials and Methods
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3.2.1 Embryo Collection
Embryos were obtained from naturally-mated C57BL6(CAST7) [B6(CAST7)] females 
crossed with C57BL6 (B6) males (Charles River, St Constant, Canada) as described 
(Mann et al., 2004; Market-Velker et al., 2010a). Briefly, B6(CAST7) females were 
checked for estrus and mated with B6 males.  Pregnancy  was determined (vaginal plug) 
the morning following mating (0.5 days postcoitum; dpc).  Embryos were flushed from 
isolated oviducts at 1.5 dpc to recover 2-cell stage embryos.  For hormone treatment 
groups, 6.25 IU PMSG (Pregnant Mare’s Serum Gonadotropin, Intervet Canada, Whitby, 
Canada) was administered to female B6(CAST7) mice, followed by  6.25 IU hCG 
(Human Serum Chorionic Gonadotropin, Intervet Canada, Whitby, Canada) 40-44 hours 
later (Table 3.1).  Hormone treatment was conducted using 6.25 IU dosage, as lower 
concentrations were not as effective at inducing superovulation in the B6(CAST7) mice. 
Experiments were performed in compliance with guidelines set by the Canadian Council 
for Animal Care, and the policies and procedures approved by the University of Western 
Ontario Council on Animal Care.  
3.2.2 Embryo Culture
Embryos were cultured in six different  media systems, two used for mouse embryo 
culture [Whitten’s (produced in-house) (Whitten, 1971), and KSOM  with amino acids 
(KSOMaa; Millipore, Ternecula, USA)], and four currently used in human clinics; two 
non-sequential [Human Tubal Fluid (HTF; LifeGlobal, Guelph, Canada), and Global
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Table 3.1: Timeline for Spontaneous / Induced Ovulation and Culture
15 sec, and 728C for 25 sec for 45 cycles, with melting-curve analysis of 958C
for 30 sec and 508C for 2 min, with 0.28C increments thereafter; Snrpn, 958C
for 1 sec, 528C for 15 sec, and 728C for 6 sec for 45 cycles, with melting-curve
analysis of 958C for 2 min and 458C for 2 min, with 0.28C increments
thereafter; and Peg3, 958C for 1 sec, 538C for 15 sec, and 728C for 8 sec for 45
cycles, with melting-curve analysis of 958C for 15 sec and 458C for 30 sec, with
0.28C increments thereafter. Parental allele-specific expression patterns were
calculated as percentage expression of the B6 or CAST allele relative to total
expression of both alleles. Monoallelic expression was defined as less than 10%
expression from the normally silent allele [29].
Statistical Methods
In the present analysis, we tested how readily methylation patterns
associated with each media could be distinguished from one another through
the following statistical model. Given a gene with n possible methylation sites,
the frequency of observing, for a given DNA strand, i methylated sites was
estimated as pi. Specifically, p0 denotes the probability of observing no sites
methylated, p
1
the probability of observing one methylated site, and so on for i
¼ 0, 1, . . ., n. Plots of p
i
versus media shown in Figure 8A, for example,
indicate three DNA strands from the in vivo pool had pi ’ 15/16 sites
methylated. The methylation-level frequencies pi are most easily estimated
from counts ni by setting pi ’ ni/n, where ni is the number of strands having i
sites methylated and n is the total number of sites. However, such simplistic
point estimates are well known to exhibit considerable systematic error when ni
, 3 for any i [41]. Therefore, to account for both this error and the effect of
finite sample sizes, a distribution for the set of frequencies p
i
was estimated
using standard Bayesian methods [42, 43] such that p
0
, p
1
, . . ., pnjn0, n1, . . ., nn
; Dirichlet([n
0
, n
1
, . . ., nn] þ 0.5). Therefore, if m embryos are sampled in the
future from the same media, these embryos are expected to display methylation
counts [m
0
, m
1
, . . ., mn] distributed according to a standard multinomial
distribution with frequencies [p
0
, p
1
, . . ., pn], where Ri mi ¼ n.
The combination of Dirichlet posterior and multinomial likelihood is called
the Multivariate Po´lya distribution for the likelihood Pr(m
0
, m
1
, . . ., m
n
jn
0
, n
1
,
. . ., nn), and it is the natural generalization of the bivariate Beta-binomial model
[44]. Although Fisher-type P-values are often used to test if two observed data
sets are ‘‘significantly’’ different, it is possible to estimate instead the
magnitude of difference between each data set. Such estimates, when available,
are often more informative than simple P-values alone [45, 46]. Using the
expected probabilities of observing counts [m
0
, m
1
, . . ., mn], we can ask how
distinguishable the different media are among themselves and the in vivo
sample via the log-likelihood ratio
log
Prðm0;m1; . . . ;mnjn0; n1; . . . ; nnÞ
Prðm0;m1; . . . ;mnjn00; n01; . . . ; n0nÞ
! "
for two media, each with methylation-level counts [n
0
, n
1
, . . ., nn] and [n
0
0, n
0
1,
. . ., n
0
n], respectively. Because any combination of counts m0, m1, . . ., mn are
possible as long as they add to m, this log-likelihood must be summed over
every possible combination of mi counts, conditioned on one of either media
being the actual source of the new samples. Formally, such a construction is
known as the Kullback-Leibler Divergence (KLD) between two alternative
hypotheses [47, 48].
The KLD is particularly attractive for distinguishing among alternative
treatments, because it is directly interpretable as an expected (log) true-positive
versus false-negative odds ratio for correctly classifying or distinguishing a
future sample of m embryos from two alternatives, given that one of the
alternatives is correct [49, 50]. The larger the KLD between different
treatments, the larger the posterior odds ratio that the future m embryos can
be correctly classified and, hence, the more distinguishable the two treatments
are. These between-treatment comparisons appear on the off-diagonal of Figure
8. Thus, the KLD can be directly interpreted as the magnitude of treatment-
effect between different treatments. Furthermore, by using the Multivariate
Po´lya likelihood, sample-size variance is automatically taken into account, and
these magnitudes are resistant to artificial inflation resulting from sampling
variance [51]. Lastly, using the given KLD framework, at no point is the
assumption of normality required or used. The KLD is also useful for
estimating statistical power through comparing two samples from the same
treatment group by estimating the ability to recognize methylation patterns for a
given treatment as having come from that treatment. These values appear on the
diagonal of Figure 8. Smaller diagonal values are indicative of higher statistical
power. If different sets of frequencies [m
0
, m
1
, . . ., mn] and [m
0
0, m
0
1, . . ., m
0
n] are
drawn given media-specific counts [n
0
, n
1
, . . ., n
n
] and [n
0
0, n
0
1, . . ., n
0
n],
respectively, the KLD is then interpreted as an expected (log) true-negative
versus false-positive odds ratio for being able to recognize methylation patterns
for a given treatment as having come from that treatment.Therefore, larger
diagonal values indicate larger posterior odds ratios that m future samples from
the same population will be erroneously distinguishable and are an indication of
lower-than-desired statistical power. Thus, for this analysis, using the diagonal
as a guide, odds ratios less than 20:1 were considered to be substantially
indistinguishable, those between 20:1 and 30:1 to be highly distinguishable,
those between 30:1 and 100:1 to be very highly distinguishable, and those
greater than 100:1 to be decisively distinguishable in approximate accordance
with standard convention [52].
With respect to the imprinted expression analysis, we used the Fisher exact
test to compute the significance of nonrandom association between embryos
cultured in different media types. Because changes in expression were
anticipated to be in only one direction (monoallelic or biallelic), a one-sided test
was utilized. P-values were calculated using software provided online (http://
www. langsrud.com/fisher.htm) and were considered to be significant at P ,
0.05.
RESULTS
In the present study, we performed a side-by-side
comparison of five commercial culture systems to determine
the susceptibility of mouse preimplantation embryos to culture-
induced epigenetic errors at three imprinted loci. The
commercial media systems that were investigated were three
TABLE 1. Timeline for spontaneous and induced superovulation and for various culture systems.
Culture system
Day %3
1600 ha
Day %1
1400–1500 ha
Day %1
.1500 hb
Day 0
900 h
Day 0
.1600 hc
Day 1
900 hc
Whittens Spont ovul Spont ovul Equilibrate mineral oil Matings Plugs Equilibrate culture drop
Whittens 6.25 IU eCG 6.25 IU hCG Equilibrate mineral oil Matings Plugs Equilibrate culture drop
KSOMaa/Global/HTF Spont ovul Spont ovul Equilibrate mineral oil Matings Plugs Equilibrate culture drop
KSOMaa/Global/HTF 6.25 IU eCG 6.25 IU hCG Equilibrate mineral oil Matings Plugs Equilibrate culture drop
P1/MB Spont ovul Spont ovul Equilibrate mineral oil Matings Plugs
Equilibrate culture drop
P1/MB 6.25 IU eCG 6.25 IU hCG Equilibrate mineral oil Matings Plugs
Equilibrate culture drop
G1.5/G2.5 Spont ovul Spont ovul Equilibrate mineral oil Matings Plugs
Equilibrate culture drop
G1.5/G2.5 6.25 IU eCG 6.25 IU hCG Equilibrate mineral oil Matings Plugs
Equilibrate culture drop
a Spont ovul, spontaneous ovulated; 6.25 IU, induced ovulated.
b Equilibrate mineral oil; filter-sterilized mineral oil in incubator for equilibration (lid loosened).
c Equilibrate culture drop; culture drops prepared, under oil, in incubator for equilibration.
d Culture embryos, culture ;one 2-cell embryo per microliter medium.
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nonrenewable, nonsequential media (KSOMaa, Global, and
HTF) and two sequential ystems (P1/MB and G1.5/G2.5).
Commercial formulations were used to valuate media
currently used in human ART. For comparison, Whitten
medium was used as the worst-case scenario and in vivo-
derived embryos as the best-case scenario.
Effects of Embryo Culture on Imprinted Methylation
For each media system, B6(CAST7)3B6 F
1
embryos were
cultured from the 2-cell stage to the blastocyst stage (72 6 1 h
after onset of culture) according to the manufacturer’s
instr ctions for the Mouse Embryo Assay (Table 1). For all
media, blastocyst develo ment was supported at a rate of
greater than 90% (Whitten, 96%; KSOMaa, 98%; Global, 91%;
HTF, 97%; P1/MB, 92%; G1.5/G2.5, 100%) (Supplemental
Table S2).
To determine whether differences exi t in the ability of
various culture systems to maintain genomic imprinting, DNA
methylation of the H19 and Snrpn imprinting control regions
(ICRs) and the Peg3 differentially methylated region (DMR)
were analyzed (Fig. 1). Methylatio analyses using bisulfit
mutagenesis and sequencing were performed on three pools of
five cultured embryos per edia system and on one pool of
five in vivo-derived blastocysts. The Snrpn ICR and the Peg3
DMR harbor maternal-specific methylation, whereas the H19
ICR possess s paternal-specific methylation [27]. Ther fore, in
B6(CAST7)3B6 embry s, the paternal B6 H19 al ele and the
maternal CAST7 Snrpn and Peg3 alleles should be methylated.
As anticipated from previous reports about pools of blastocysts
[29, 53–55], paternal H19 DNA strands and maternal Snrpn
and Peg3 DNA strands were hypermethylate (82%, 92%, and
100%, respectively) in the in vivo-derived embryo pool (Fig.
1).
Analysis of the H19 ICR in cultured embryos (Figs. 2–7)
showed that Whitten-cultured embryos displayed a loss of
methylation, with 54%, 67%, and 63% (mean, 61%) hyper-
methylated pat rnal DNA strands (Fig. 2). Embryos cultured in
all media revealed a loss of paternal-specific methylation as
follows: KSOMaa, 55%, 94%, and 75% (mean, 75%) hyper-
methylation; Global, 60%, 63%, and 72% (mean, 65%); HTF,
21%, 67%, and 67% (mean, 52%); P1/MB, 93%, 64%, and
FIG. 1. Top) Schematic diagram of regions analyzed for imprinted methylation. The paternal methylated H19 allele and the maternal methylated Snrpn
and Peg3 alleles are indicated. Open circles indicate CpGs. A blunt arrow designates the transcription start site of a nontranscribed allele. Regions
analyzed are as follows: H19 ICR, 17 CpGs (16 CpGs in paternal B6 allele) in the ICR located 2–4 kb upstream of the transcriptional start site of H19;
Snrpn ICR, 16 CpGs (15 CpGs in maternal CAST alleles) located in the promoter and first exon of the Snrpn gene; and Peg3 DMR, 24 CpGs located in the
promoter and first exon of the Peg3 gene. Bottom) Methylation of the paternal H19 ICR and the maternal Snrpn ICR and Peg3 DMR in B6(CAST7)3B6 F1
in vivo-derived embryos (pool of five blastocysts). Methylation status of individual DNA strands in blastocysts derived from spontaneously ovulated
females was determined by bisulfite mutagenesis and sequencing analysis. Unmethylated CpGs are represented as empty circles; methylated CpGs are
depicted as filled circles. Each line denotes an individual strand of DNA. The identity of clones with identical methylation patterns and non-CpG-
conversion rates representing the same DNA strand were included once. Each group of DNA strands represents data from one pool of five embryos.
Percentage methylation is indicated above each set of DNA strands and was calculated as the number of hypermethylated DNA strands divided by the
total number of DNA strands. Hypermethylated DNA strands were those displaying greater than 50% methylated CpGs.
TABLE 1. Extended.
Culture system
Day 1
1200 hd
Day 1 .
1600 hc
Day 2
900 hd
Day 4
1200 h
Whittens Flush 2-cell
Culture embryos
Collect blastocysts
Freeze
Whittens Flush 2-cell
Culture embryos
Collect blas ocysts
Freeze
KSOMaa/Global/HTF Flush 2- ell
Culture embryos
Collect blastocysts
Freeze
KSOMaa/Global/HTF Flush 2-cell
Culture embryos
Collec blastocysts
Freeze
P1/MB Flush 2-cell
Culture embryos
Equilibrat 2nd culture drop Culture embryos Collect blast cysts
Fre ze
P1/MB Flush 2-cell
Culture embryos
Equilibrate 2nd culture drop Cul u e embryos Collect blastocysts
Freeze
G1.5/G2.5 Flush 2-cell
Culture embryos
Equilibrate 2nd cultur drop Wash in G-MOPSþ
Cul ure embryos
Collect blastocysts
Fr eze
G1.5/G2.5 Flush 2-cell
Culture embryos
Equilibrate 2nd culture drop W sh i G-MOPSþ
Culture mbry s
Collect blastocysts
Freeze
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15 sec, and 728C for 25 s c for 45 cycles, with melting-curve analysis of 958C
for 30 sec and 508C for 2 min, with 0.28C increments ther after; Snrpn, 958C
for 1 ec, 528C for 15 sec, and 728C for 6 sec for 45 cycles, with melting-curve
analysis of 958C for 2 min and 458C for 2 min, with 0.28C increments
thereafter; and Peg3, 958C for 1 sec, 538C for 15 sec, and 728C for 8 sec for 45
cycles, with melting-curve analysis of 958C for 15 sec and 458C for 30 sec, with
0.28C increments thereafter. Parental allele-specific expression patterns were
calculated as percentage expressio of the B6 or CAST allele relative to total
expression of both alleles. Monoallelic expression was defined as less than 10%
expression from the normally silent allele [29].
Statistical M thods
In the present analysis, we tested how readily methylation patterns
associated with each media could be distinguished from one another through
the following statistical model. Given a gene with n possible methylation sites,
the frequency of observing, for a given DNA strand, i methylated sites was
estimated as pi. Specifically, p0 denotes the probability of observing no sites
methylated, p
1
the probability of observing one methylated site, and so on for i
¼ 0, 1, . . ., n. Plots of p
i
versus media shown in Figure 8A, for example,
indicate three DNA strands from the in vivo pool had pi ’ 15/16 sites
methylated. The methylation-level frequencies pi are most easily esti ated
from counts ni by setting pi ’ ni/n, where ni is the number of strands having i
sites methylated and n is the total number of sites. However, such simplistic
point estimates are well known to exhibit considerable systematic error when ni
, 3 for any i [41]. Therefore, to account for both this error and the effect of
finite sample sizes, a distribution for the set of frequencies p
i
was estimated
using standard Bayesian methods [42, 43] such that p
0
, p
1
, . . ., pnjn0, n1, . . ., nn
; Dirichlet([n
0
, n
1
, . . ., nn] þ 0.5). Therefore, if m embryos are sampled in the
future from the same media, these embryos are expected to display methylation
counts [m
0
, m
1
, . . ., mn] dist ibuted accor ing to a standard multinomial
distribution with frequencies [p
0
, p
1
, . . ., pn], where Ri mi ¼ n.
The combination of Dirichlet posterior and multinomial likelihood is called
the Multivariate Po´lya distribution for the likelihood Pr(m
0
, m
1
, . . ., m
n
jn
0
, n
1
,
. . ., nn), and it is the natural generalization of th biv riate Beta-binom al model
[44]. Although Fisher-type P-values are ofte used to test if two observed data
sets are ‘‘significantly’’ different, it is possible to estimate instead the
magnitude of difference between each data set. Such estimates, when available,
are often more informative than simple P-values alone [45, 46]. Using the
expected probabilities of observing counts [m
0
, m
1
, . . ., mn], we can ask how
distinguishable the different media are among themselves and the in vivo
sample via the log-likelihood ratio
log
Prðm0;m1; . . . ;mnjn0; n1; . . . ; nnÞ
Prðm0;m1; . . . ;mnjn00; n01; . . . ; n0nÞ
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for two media, each with methylation-level counts [n
0
, n
1
, . . ., nn] and [n
0
0, n
0
1,
. . ., n
0
n], respectively. Because any combination of counts m0, m1, . . ., mn are
possible as long as they add to m, this log-likelihood must be summed over
every possible combination of mi counts, conditioned on one of either media
being the actual source of the new sampl s. Formally, such a construction is
known as the Kullback-Leibler Divergence (KLD) between two alternative
hypotheses [47, 48].
The KLD is particularly attractive for distinguishing among alternative
treatments, beca e it is directly interpretable as an expected (log) true-positive
ver us false-negative odds ratio for correc ly classifying or distinguishing a
future sample of m embryos from two alternatives, given that one of the
alternatives is correct [49, 50]. The larger the KLD between different
treatments, the larger the posterior odds ratio that the future m embryos can
b cor ectly cla fied nd, hence, t more distinguishable the two treatments
are. These between-treatment c mparisons appear on the off-diagonal of Figure
8. Thus, the KLD can be directly interpreted as the magnitude of treatment-
effect between different treatments. Furthermore, by using the Multivariate
Po´lya likelihood, sample-size variance is automatically taken into account, and
these magnitudes are resistant to artificial inflation resulting from sampling
variance [51]. Lastly, using the given KLD framework, at no point is the
assumption of normality required or used. The KLD is also useful for
estimating statistical power through comparing two samples from the same
treatment group by estimating the ability to recognize methylation patterns for a
given treatment as having come from that treatment. These values appear on the
diagonal of Figure 8. Smaller diagonal values are indicative of higher statistical
power. If different sets of frequencies [m
0
, m
1
, . . ., mn] and [m
0
0, m
0
1, . . ., m
0
n] are
drawn given media-specific counts [n
0
, n
1
, . . ., n
n
] and [n
0
0, n
0
1, . . ., n
0
n],
respectively, the KLD is then interpreted as an expected (log) true-negative
versus false-positive odds ratio for being able to recognize methylation patterns
for a given treatment as having come from that treatment.Therefore, larger
diagonal values indicate larger posterior odds ratios that m future samples from
the same population will be erroneously distinguishable and are an indication of
lower-than-desired statistical power. Thus, for this analysis, using the diagonal
as a guide, odds ratios less than 20:1 were considered to be substantially
indistinguishable, those between 20:1 and 30:1 to be highly distinguishable,
those between 30:1 and 100:1 to be very highly distinguishable, and those
greater than 100:1 to be decisively distinguishable in approximate accordance
with standard convention [52].
With respect to the imprinted expression analysis, we used the Fisher exact
test to compute the significanc of nonrandom association between embryos
cultured in different media types. Because changes in expression were
anticipated to be in only one direction (monoallelic or biallelic), a one-sided test
was utilized. P-values were calculated using software provided online (http://
www. langsrud.com/fisher.htm) and were considered to be significant at P ,
0.05.
RESULTS
In the present study, we performed a side-by-side
comparison of five commercial culture systems to determine
the susceptibility of mouse preimplantation embryos to culture-
induced epigenetic errors at three imprinted loci. The
commercial media systems that were investigated were three
TABLE 1. Timeline for spontaneous and induced superovulation and for various culture systems.
Culture system
Day %3
1600 ha
Day %1
1400–1500 ha
Day %1
.1500 hb
Day 0
900 h
Day 0
.1600 hc
Day 1
900 hc
Whittens Spont ovul Spont ovul Equilibrate mineral oil Matings Plugs Equilibrate culture drop
hittens 6.25 IU CG 6.25 IU hCG Equilibrate mineral oil Matings Plugs Equilibrate culture drop
KSOMaa/Global/HTF Spont ovul Spont ovul Equilibrate mineral oil Matings Plugs Equilibrate culture drop
KSOMaa/Global/HTF 6.25 IU eCG 6.25 IU hCG Equilibrate mineral oil Matings Plugs Equilibrate culture drop
P1/MB Spont ovul Spont vul Equilibrate mineral il Matings Plugs
Equilibrate culture drop
P1/MB 6.25 IU eCG 6.25 IU hCG Equilibrate mineral oil Matings Plugs
Equili rate culture drop
1.5/G2.5 Spont ovu Spont ovul Equilibrate min ral oil Matings Plugs
Equilibrate culture drop
G1.5/G2.5 6.25 IU eCG 6.25 IU hCG Equilibrate mineral oil Matings Plugs
Equilibrate culture drop
a Spont ovul, spontaneous ovulated; 6.25 IU, induced ovulated.
b Equilibrate mineral oil; filter-sterilized mineral oil in incubator for equilibration (lid loos ned).
c Equilibra e culture drop; culture drops prepared, under oil, in incubator for quilibrat on.
d Cultu e embry s, cult re ;one 2-cell embryo per microliter medium.
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Medium (LifeGlobal)], and two sequential systems [Preimplantation 1/Multiblast  (P1/
MB; Somagen Diagnostics Inc, Edmonton, Canada), and G1v5PLUS/G2v5PLUS (G1.5/
G2.5; Vitrolife, Goteborg, Sweden )] (Table 3.1).  The commercial media systems were 
used according to the manufacturer’s instructions for the Mouse Embryo Assay.  Where 
indicated by the manufacturer (Global 4 mg/mL; HTF 4 mg/mL; P1/MB 0.5%), media 
were supplemented with BSA (Cat# A3311, Sigma, Oakville, Canada).  Mineral oil 
(Sigma, Oakville, Canada) was filter sterilized and equilibrated at least 48 hours prior to 
culture.  Culture drops were prepared prior to 9 AM  on the morning of collection for 
Whitten’s and KSOMaa, or after 4 PM the day prior to collection for the remaining media 
to allow for equilibration.  Embryos were cultured in drops of 20 µl containing ~20 
embryos.  Culture conditions for Whitten’s medium were 37°C, 5% CO2 in air, and 37°C, 
5 %O2, 5% CO2, 90% N2 for the others.  For sequential culture systems, the second 
medium drops (MB or G2.5) were prepared the day prior to transfer (after 4 PM), and 
equilibrated overnight.  Prior to culture in G2.5, embryos were washed 2X in pre-
equilibrated GMOPS+ (Vitrolife).  All embryos were scored for blastocyst development 
(defined by the presence of a blastocoel cavity) at noon on day 4 of culture, frozen 
individually or in pools of 5, and stored at –80°C (Table 3.1).  For each media system, 
embryos were recovered from multiple litters, and embryo culture was performed at least 
four times.
3.2.3 Imprinted Methylation Analysis 
Bisulfite mutagenesis and sequencing analysis was performed as described (Market-
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Velker et al., 2010a), with modifications for pools of 5 blastocysts.  Briefly, embryo pools 
were lysed in 25 µL lysis buffer for 1 hour at  50˚C, embedded in 2% low melting point 
agarose (Sigma, Oakville, Canada) and split into three 30 µL beads. For each PCR 
reaction, 20 µL agarose/DNA was added to one Ready-To-Go PCR Bead (RTG; GE, 
Baie-d’Urfe, Canada) containing gene specific primers (Supplementary Table 3.1) 
(Sigma, Oakville, Canada) (Market-Velker et al., 2010a) and 1 µL 240 ng/mL tRNA 
(Sigma, Oakville, Canada).  PCR reactions were split in half allowing for two 
independent PCR reactions.  Negative controls (no embryo) were processed alongside 
each bisulfite reaction.  For each sample and gene analyzed, 40-50 clones were 
sequenced.  Chromatograms from each sequence were visualized using FinchTV (Version 
1.4.0, Geospiza, Seattle, USA).  Ambiguous base pairs were manually reviewed and 
assigned a designation (where possible).  Each sequence was analyzed for total number 
and location of CpG associated cytosines, as well as location and number of converted 
and unconverted non-CpG associated cytosines to obtain conversion rates (number of 
converted non-CpG cytosines / total number of non-CpG cytosines).  Sequences with less 
than 85% conversion rates were not included.  Identical clones (identical location and 
number of unconverted CpG associated cytosines, and identical location and number of 
unconverted non-CpG associated cytosines) were not included.  Multiple polymorphisms 
are present between B6 and CAST sequences at each gene analyzed, allowing parental 
alleles to be discriminated.  Clones possessing both B6 and CAST polymorphisms were 
likely due to crossover during PCR amplification, and were not included. 
Hypermethylation of a DNA strand was defined at >50% methylated CpGs on a given 
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strand.
3.2.4 Imprinted Expression Analysis
RNA isolation, synthesis of a reusable cDNA library using individual embryos, 
and H19 and Snrpn expression analysis using the LightCycler Real Time PCR System 
(Roche Molecular Biochemicals, Mississauga, Canada) was performed as described 
(Mann et al., 2004), except HotStart RTG Beads (GE, Baie-d’Urfe, Canada) and TIB 
MolBiol hybridization probes (Adelphia, USA) were used (Supplementary  Table 3.1). 
For the Peg3 expression analysis, Peg3 primers were used to amplify a 317-bp region 
(AF038939).  Fluorescence resonance energy transfer hybridization probes were designed 
to the CAST amplicon (Supplementary Table 3.1).  The Peg3 sensor probe spans a single 
nucleotide polymorphism at nucleotide 3433 between B6 (T) and CAST (C) on the 
antisense strand.  Following denaturation at 95°C for 2 minutes, PCR reactions were as 
follows: H19 95°C 1 second, 55°C 15 seconds, 72°C 25 seconds for 45 cycles, with 
melting curve analysis of 95°C 30 seconds, 50°C 2 minutes, with 0.2°C increments 
thereafter; Snrpn 95°C 1 second, 52°C 15 seconds, 72°C 6 seconds for 45 cycles, with 
melting curve analysis of 95°C 2 minutes, 45°C 2 minutes, with 0.2°C increments 
thereafter; Peg3 95°C 1 second, 53°C 15 seconds, 72°C 8 seconds for 45 cycles, with 
melting curve analysis of 95°C 15 seconds, 45°C 30 seconds, with 0.2°C increments 
thereafter.  Parental allele-specific expression patterns were calculated as percent 
expression of the B6 or CAST allele relative to total expression of both alleles. 
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Monoallelic expression was defined as <10% expression from the normally silent allele 
(Mann et al., 2004).
3.2.5 Statistical Methods
In this analysis, we tested how readily  methylation patterns associated with each media 
could be distinguished from one another through the following statistical model.  Given a 
gene with n possible methylation sites, the frequency of observing, for a given DNA 
strand, i methylated sites was estimated as pi.  Specifically, p0 denotes the probability  of 
observing no sites methylated, p1 denotes the probability  of observing one methylated 
site, and so on for i = 0, 1, …, n.  Plots of pi versus media show in Figure 8a, for example, 
three DNA strands from the in vivo pool had pi ≈ 15/16 sites methylated.  Methylation-
level frequencies pi are most easily estimated from counts ni by setting pi ≈ ni /n, where ni 
is the number of strands having i sites methylated and n is the total number of sites. 
However, such simplistic point-estimates are well known to exhibit considerable 
systematic error when ni < 3 for any i (Sokal and Rohlf, 1994).  Therefore to account for 
both this error and the effect of finite sample sizes, a distribution for the set of frequencies 
pi was estimated using standard Bayesian methods [42,43] such that 
p0 ,p1 ,…,pn |n0 ,n1 ,…,nn Dirichlet [n0 ,n1 ,…,nn]+1 2( ) .  Therefore, if m embryos are 
sampled in the future from the same media, these embryos are expected to display 
methylation counts [m0, m1, …, mn] distributed according to a standard multinomial 
distribution with frequencies [p0, p1, …, pn], where mii∑ = n .  The combination of 
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Dirichlet posterior and multinomial likelihood is called the Multivariate Pólya distribution 
for the likelihood Pr m0 ,m1 ,…,mn |n0 ,n1 ,…,nn( ) , and it is the natural generalization of the 
bivariate Beta-binomial model [44].  Although Fisher-type p-values are often used to test 
if two observed data sets are "significantly" different, it is possible to instead estimate the 
magnitude of difference between each data set.  Such estimates, when available, are often 
more informative than simple p-values alone (Goodman, 1999; Hubbard and Bayarri, 
2003).  Using the expected probabilities of observing counts [m0, m1, …, mn], we can ask 
how distinguishable the different media are among themselves and the in vivo sample via 
log-likelihood ratio log Pr m0 ,m1 ,…,mn |n0 ,n1 ,…,nn( )Pr m0 ,m1 ,…,mn | ′n0 , ′n1 ,…, ′nn( )   for two media, each with 
methylation-level counts [n0 ,n1 ,…,nn]  and [ ′n0 , ′n1 ,…, ′nn] , respectively.  Since any 
combination of counts m0 ,m1 ,…,mn  are possible as long as they add to m, this log-
likelihood must be summed over every possible combination of mi counts, conditioned on 
one of either media being the actual source of the new samples.  Formally, such a 
construction is known as the Kullback-Leibler Divergence (KLD) between two 
alternative hypotheses (Kullback and Leibler, 1951; Kullback, 1978).  The KLD is 
particularly attractive for distinguishing among alternative treatments because it is 
directly  interpretable as an expected (log) true-positive versus false-negative odds-ratio 
for correctly classifying or distinguishing a future sample of m embryos from two 
alternatives, given that one of the alternatives is correct (Neyman and Pearson, 1933; 
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Fawcett, 2006).  The larger the KLD between different treatments, the larger the posterior 
odds-ratio that the future m embryos can be correctly  classified, and hence the more 
distinguishable the two treatments are.  These between-treatment comparisons appear on 
the off-diagonal of Figure 8.  Thus the KLD can be directly interpreted as the magnitude 
of treatment-effect between different treatments.  Furthermore, by using the Multivariate 
Pólya likelihood, sample-size variance is automatically taken into account, and these 
magnitudes are resistant to artificial inflation due to sampling variance (Kass and Raftery, 
1995).  Lastly, using the given KLD framework at no point is the assumption of normality 
required or used.  The KLD is also useful for estimating statistical power by comparing 
two samples from the same treatment group by estimating the ability  to recognize 
methylation patterns for a given treatment as having come from that treatment.  These 
values appear on the diagonal of Figure 8.  Smaller diagonal values are indicative of 
higher statistical power.  If different sets of frequencies [n0 ,n1 ,…,nn]  and [ ′n0 , ′n1 ,…, ′nn]  
are drawn media-specific counts [n0 ,n1 ,…,nn]  and [ ′n0 , ′n1 ,…, ′nn] , respectively, the KLD is 
then interpreted as an expected (log) true-negative versus false-positive odds-ratio for 
being able to recognize methylation patterns for a given treatment as having come from 
that treatment.  Therefore, larger diagonal values indicate larger posterior odds ratio that 
m future samples from the same population will be erroneously distinguishable and are an 
indication of lower than desired statistical power.  Thus, for this analysis, using the 
diagonal as a guide, odds ratios below 20:1 were considered substantially 
indistinguishable, between 20:1 and 30:1 to be highly  distinguishable, between 30:1 and 
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100:1 to be very  highly distinguishable, and over 100:1 to be decisively distinguishable in 
approximate accordance with standard convention (Jeffreys, 1961).
 With respect to the imprinted expression analysis, to compute the signiﬁcance of 
non-random association between embryos cultured in different media types, we used the 
Fisher’s exact test.  As changes in expression were anticipated to be in only  one direction 
(monoallelic or biallelic), a one-sided test  was utilized.  P-values were calculated using 
software provided online (http://faculty.vassar.edu/lowry/fisher.html) and were considered 
to be signiﬁcant at p < 0.05. 
3.3 Results
In this study, we performed a side-by-side comparison of five commercial culture 
systems to determine the susceptibility  of mouse preimplantation embryos to culture-
induced epigenetic errors at  three imprinted loci.  The commercial media systems that 
were investigated were three nonrenewable, non-sequential media, KSOMaa, Global, and 
HTF, and two sequential systems, P1/MB and G1.5/G2.5.  Commercial formulations were 
used to evaluate media currently used in human ART.  For comparison, Whitten’s medium 
was used as the worst-case scenario, and in vivo-derived embryos as the best-case 
scenario. 
3.3.1 Effects of Embryo Culture on Imprinted Methylation
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 For each media system, B6(CAST7) X B6 F1 embryos were cultured from the 2-
cell stage to the blastocyst stage (72 +1 hours after onset of culture) according to the 
manufacturer’s instructions for the Mouse Embryo Assay (Table 3.1).  For each media, 
blastocyst development was supported at a rate >90% (Whitten’s 96%; KSOMaa 98%; 
Global 91%; HTF 97%; P1/MB 92%; G1.5/G2.5 100%) (Supplementary Table 2). 
To determine whether differences existed in the ability of various culture systems 
to maintain genomic imprinting, DNA methylation of the H19 and Snrpn imprinting 
control regions (ICRs), and the Peg3 differentially methylated region (DMR) were 
analyzed (Figure 3.1).  Methylation analyses using bisulfite mutagenesis and sequencing 
were performed on three pools of 5 cultured embryos per media system, and on one pool 
of 5 in vivo-derived blastocysts.  The Snrpn ICR and the Peg3 DMR harbour maternal-
specific methylation, while the H19 ICR possesses paternal-specific methylation (Verona 
et al., 2003). Therefore, in B6(CAST7) X B6 embryos, the paternal B6 H19 allele and the 
maternal CAST7 Snrpn and Peg3 alleles should be methylated.  As anticipated from 
previous reports of pools of blastocysts (Tremblay et al., 1997; Thorvaldsen et  al., 1998; 
Mann et al., 2004; Reese et al., 2007), paternal H19 DNA strands, and maternal Snrpn 
and Peg3 DNA strands were hypermethylated (82%, 92%, and 100%, respectively) in the 
in vivo-derived embryo pool (Figure 3.1).
Analysis of the H19 ICR in cultured embryos (Figure 3.2-3.7) showed that 
Whitten’s cultured embryos displayed a loss of methylation, with 54%, 67% and 63% 
(mean 61%) paternal DNA strands hypermethylated (Figure 3.2).  Embryos cultured in all 
media revealed a loss of paternal-specific methylation, KSOMaa (55%, 94% and 75%; 
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Figure 3.1. Schematic Diagram of Regions Analyzed for Imprinted Methylation. 
Top: The paternal methylated H19 allele and the maternal methylated Snrpn and Peg3 
alleles are indicated.  ICR, Imprinted Control Region. DMR, Differentially Methylated 
Region. Open circles, CpGs. Blunt arrow designates transcription start site of non-
transcribed allele.  Regions analyzed are as follows: H19 ICR, 17 CpGs (16 CpGs in 
paternal B6 allele) in the ICR located 2-4 kb upstream of the transcriptional start site of 
H19; Snrpn ICR, 16 CpGs (15 CpGs in maternal CAST alleles) located in the promoter 
and first exon of the Snrpn gene; and Peg3 DMR, 24 CpGs located in the promoter and 
first exon of the Peg3 gene.  Bottom.  Methylation of the paternal H19 ICR, and the 
maternal Snrpn ICR and Peg3 DMR in B6(CAST7) X B6 F1 in vivo-derived embryos 
(pool of 5 blastocysts).  Methylation status of individual DNA strands in blastocysts 
derived from spontaneously ovulated females was determined by bisulfite mutagenesis 
and sequencing analysis.  Unmethylated CpGs are represented as empty circles while 
methylated CpGs are depicted as filled circles.  Each line denotes an individual strand of 
DNA.  The identity of clones with identical methylation patterns and non-CpG 
conversion rates representing the same DNA strand were included once. Each group of 
DNA strands represents data from one pool of 5 embryos.  Percent methylation is 
indicated above each set of DNA strands, and was calculated as the number of 
hypermethylated DNA strands / total number of DNA strands.  Hypermethylated DNA 
strands were those displaying >50% methylated CpGs.
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Figure 3.2.  Methylation in Whitten’s Medium.
Methylation of the paternal H19 ICR, the maternal Snrpn ICR and the maternal Peg3 
DMR in B6(CAST7) X B6 F1 embryos derived from spontaneously ovulated females and 
cultured in non-sequential Whitten’s medium.  Each group of DNA strands represents 
data from three pools of 5 embryos (A, B and C).  See Figure 3.1 for additional details. 
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Figure 3.3.  Methylation in KSOMaa.
Methylation of the paternal H19 ICR, the maternal Snrpn ICR and the maternal Peg3 
DMR in B6(CAST7) X B6 F1 embryos derived from spontaneously ovulated females and 
cultured in non-sequential KSOMaa. Each group of DNA strands represents data from 
three pools of 5 embryos (A, B and C).  See Figure 3.1 for additional details.   
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Figure 3.4. Methylation in Global Medium.
Methylation of the paternal H19 ICR, the maternal Snrpn ICR and the maternal Peg3 
DMR in B6(CAST7) X B6 F1 embryos derived from spontaneously ovulated females and 
cultured in non-sequential Global media. Each group of DNA strands represents data 
from three pools of 5 embryos (A, B and C).  See Figure 3.1 for additional details.
117
86%
H
T
F
A
B
H19 Snrpn Peg3
67%
C
100%0%21%
61%77%67%
93%
Figure 3.5. Methylation in HTF Medium.
Methylation of the paternal H19 ICR, the maternal Snrpn ICR and the maternal Peg3 
DMR in B6(CAST7) X B6 F1 embryos derived from spontaneously ovulated females and 
cultured in non-sequential HTF media.  Each group of DNA strands represents data from 
three pools of 5 embryos (A, B and C).  See Figure 3.1 for additional details.
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Figure 3.6. Methylation in P1/MB Medium.
Methylation of the paternal H19 ICR, the maternal Snrpn ICR and the maternal Peg3 
DMR in B6(CAST7) X B6 F1 embryos derived from spontaneously ovulated females and 
cultured in sequential media P1/MB.  Each group of DNA strands represents data from 
three pools of 5 embryos (A, B and C).  See Figure 3.1 for additional details.
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Figure 3.7. Methylation in G1.5/G2.5 Medium.
Methylation of the paternal H19 ICR, the maternal Snrpn ICR and the maternal Peg3 
DMR in B6(CAST7) X B6 F1 embryos derived from spontaneously ovulated females and 
cultured in sequential media G1.5/G2.5.  Each group of DNA strands represents data from 
three pools of 5 embryos (A, B and C).  See Figure 3.1 for additional details.
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mean 75% hypermethylation), Global (60%, 63% and 72%; mean 65%), HTF (21%, 67% 
and 67%; mean 52%), P1/MB (93%, 64% and 38%; mean 65%), and G1.5/G2.5 (82%, 
62% and 21%; mean 55%) (Figure 3.3-3.7).  In these analyses, we attribute inter embryo 
pool variation to composition of blastocysts within the pool; variable number of 
blastocysts that maintained and lost imprinted methylation.  This is support by our recent 
report on the effects of superovulation on genomic imprinting where we observed a 
stochastic response by  individual embryos to superovulation (Market-Velker et al., 
2010a).
To quantify these differences in H19 imprinted methylation, the ability  to 
distinguish DNA strands from embryos derived in vivo from those cultured in each media 
system were calculated as posterior odds ratios (Figure 3.8).  Higher posterior odd ratios 
indicate a greater ability  to distinguish between DNA strands obtained from embryo 
culture in one media compared to another (or to in vivo), while lower posterior odds ratios 
indicate an inability  to distinguish between culture conditions.  Using the table 
representing three samples (i.e. three groups of 5 embryos), this analysis demonstrated 
that the in vivo-derived embryo pool was highly distinguishable from Whitten’s cultured 
embryos (Figure 3.8A).  In addition, embryos cultured in KSOMaa, Global and P1/MB 
were least distinguishable from in vivo-derived embryos, but highly distinguishable from 
embryos cultured in Whitten’s. Embryos cultured in HTF and G1.5/G2.5 displayed 
methylation levels least  distinguishable from Whitten’s, but  were highly distinguishable 
from in vivo-derived embryos.  Therefore, for H19, KSOMaa, Global and P1/MB 
appeared best able to maintain imprinted methylation.  These results for embryos cultured
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Figure 3.8.  Methylation Analysis 
Methylation analysis of the paternal H19 ICR, the maternal Snrpn ICR and the maternal 
Peg3 DMR for in vivo-derived and cultured embryos.  Left, plots of the fraction of CpG 
methylation per DNA strand (black oval).  Vertical bars are mean hypermethylation of 
embryo pools.  Right, posterior odd ratios tables as calculated independently for each 
gene.  Higher posterior odd ratios (dark grey-black) indicate a greater ability to 
distinguish between DNA strands obtained from embryo culture in one media compared 
to another (or to in vivo), while lower posterior odds ratios (white to light grey) indicate 
an inability to distinguish between culture conditions.  Using the diagonal as a guide, 
odds ratios below 20:1 were considered substantially indistinguishable, between 20:1 and 
30:1 to be highly distinguishable, between 30:1 and 100:1 to be very highly 
distinguishable, and over 100:1 to be decisively distinguishable.
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 in Whitten’s medium and KSOMaa are consistent with our previous analysis, which 
showed better maintenance of H19 imprinted methylation in KSOMaa (Mann et  al., 
2004).
 The same embryo pools from the H19 analysis were examined for changes in 
imprinted methylation at Snrpn and Peg3.  For Snrpn, Whitten’s cultured embryos 
displayed a loss of methylation with 67%, 58% and 50% of maternal DNA strands 
hypermethylated (mean 58%) (Figure 3.2).  Similar to H19, methylation loss was 
observed in embryos cultured in all media, KSOMaa (60%, 89% and 69%; mean 73%), 
Global (100%, 55% and 60%; mean 72%), HTF (0%, 77% and 86%; mean 54% 
hypermethylation), P1/MB (56%, 62% and 78%; mean 65%) and G1.5/G2.5 (83%, 77% 
and 33%; mean 64%) (Figure 3.3-3.7). 
Quantification of posterior odds ratios for Snrpn revealed that the in vivo-derived 
embryos were highly  distinguishable from Whitten’s cultured embryos.  Furthermore, 
embryos cultured in KSOMaa, Global, HTF, P1/MB, and G1.5/G2.5 were highly 
distinguishable from in vivo-derived embryos.  However, embryos cultured in HTF, P1/
MB, and G1.5/G2.5 were least distinguishable from those cultured in Whitten’s medium, 
while KSOMaa and Global cultured embryos were highly  distinguishable from Whitten’s 
cultured embryos (Figure 3.8B).  Therefore, for Snrpn, KSOMaa and Global appeared 
better able to maintain imprinted methylation when compared to Whitten’s, HTF, P1/MB, 
and G1.5/G2.  Consistent with our previous study (Mann et al., 2004), we observed that 
embryos cultured in KSOMaa harbored greater Snrpn methylation than those cultured in 
Whitten’s medium.
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For the Peg3 DMR methylation analysis, Whitten’s cultured embryos displayed a 
loss of methylation with 71%, 24% and 67% maternal DNA strands hypermethylated 
(mean 54%) (Figure 3.2).  Embryos cultured in G1.5/G2.5 (44%, 50% and 56%; mean 
50% hypermethylation) (Figure 3.7) also produced a severe loss of Peg3 methylation, 
while embryos cultured in KSOMaa (80%, 100% and 100%; mean 93% 
hypermethylation), Global (70%, 89% and 73%; mean 77%), HTF (100%, 61% and 93%; 
mean 85%) and P1/MB (91%, 44% and 89%; mean 75%) harbored higher maternal Peg3 
hypermethylation levels (Figure 3.3-3.6).
Quantification of posterior odds ratios for Peg3 revealed that the in vivo-derived 
embryo pool was highly  distinguishable from Whitten’s cultured embryos (Figure 3.8C). 
Embryos cultured in KSOMaa were least distinguishable from in vivo-derived embryos 
and highly distinguishable from Whitten’s medium.  Embryos cultured in G1.5/G2.5 were 
highly  distinguishable from in vivo-derived embryos and least  distinguishable from 
Whitten’s medium.  Global, HTF and P1/MB cultured embryos displayed levels 
distinguishable from both in vivo-derived and Whitten’s cultured embryos.  Thus, for 
Peg3, KSOMaa culture appeared best able to maintain imprinted methylation,
From the imprinted methylation analysis, we conclude that all commercial media 
systems are suboptimal in their ability  to maintain genomic imprinting as none displayed 
methylation levels comparable to in vivo-derived embryos for all three genes (Figure 3.8). 
Having said this, some media systems were better able to maintain imprinted methylation; 
KSOMaa, Global and P1/MB for H19, KSOMaa and Global for Snrpn; and KSOMaa 
followed by Global, HTF and P1/MB for Peg3.  As well, there was a differential response 
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of imprinted genes to various culture systems as evidenced by  the response of the three 
loci to HTF medium where the most severe loss of H19 and Snrpn methylation was 
observed compared to other media systems, while higher methylation levels were seen for 
Peg3. 
3.3.2 Effects of Embryo Culture on Imprinted Gene Expression
 To investigate the effects of the commercial media systems on imprinted gene 
expression, individual embryos were analyzed for H19, Snrpn and Peg3 imprinted 
expression.  Approximately 20-30 individual embryos were analyzed from each media 
system as well as for in vivo-derived control embryos.  For Snrpn, in vivo-derived control 
embryos displayed paternal-specific Snrpn expression (100% Snrpn expression, 100% 
monoallelic expression) (Supplementary  Table 3.3).  For Peg3, 23 of 24 control embryos 
(96%) expressed Peg3 with all but one embryo exhibiting paternal-specific expression 
(96% monoallelic) (Supplementary  Table 3.3).  Analysis of cultured embryos 
demonstrated that Snrpn and Peg3 also maintained monoallelic expression following 
embryo culture in all media systems, similar to in vivo-derived embryos, although a small 
percentage of embryos exhibited biallelic Peg3 expression (4-11%), however this 
difference was not statistically  significant (Table 3.2).  These results are similar to our 
previous study  where monoallelic Snrpn and Peg3 expression were maintained in 
Whitten’s and KSOMaa cultured embryos at the blastocyst stage (Mann et al., 2004).
 Maintenance of Snrpn and Peg3 imprinted expression following culture contrasted 
sharply with that of H19.  Analysis of H19 imprinted expression showed that 100% of in
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Table 3.2: Expression Analysis of Cultured and Superovulation and Cultured 
EmbryosTABLE 2. Expression analysis of cultured and superovulated/cultured embryos.
Culture media
Snrpn Peg3
Analyzed Expressed Biallelic Analyzed Expressed Biallelic
Whittens 29 29 (100%) 0 23 22 (96%) 2 (9%)
KSOMaa 22 22 (100%) 0 22 18 (82%) 0
HTF 22 22 (100%) 0 28 26 (93%) 1 (4%)
Global 25 25 (100%) 0 25 24 (96%) 1 (4%)
P1/MB 24 24 (100%) 0 24 22 (92%) 0
G1.5/G2.5 19 19 (100%) 0 19 18 (95%) 0
6.25 IU/Whittens 23 23 (100%) 0 23 23 (100%) 0
6.25 IU/KSOMaa 21 21 (100%) 0 22 21 (95%) 0
6.25 IU/Global 21 21 (100%) 0 21 21 (100%) 0
6.25 IU/HTF 22 22 (100%) 0 22 21 (95%) 1 (5%)
6.25 IU/P1/MB 19 19 (100%) 1 (5%) 19 19 (100%) 2 (11%)
6.25 IU/G1.5/G2.5 13 13 (100%) 0 13 13 (100%) 0
FIG. 9. Imprinted expression of H19 in
B6(CAST7) 3 B6 embryos derived from
spontaneously ovulated females and cul-
tured in six different media systems. Embryo
designations are indicated on the x-axis;
percentage allelic expression from each
allele is indicated on the y-axis. Gray bar
height indicates percentage of maternal
expression; black bar height represents
percentage of paternal-specific expression.
Percentage expressed (% Exp) was calcu-
lated as number of embryos displaying H19
expression divided by total number of
embryos analyzed, and percentage loss of
imprinted expression (% LOI) was calculat-
ed as number of embryos displaying greater
than 10% expression from the normally
silenced allele divided by total number of
embryos expressing H19.
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 vivo-derived controls displayed maternal-specific expression (Supplementary Table 3.3), 
while 40% of Whitten’s cultured embryos displayed loss of imprinting (LOI, defined as 
biallelic / abnormal paternal H19 expression) (Figure 3.9).  Similar to Whitten’s, all five 
commercial culture systems had increased numbers of embryos with loss of imprinted 
H19 expression; KSOMaa 60%, Global 50%, HTF 47%, P1/MB 53%, and G1/G2 41% 
(Figure 3.9).  No statistically  significant difference in LOI was observed between all 
media analyzed, however there was a significant difference between all media and in 
vivo-derived embryos with respect to biallelic expression using Fisher’s exact test (p < 
0.05, Supplementary Table 3.4).  These results are discordant from our previous study 
where better maintenance of H19 imprinted expression was observed in KSOMaa 
compared to Whitten’s culture (Mann et al., 2004).  While the reason for this discordance 
is not clear, we do note that our current cultured embryos possess fewer cell numbers 
compared to those in our previous analysis.  We are currently investigating the 
relationship between cell number and loss of imprinting.
 A change in frequency of embryos expressing H19 was also observed between 
experimental and control groups.  Thirteen percent of in vivo-derived embryos expressed 
H19 (9/68 embryos) (Supplementary Table 3.3), while 69% of Whitten’s cultured 
embryos expressed H19 (Figure 3.9).  Snrpn was expressed in all these embryos, acting as 
a control for RNA isolation and cDNA synthesis.  Similar to Whitten’s, H19 expression 
was more frequent in embryos cultured in all commercial media systems compared to in 
vivo-derived embryos; KSOMaa 91%, Global 80%, HTF 54%, P1/MB 79%, and G1/G2 
89% (p < 0.05, Supplementary Table 3.5) (Figure 3.9). 
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Figure 3.9. Imprinted Expression of H19 - Spontaneous Ovulation and Culture
Imprinted expression of H19 in B6(CAST7)xB6 embryos derived from spontaneously 
ovulated females and cultured in six different media systems.  Embryo designations are 
indicated on the X-axis; percent allelic expression from each allele is indicated on the Y-
axis.  Grey bar height indicates percent of maternal expression while black bar height 
represents the percent of paternal-specific expression.  Percent expressed (% Exp) was 
calculated as number of embryos displaying H19 expression / total number of embryos 
analyzed, and percent loss of imprinted expression (% LOI) was calculated as number of 
embryos displaying >10% expression from the normally silenced allele / total number of 
embryos expressing H19.
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3.3.3 Effects of Superovulation and Embryo Culture on Imprinted Expression 
 In a recent study, we demonstrated that superovulation (without culture) perturbed 
H19, Snrpn, and Peg3 imprinted methylation (Market-Velker et al., 2010a).  To examine 
the effect of superovulation in combination with embryo culture, we examined H19, 
Snrpn and Peg3 imprinted expression in individual embryos derived from superovulated 
females and cultured in each of the five commercial media systems.  Since our primary 
goal was to determine the synergistic effects of superovulation and embryo culture, we 
used low hormone dosages; this treatment had less effect on imprinted methylation 
patterns compared to high hormone dosage (Market-Velker et al., 2010a).  Blastocyst 
development was supported at a rate >85% in the various culture systems in combination 
with superovulation (6.25 IU/Whitten’s 92%; 6.25 IU/KSOMaa 96%; 6.25 IU/Global 
97%; 6.25 IU/HTF 89%; 6.25 IU/P1/MB 86%; 6.25 IU/G1.5/G2.5 96%) (Supplementary 
Table 3.2).
Similar to non-hormone treated groups, Snrpn and Peg3 imprinted expression was 
maintained in superovulated-cultured groups (Table 3.2).  For H19, hormone treatment in 
conjunction with Whitten’s culture resulted in a dramatic increase in the number of 
embryos with loss of imprinted H19 expression from 40% to 81% (Figure 3.9-3.10).  A 
similar increase was observed in all five culture systems; KSOMaa 60% vs 81%; Global 
50% vs 71%; HTF 47% vs 76; P1/MB 53% vs 79%; and G1.5/G2.5 41% vs 67% for 
culture alone compared to combined treatment, respectively. 
An overall comparison of the three paradigms, in vivo-derived (68 embryos), 
spontaneously ovulated-cultured (147 embryos) and superovulated-cultured (120
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Figure 3.10. Imprinted Expression of H19 - Superovulation and Cultured Embryos
Imprinted expression of H19 in B6(CAST7)xB6 embryos derived from superovulated 
females and cultured in six different media systems.  Details are as described in Figure 
3.9.
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embryos) groups, revealed that loss of imprinted expression occurred more frequently in 
the superovulated-cultured treatment group (73%) compared to the spontaneously 
ovulated-cultured treatment group (47%) and to controls (0%) (p < 0.01) (Supplementary 
Table 3.6).  Furthermore, H19 was expressed in a greater percentage of embryos in the 
superovulated-culture group (94%) than in the spontaneously  ovulated-cultured group 
(75%) and in in vivo-derived embryos (13% expression) (Supplementary Table 3.6) (p < 
0.05).  These results indicated that superovulation together with embryo culture results in 
greater H19 expression perturbations.
3.4 Discussion
In this study, we performed a side-by-side comparison of five commercial culture 
systems to determine their effects on genomic imprinting.  All five culture systems had 
compromised ability  to maintain genomic imprinting compared to in vivo-derived 
embryos, although in comparison to Whitten’s culture, some media systems were better 
able to maintain imprinted methylation.  We also observed that combined treatment of 
superovulation and embryo culture resulted in increased disruption of genomic 
imprinting, as evidenced by increased loss of imprinted H19 expression.  Thus, we 
conclude that minimizing times in culture and number of ART procedures is important to 
ensure the fidelity of imprinted gene expression during preimplantation development. 
3.4.1 Comparison of Media Systems
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Many studies have been performed to evaluate culture systems with respect to 
developmental competence, epigenetic status, embryo grade (quality), development rate, 
implantation rate, and pregnancy rate in humans (Staessen et al., 1998; Mauri et al., 2001; 
Artini et al., 2004; Ben-Yosef et al., 2004; Zollner et al., 2004; Sepulveda et al., 2009; 
Xella et al., 2010) and mouse (Sasaki et al., 1995; Doherty et al., 2000; Ecker et al., 2004; 
Fernandez-Gonzalez et al., 2004; Mann et al., 2004; Li et al., 2005; Fauque et al., 2007; 
Rivera et al., 2008).  However, comparisons between studies, even those evaluating the 
same culture system, remain problematic due to variations in culture parameters including 
type of overlay, oxygen tension, culture drop  volume, serum supplement, combined 
procedures such as IVF/ICSI, and many  more.  This study is the first  to provide a 
comparative analysis of five different, commercially  available culture systems.  To allow 
reliable comparison between media systems, all embryos were cultured with the same oil 
overlay and drop  volume, and in the same incubator, under the same oxygen conditions 
(except Whitten’s medium, which requires different oxygen tension than the other media 
formulations).  Embryos were flushed from oviducts in their respective culture media, 
supplemented with the same lot of serum substitute (according to manufacturer’s 
instructions for mouse embryo assay), and were handled by the same individual.  Our 
strategy was to introduce as little variation between culture conditions as possible to 
allow true comparisons between systems.
Furthermore, confusion has arisen, as controversy  exists in the literature regarding 
the best embryo culture system (Summers and Biggers, 2003; Lane and Gardner, 2007; 
Biggers and Summers, 2008).  However, no significant advantage has been shown for one 
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system over another with respect to blastocyst development, implantation rates or 
pregnancy rates (Staessen et al., 1998; Mauri et al., 2001; Fauque et al., 2007).  While 
blastocyst formation and embryo morphology are currently the best predictors available 
for assessing embryo quality, they may  not necessarily be predictive of epigenetic health. 
Thus, understanding effects of embryo culture at the molecular level is essential.  As such, 
we set out  to determine whether one culture media system was more favourable for 
imprint maintenance during preimplantation development. 
An important finding from these experiments is that culture media actively used 
for both mice and humans generated a loss of imprinting following in vitro culture of 
mouse embryos.  Previous studies have shown aberrant imprinted methylation following 
mouse embryo culture using KSOMaa and Whitten’s media systems, with KSOMaa being 
named the better media system (Doherty et al., 2000; Mann et al., 2004).  These data 
support our results, as we demonstrate greater H19, Snrpn and Peg3 imprinted 
methylation levels in embryos cultured in KSOMaa compared to the other media system 
for which lower methylation levels were observed for at least one imprinted gene. 
However, these differences in methylation did not translate into differences in the ability 
to maintain H19, Snrpn or Peg3 imprinted expression at the blastocyst stage.  Imprinted 
expression was maintained for Snrpn and Peg3 in all media systems while H19 displayed 
similar levels of biallelic expression in all media systems when compared to control 
embryos. 
There are number of explanations for this discordance.  Firstly, H19 imprinted 
expression is restricted to the trophectoderm in blastocyst stage embryos (Poirier et al., 
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1991).  As we observed greater imprinting perturbations in the placenta compared to the 
embryo proper in midgestation embryos, it may indicate that greater methylation loss 
occurs in trophectoderm cells than in inner mass cells.  Alternatively, differences in the 
ability  to maintain imprinted expression in culture may relate to Snrpn and Peg3 being 
protein-coding genes, while H19 is a noncoding RNA.  Finally, DNA methylation is but 
one indicator of chromatin status.  As a combination of DNA methylation and histone 
modifications likely direct parental-specific expression, adverse effects of in vitro culture 
on histone modifications may also lead to greater misregulation of imprinted gene 
expression.  Combined expression and methylation analyses in single blastocyst stage 
embryos will allow direct  comparison of imprinted DNA methylation loss and loss of 
imprinted expression.  Analysis of histone modification in blastocyst stage embryos will 
also provide greater insight into the effects of embryo culture on imprinted gene 
regulation.
A second finding from this study  is that results from one gene cannot be 
generalized to all imprinted genes.  For H19, embryos cultured in KSOMaa, Global and 
P1/MB displayed levels of H19 imprinted methylation more similar to in vivo-derived 
embryos than other media systems.  Embryos cultured in HTF and G1.5/G2.5 displayed 
H19 methylation levels least distinguishable from Whitten’s, but were highly 
distinguishable from in vivo-derived embryos.  For Snrpn, while distinguishable from in 
vivo-derived embryos, KSOMaa and Global better maintained imprinted methyation than 
the other media systems.  For Peg3, levels of imprinted methylation for KSOMaa 
cultured embryos were least distinguishable from in vivo, while methylation levels for 
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G1.5/G2.5 cultured embryos were most distinguishable from in vivo and least 
distinguishable from Whitten’s.  These finding illustrate the point that certain media 
appear to support levels of imprinted methylation similar to in vivo-derived embryos at 
some but not at all loci.  
The five commercial media systems used in this study post the compounds present 
in the medium. However, specific concentrations are proprietary, preventing an in-depth 
comparison of the media systems.  Based on components, KSOMaa and Global are likely 
the most similar media.  Thus, it  is not surprising that they performed similarly. HTF is 
likely more similar to Whitten’s in that  it lacks amino acids, possibly accounting for the 
more severe loss of methylation produced by these media.  The rest of the media systems 
contain amino acids with the caveat that of the two-step systems, P1 contains no amino 
acids and G1.5 has nonessential amino acids plus methionine while both MB and G2.5 
harbor essential and nonessential amino acids.  For these two sequential systems, it is not 
readily apparent why they did not generate more similar effects on imprinted methylation 
loss, although it  may lie in their differences.  P1/MB contains the antioxidant sodium 
citrate while G1.5/G2.5 contains vitamins.  What can be concluded is that sequential 
media systems did not seem to confer an advantage with respect to maintenance of 
genomic imprinting compared to their single step counterparts, nor did medium renewal.
3.4.2 Combined effects of ART treatments
Experiments presented in Chapter 2 showed that superovulation alone can perturb 
imprint acquisition at multiple imprinted loci, in a dose-dependent manner.  Thus, we set 
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out to determine whether a combination of ART treatments would lead to greater 
perturbation of imprinting.  We observed that increased loss of H19 imprinted expression 
as a result of embryo culture was exacerbated by the use of superovulation.  A study  by 
Rivera et al. also demonstrated an increase in biallelic expression of many imprinted 
genes following superovulation with embryo transfer compared to controls, with a further 
increase in biallelic expression following embryo culture combined with superovulation 
and embryo transfer (Rivera et al., 2008).  Together, these studies demonstrate that 
combined ART procedures result in greater perturbation of genomic imprinting compared 
to single interventions.
One critical question that must be answered is how transferable these results and 
those of other studies are to human embryo culture.  The main aim of this study was to 
employ commercial formulations of various culture systems to allow for evaluation of 
media currently used in human ART.  However, the possibility remains that human 
embryos may not be as susceptible to culture-induced errors, or may display different 
sensitivities to these culture systems than the mouse.  To address the question of 
proclivity  of ART procedures to induced epigenetic errors, retrospective studies were 
performed on BWS children born after ARTs (DeBaun et al., 2003; Chang et al., 2005). 
Variable ART procedures were reported in ART-associated BWS children with no 
common factor emerging.  Differences were observed in cause of infertility, embryo 
culture media (varied in glucose, amino acid and human serum albumin content), day  of 
transfer, and ART method (IVF, ICSI, ovarian stimulation regime) employed (DeBaun et 
al., 2003; Chang et al., 2005).  These data suggest that  human embryos are susceptible to 
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ART-induced errors but that it is not a specific system that generates epigenetic errors. 
Instead, it  is multiple ART procedures, such as ovarian stimulation combined with 
embryo culture, that pose greater risks for developing imprinting disorders.  As the genes 
investigated in this study play an important role in early development, and genetic and 
epigenetic perturbations lead to imprinting disorders, we propose that culture time and 
number of ART procedures should be minimized to ensure fidelity of genomic imprint 
maintenance during development. 
139
3.5 References
Artini, P. G., Valentino, V., Cela, V., Cristello, F., Vite, A. and Genazzani, A. R. (2004) 'A 
randomized control comparison study of culture media (HTF versus P1) for 
human in vitro fertilization', Eur J Obstet Gynecol Reprod Biol 116(2): 196-200.
Barker, D. J. (2000) 'In utero programming of cardiovascular disease', Theriogenology 
53(2): 555-74.
Bavister, B. D. (1995) 'Culture of preimplantation embryos: facts and artifacts', Hum 
Reprod Update 1(2): 91-148.
Ben-Yosef, D., Amit, A., Azem, F., Schwartz, T., Cohen, T., Mei-Raz, N., Carmon, A., 
Lessing, J. B. and Yaron, Y. (2004) 'Prospective randomized comparison of two 
embryo culture systems: P1 medium by Irvine Scientific and the Cook IVF 
Medium', J Assist Reprod Genet 21(8): 291-5.
Bertolini, M., Beam, S. W., Shim, H., Bertolini, L. R., Moyer, A. L., Famula, T. R. and 
Anderson, G. B. (2002) 'Growth, development, and gene expression by in vivo- 
and in vitro-produced day 7 and 16 bovine embryos', Mol Reprod Dev 63(3): 
318-28.
Biggers, J. D. and Summers, M. C. (2008) 'Choosing a culture medium: making informed 
choices', Fertil Steril 90(3): 473-83.
Bowman, P. and McLaren, A. (1970) 'Viability and growth of mouse embryos after in 
vitro culture and fusion', J Embryol Exp Morphol 23(3): 693-704.
Chang, A. S., Moley, K. H., Wangler, M., Feinberg, A. P. and Debaun, M. R. (2005) 
'Association between Beckwith-Wiedemann syndrome and assisted reproductive 
technology: a case series of 19 patients', Fertil Steril 83(2): 349-54.
Cox, G. F., Burger, J., Lip, V., Mau, U. A., Sperling, K., Wu, B. L. and Horsthemke, B. 
(2002) 'Intracytoplasmic sperm injection may increase the risk of imprinting 
defects', Am J Hum Genet 71(1): 162-4.
DeBaun, M. R., Niemitz, E. L. and Feinberg, A. P. (2003) 'Association of in vitro 
fertilization with Beckwith-Wiedemann syndrome and epigenetic alterations of 
LIT1 and H19', Am J Hum Genet 72(1): 156-60.
Doherty, A. S., Mann, M. R., Tremblay, K. D., Bartolomei, M. S. and Schultz, R. M. 
(2000) 'Differential effects of culture on imprinted H19 expression in the 
preimplantation mouse embryo', Biol Reprod 62(6): 1526-35.
Ecker, D. J., Stein, P., Xu, Z., Williams, C. J., Kopf, G. S., Bilker, W. B., Abel, T. and 
Schultz, R. M. (2004) 'Long-term effects of culture of preimplantation mouse 
embryos on behavior', Proc Natl Acad Sci U S A 101(6): 1595-600.
Edwards, L. J., Batt, P. A., Gandolfi, F. and Gardner, D. K. (1997) 'Modifications made to 
culture medium by bovine oviduct epithelial cells: changes to carbohydrates 
stimulate bovine embryo development', Mol Reprod Dev 46(2): 146-54.
Fauque, P., Jouannet, P., Lesaffre, C., Ripoche, M. A., Dandolo, L., Vaiman, D. and 
Jammes, H. (2007) 'Assisted Reproductive Technology affects developmental 
kinetics, H19 Imprinting Control Region methylation and H19 gene expression in 
individual mouse embryos', BMC Dev Biol 7: 116.
140
Fawcett, T. (2006) 'An introduction to ROC analysis. ', Pattern Recognit Lett(27): 
861-874.
Fernandez-Gonzalez, R., Moreira, P., Bilbao, A., Jimenez, A., Perez-Crespo, M., Ramirez, 
M. A., Rodriguez De Fonseca, F., Pintado, B. and Gutierrez-Adan, A. (2004) 
'Long-term effect of in vitro culture of mouse embryos with serum on mRNA 
expression of imprinting genes, development, and behavior', Proc Natl Acad Sci U 
S A 101(16): 5880-5.
Gardner, D. K. (1994) 'Mammalian embryo culture in the absence of serum or somatic 
cell support', Cell Biol Int 18(12): 1163-79.
Gardner, D. K. and Lane, M. (1998) 'Culture of viable human blastocysts in defined 
sequential serum-free media', Hum Reprod 13 Suppl 3: 148-59; discussion 160.
Gicquel, C., Gaston, V., Mandelbaum, J., Siffroi, J. P., Flahault, A. and Le Bouc, Y. (2003) 
'In vitro fertilization may increase the risk of Beckwith-Wiedemann syndrome 
related to the abnormal imprinting of the KCN1OT gene', Am J Hum Genet 72(5): 
1338-41.
Goodman, S. (1999) 'Toward evidence-based medical statistics.  1.  The p-value fallacy.', 
Ann Intern Med(130): 995-1004.
Halliday, J., Oke, K., Breheny, S., Algar, E. and D, J. A. (2004) 'Beckwith-Wiedemann 
syndrome and IVF: a case-control study', Am J Hum Genet 75(3): 526-8.
Ho, Y., Wigglesworth, K., Eppig, J. J. and Schultz, R. M. (1995) 'Preimplantation 
development of mouse embryos in KSOM: augmentation by amino acids and 
analysis of gene expression', Mol Reprod Dev 41(2): 232-8.
Hubbard, R. and Bayarri, M. (2003) 'Confusion over measures of evidence (p's) versus 
errors (_'s) in classical statistical testing.', Am Stat(57): 171-178.
Jeffreys, H. (1961) The theory of probability, Oxford: Oxford University Press.
Kaffer, C. R., Grinberg, A. and Pfeifer, K. (2001) 'Regulatory mechanisms at the mouse 
Igf2/H19 locus', Mol Cell Biol 21(23): 8189-96.
Kass, R. and Raftery, A. (1995) 'Bayes Factors', J Am Stat Asso(90): 773-795.
Khosla, S., Dean, W., Brown, D., Reik, W. and Feil, R. (2001) 'Culture of preimplantation 
mouse embryos affects fetal development and the expression of imprinted genes', 
Biol Reprod 64(3): 918-26.
Kullback, S. (1978) Information theory and statistics., New York: Dover.
Kullback, S. and Leibler, R. (1951) 'On information and sufficiency.', Ann Math Stat(22): 
79-86.
Lane, M. and Gardner, D. K. (2007) 'Embryo culture medium: which is the best?', Best 
Pract Res Clin Obstet Gynaecol 21(1): 83-100.
Lawitts and Biggers, J. D. (2003) Culture of preimplantation embryos, San Diego: 
Academic Press.
Leese, H. J. and Barton, A. M. (1984) 'Pyruvate and glucose uptake by mouse ova and 
preimplantation embryos', J Reprod Fertil 72(1): 9-13.
Li, T., Vu, T. H., Ulaner, G. A., Littman, E., Ling, J. Q., Chen, H. L., Hu, J. F., Behr, B., 
Giudice, L. and Hoffman, A. R. (2005) 'IVF results in de novo DNA methylation 
141
and histone methylation at an Igf2-H19 imprinting epigenetic switch', Mol Hum 
Reprod 11(9): 631-40.
Ludwig, M., Katalinic, A., Gross, S., Sutcliffe, A., Varon, R. and Horsthemke, B. (2005) 
'Increased prevalence of imprinting defects in patients with Angelman syndrome 
born to subfertile couples', J Med Genet 42(4): 289-91.
Mann, M. R., Lee, S. S., Doherty, A. S., Verona, R. I., Nolen, L. D., Schultz, R. M. and 
Bartolomei, M. S. (2004) 'Selective loss of imprinting in the placenta following 
preimplantation development in culture', Development 131(15): 3727-35.
Market-Velker, B. A., Zhang, L., Magri, L. S., Bonvissuto, A. C. and Mann, M. R. 
(2010a) 'Dual effects of superovulation: loss of maternal and paternal imprinted 
methylation in a dose-dependent manner', Hum Mol Genet 19(1): 36-51.
Mauri, A. L., Petersen, C. G., Baruffi, R. L. and Franco, J. G., Jr. (2001) 'A prospective, 
randomized comparison of two commercial media for ICSI and embryo culture', J 
Assist Reprod Genet 18(7): 378-81.
Neyman, J. and Pearson, E. (1933) 'On the problem of the most efficient tests of statistical 
hypothesies', Philos Trans R Soc Lond A(231): 289-337.
Orstavik, K. H., Eiklid, K., van der Hagen, C. B., Spetalen, S., Kierulf, K., Skjeldal, O. 
and Buiting, K. (2003) 'Another case of imprinting defect in a girl with Angelman 
syndrome who was conceived by intracytoplasmic semen injection', Am J Hum 
Genet 72(1): 218-9.
Poirier, F., Chan, C. T., Timmons, P. M., Robertson, E. J., Evans, M. J. and Rigby, P. W. 
(1991) 'The murine H19 gene is activated during embryonic stem cell 
differentiation in vitro and at the time of implantation in the developing embryo', 
Development 113(4): 1105-14.
Quinn, P. and Horstman, F. C. (1998) 'Is the mouse a good model for the human with 
respect to the development of the preimplantation embryo in vitro?', Hum Reprod 
13 Suppl 4: 173-83.
Quinn, P., Kerin, J. F. and Warnes, G. M. (1985) 'Improved pregnancy rate in human in 
vitro fertilization with the use of a medium based on the composition of human 
tubal fluid', Fertil Steril 44(4): 493-8.
Reese, K. J., Lin, S., Verona, R. I., Schultz, R. M. and Bartolomei, M. S. (2007) 
'Maintenance of paternal methylation and repression of the imprinted H19 gene 
requires MBD3', PLoS Genet 3(8): e137.
Rinaudo, P. and Schultz, R. M. (2004) 'Effects of embryo culture on global pattern of 
gene expression in preimplantation mouse embryos', Reproduction 128(3): 
301-11.
Rivera, R. M., Stein, P., Weaver, J. R., Mager, J., Schultz, R. M. and Bartolomei, M. S. 
(2008) 'Manipulations of mouse embryos prior to implantation result in aberrant 
expression of imprinted genes on day 9.5 of development', Hum Mol Genet 17(1): 
1-14.
Roberts, R. M. (2005) 'Embryo culture conditions: what embryos like best', 
Endocrinology 146(5): 2140-1.
142
Santos, F. and Dean, W. (2004) 'Epigenetic reprogramming during early development in 
mammals', Reproduction 127(6): 643-51.
Sasaki, H., Ferguson-Smith, A. C., Shum, A. S., Barton, S. C. and Surani, M. A. (1995) 
'Temporal and spatial regulation of H19 imprinting in normal and uniparental 
mouse embryos', Development 121(12): 4195-202.
Schieve, L. A., Meikle, S. F., Ferre, C., Peterson, H. B., Jeng, G. and Wilcox, L. S. (2002) 
'Low and very low birth weight in infants conceived with use of assisted 
reproductive technology', N Engl J Med 346(10): 731-7.
Sepulveda, S., Garcia, J., Arriaga, E., Diaz, J., Noriega-Portella, L. and Noriega-Hoces, L. 
(2009) 'In vitro development and pregnancy outcomes for human embryos 
cultured in either a single medium or in a sequential media system', Fertil Steril 
91(5): 1765-70.
Sinclair, K. D., McEvoy, T. G., Maxfield, E. K., Maltin, C. A., Young, L. E., Wilmut, I., 
Broadbent, P. J. and Robinson, J. J. (1999) 'Aberrant fetal growth and 
development after in vitro culture of sheep zygotes', J Reprod Fertil 116(1): 
177-86.
Sokal, R. and Rohlf, F. (1994) Biometry: the principles and practice of statistics in 
biological research., New York: WH Freeman and Co.
Staessen, C., Janssenswillen, C., De Clerck, E. and Van Steirteghem, A. (1998) 
'Controlled comparison of commercial media for human in-vitro fertilization: 
Menezo B2 medium versus Medi-Cult universal and BM1 medium', Hum Reprod 
13(9): 2548-54.
Summers, M. C. and Biggers, J. D. (2003) 'Chemically defined media and the culture of 
mammalian preimplantation embryos: historical perspective and current issues', 
Hum Reprod Update 9(6): 557-82.
Sunderam, S., Chang, J., Flowers, L., Kulkarni, A., Sentelle, G., Jeng, G. and Macaluso, 
M. (2009) 'Assisted reproductive technology surveillance--United States, 2006', 
MMWR Surveill Summ 58(5): 1-25.
Thorvaldsen, J. L., Duran, K. L. and Bartolomei, M. S. (1998) 'Deletion of the H19 
differentially methylated domain results in loss of imprinted expression of H19 
and Igf2', Genes Dev 12(23): 3693-702.
Tremblay, K. D., Duran, K. L. and Bartolomei, M. S. (1997) 'A 5' 2-kilobase-pair region 
of the imprinted mouse H19 gene exhibits exclusive paternal methylation 
throughout development', Mol Cell Biol 17(8): 4322-9.
Verona, R. I., Mann, M. R. and Bartolomei, M. S. (2003) 'Genomic imprinting: intricacies 
of epigenetic regulation in clusters', Annu Rev Cell Dev Biol 19: 237-59.
Walker, S. K., Hill, J. L., Kleemann, D. O. and Nancarrow, C. D. (1996) 'Development of 
ovine embryos in synthetic oviductal fluid containing amino acids at oviductal 
fluid concentrations', Biol Reprod 55(3): 703-8.
Weksberg, R., Nishikawa, J., Caluseriu, O., Fei, Y. L., Shuman, C., Wei, C., Steele, L., 
Cameron, J., Smith, A., Ambus, I. et al. (2001) 'Tumor development in the 
Beckwith-Wiedemann syndrome is associated with a variety of constitutional 
143
molecular 11p15 alterations including imprinting defects of KCNQ1OT1', Hum 
Mol Genet 10(26): 2989-3000.
Xella, S., Marsella, T., Tagliasacchi, D., Giulini, S., La Marca, A., Tirelli, A. and Volpe, A. 
(2010) 'Embryo quality and implantation rate in two different culture media: ISM1 
versus Universal IVF Medium', Fertil Steril 93(6): 1859-63.
Young, E., Kenny, A., Puigdomenech, E., Van Thillo, G., Tiveron, M. and Piazza, A. 
(1998) 'Triplet pregnancy after intracytoplasmic sperm injection of cryopreserved 
oocytes: case report', Fertil Steril 70(2): 360-1.
Zollner, K. P., Zollner, U., Schneider, M., Dietl, J. and Steck, T. (2004) 'Comparison of 
two media for sequential culture after IVF and ICSI shows no differences in 
pregnancy rates: a randomized trial', Med Sci Monit 10(1): CR1-7.
144
Chapter 4: Rates of Embryo Development Correlate with Loss of Genomic 
Imprinting
The work in this chapter originates from the manuscript:
Market Velker, B. A., Denomme, M. M., and Mann, M. R. Loss of Genomic Imprinting in 
Embryos with Rapid Rates of Preimplantation Development, submitted for publication in 
the journal Human Reproduction in June 2011.
4.1 Introduction
 One of the first observations of deleterious effects of embryo culture is that 
development of mouse embryos in vitro results in an 18 to 24 hour lag in reaching the 
blastocyst stage (Bowman and McLaren, 1970; Harlow and Quinn, 1982).  Since then, 
while culture conditions for preimplantation embryos have steadily improved (Biggers 
and Summers, 2008; Gardner, 2008), even the best media currently available are 
suboptimal for embryo development.  Cultured embryos from all mammalian species 
have reduced viability and reduced pregnancy rates following embryo transfer, display 
aberrant patterns and levels of gene expression, developmental abnormalities and 
deviations in behaviour, and are prone to metabolic and growth disorders (Sasaki et al., 
1995; Sinclair et al., 1999; Barker, 2000; Boerjan et al., 2000; Doherty et al., 2000; 
Khosla et al., 2001; Summers and Biggers, 2003; Ecker et al., 2004; Fernandez-Gonzalez 
et al., 2004; Rinaudo and Schultz, 2004; Morgan et al., 2005).  Preimplantation embryos 
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survive in vitro culture by adapting to the culture environment and stresses it imposes 
(Niemann and Wrenzycki, 2000).
 We and others have also demonstrated that preimplantation embryo culture 
disrupts genomic imprinting in mice (Sasaki et al., 1995; Doherty et al., 2000; Mann et 
al., 2004; Market-Velker et al., 2010b).  In vitro culture of mouse preimplantation 
embryos results in loss of imprinted gene regulation with biallelic expression of the H19 
gene and loss of H19, Snrpn and Peg3 imprinted methylation (Sasaki et al., 1995; 
Doherty et  al., 2000; Mann et al., 2004; Market-Velker et al., 2010b).  In Chapter 3, the 
comparison of six embryo culture media showed that while all were suboptimal in their 
ability  to maintain imprinting, some media systems performed better and others were 
decidedly  worse, such as Whitten’s medium, HTF Medium and G1/G2 (Market-Velker et 
al., 2010b).
 In humans, while the absolute risks remain low, assisted reproductive technologies 
have been linked to imprinting perturbations that lead to the development of Angelman 
Syndrome (AS) and Beckwith-Wiedemann Syndrome (BWS) (Cox et al., 2002; DeBaun 
et al., 2003; Maher et al., 2003; Orstavik et  al., 2003; Halliday et al., 2004; Chang et al., 
2005; Ludwig et al., 2005; Sutcliffe et al., 2006).  In AS patients conceived by assisted 
reproduction, imprinting defects at the maternal SNRPN ICR result in loss of maternal-
specific SNRPN methylation and the entire maternal imprinted domain acquires a paternal 
epigenetic identity  (Cox et al., 2002; Orstavik et al., 2003; Ludwig et al., 2005; Sutcliffe 
et al., 2006).  For BWS patients conceived by assisted reproduction, imprinting defects at 
the maternal H19 ICR (2-7% patients) result in a gain of maternal-specific H19 
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methylation and overexpression of the paternally-transcribed IGF2 gene, while imprinting 
defects at the KCNQ1OT1 ICR (50% patients) result in loss of maternal-specific 
methylation at  the KCNQ1OT1 ICR and biallelic repression of maternally expressed 
genes across the imprinting domain, including CDKN1C (DeBaun et al., 2003; Maher et 
al., 2003; Halliday et al., 2004; Chang et al., 2005).  The maternally-transcribed 
CDKN1C/Cdkn1c gene is an important inhibitor of the cell cycle through its interaction 
with cyclin-CDK complexes (Lee et al., 1995; Matsuoka et al., 1996), and its aberrant 
expression generates major pathologies present in BWS (Hatada and Mukai, 1995; 
Hatada et al., 1996; Zhang et  al., 1997; Yan et al., 1997).  Thus, this imprinted cell cycle 
regulator provides an important link between embryo development and epigenetic 
perturbations in the early embryo. 
 Imprinting marks acquired during gametogenesis must be maintained during the 
preimplantation epigenetic reprogramming period.  However, very little is known about 
the mechanisms that maintain genomic imprinting in the preimplantation embryo, and 
how dysregulation of genomic imprinting during this time period may lead to aberrant 
embryonic growth and development.  In mouse, cell divisions from the 2-cell to 
blastocyst stage occur approximately  every 10-18 hours in vivo, with development from 
fertilization to blastocyst stage taking about 3.5 days (Bowman and McLaren, 1970).  In 
contrast, embryos cultured in vitro to the blastocyst stage generally  require an extra day of 
development in culture.  This has led us to hypothesize that loss of imprinting during 
early mouse development will correlate with slower rates of embryonic development.  To 
test our hypothesis, we separated embryos based on rates of development and examined 
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cell number, embryo volume, and embryo sex, together with imprinted methylation and 
expression at two key loci, H19 and Snrpn, that  are involved in the development of 
imprinting disorders observed in the ART population.  Given the variable response of 
individual embryos to suboptimal culture, these analyses were performed in the same 
individual embryo.  To explore the connection between rates of development and genomic 
imprinting, we also examined expression of the cell cycle inhibitor, Cdkn1c, on the 
premise that biallelic Cdkn1c expression will lead to slower rates of embryo development. 
In addition, as slower rates of development may be linked with metabolic changes, we 
evaluated the expression of three markers of embryonic metabolism, sodium/potassium 
transporting ATPase 1a1 (Atp1a1) which is critical for blastocoel formation (Kidder and 
Watson, 2005), solute carrier 2a1 (Slc2a1/Glut1), a glucose transporter expressed 
throughout preimplantation development (Pantaleon and Kaye, 1998; Augustin et al., 
2001), and mitogen-activated protein kinase 14 (Mapk14/p38 alpha) which is a signaling 
molecule involved in embryo response to suboptimal environments (Natale et al., 2004; 
Paliga et al., 2005; Fong et al., 2007) and in trophoblast differentiation (Johnstone et al., 
2005; Winger et al., 2007).   
 This study demonstrates significant differences in cell number, embryo volume, 
imprinted methylation of H19 and Snrpn, imprinted expression of H19 and Cdkn1c, and 
expression of genes related to embryo metabolism between the four groups of embryos 
separated by rates of development in culture, and when compared to in vivo-derived 
embryos.  Overall, embryos that developed the fastest contained more cells and had the 
largest embryo volume. However, they also had increased loss of methylation at both the 
148
H19 and Snrpn ICRs, and aberrant H19 imprinted expression.  Embryos in the slowest 
group that developed to the blastocyst stage demonstrated more normal levels of 
imprinted methylation at the H19 and Snrpn ICRs, and imprinted expression of H19. 
However, nearly 40% embryos in this group arrested prior to the blastocyst stage (data 
not shown).  Embryos with slow to moderate rates of development were most similar to in 
vivo-derived embryos, displaying cell numbers, embryo volume, H19 and Snrpn 
methylation, H19 imprinted expression, and Atp1a1 and Slc2a1 expression most similar 
to in vivo-derived embryos.  We conclude that rates of preimplantation development in 
vitro are correlated with genomic imprinting and embryo metabolism, and that embryos 
displaying slower rates of development are likely most suitable for embryo transfer. 
4.2 Materials and Methods
4.2.1 Embryo Collection
 Embryos were obtained from naturally-mated C57BL6(CAST7partial6) 
[B6(CAST7p6)] females crossed with C57BL6 (B6) males (Charles River, St Constant, 
Canada) as described (Market-Velker et al., 2010a; Market-Velker et al., 2010b). Briefly, 
B6(CAST7p6) females were checked for estrus and mated with B6 males. Pregnancy  was 
determined (vaginal plug) the morning following mating (0.5 days postcoitum; dpc). 
Embryos were flushed from isolated oviducts at  1.5 dpc to recover 2-cell stage embryos. 
In vivo control blastocysts were recovered from uteri on day 3.5 following natural 
matings. Experiments were performed in compliance with guidelines set by  the Canadian 
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Council for Animal Care, and the policies and procedures approved by the University  of 
Western Ontario Council on Animal Care.  
4.2.2 Embryo Culture
 Embryos were flushed at the 2-cell stage, washed twice and cultured in Whitten’s 
medium (made in-house) at a concentration 1 embryo per µL of medium in either 10, 15 
or 20 µL drops with filter-sterilized mineral oil overlay (Sigma).  Embryos in the “Fast” 
group were those containing 8 or more cells and were transferred to new culture drops, 
while embryos in the “Slow” group contained less than 8 cells and were transferred to 
separate culture drops.  On day 2 of culture, embryos were again separated at 3 PM  +/- 1 
hr.  Embryos in the “Fast/Fast” (FF) group had begun cavitation, while those in the “Fast/
Slow” (FS) group  had not.  Embryos in the “Slow/Fast” (SF) group had reached the 
compacted morula stage, while those in the “Slow/Slow” (SS) group had not yet 
compacted.  All embryo groups were again transferred to new pre-equilibrated culture 
drops.  Embryos were subjected to image analysis (below) then placed in individual tubes 
in approximately 1 µL culture medium at noon on day  3 (107 hours after mid-point of 
light:dark cycle), snap frozen on dry ice and stored at -80°C.  Culture was performed at 
least 10 times, and embryos were analyzed from multiples litters.
4.2.3 Imaging and Cell Counting
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 On day 3 of embryo culture prior to freezing, embryos were transferred to culture 
drops containing Hoechst 33342.  This dye was chosen as it binds in the minor groove of 
DNA and does not intercalate between the base pairs.  Prior to experimental analysis, we 
determined that Hoechst 33342 staining had no effect on downstream methylation 
analyses of embryonic DNA (data not shown).  Embryos were incubated in Hoechst 
33342 for 7-10 minutes, and transferred to fresh drops of Whitten’s medium for imaging.  
Images were obtained using Fluoview 1000 laser scanning confocal microscope 
(Olympus Corp), using the 20x objective (Olympus superapochromat 0.75), with a band 
pass of 425-475 nm for Hoescht. Z-stacks were taken for each embryo with a distance of 
4 µm between each slice.  Bright field images were also taken of each embryo to facilitate 
downstream cell counting.
 Cell counting was performed in duplicate from the top and from the bottom of 
each Z-stack using the Fluoview V10-ASW 2.1 Software.  Embryo volume was 
calculated using 2 measurements of embryo length (µm) taken in perpendicular planes 
using the Image Pro Analyzer 6.2. Software.  These lengths were averaged and then 
divided by 2 to generate an average radius for each embryo.  Volume of a sphere 
(V=4/3π·r3) was used to calculate embryo volumes.
4.2.4 Analysis of Imprinted Methylation and Expression
 Bisulfite mutagenesis and imprinted expression analysis was performed as 
described previously (Market-Velker et al., 2010a; Market-Velker et  al., 2010b), with 
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modifications to allow the concurrent analysis of imprinted methylation and expression. 
Briefly, stored embryos were quickly thawed on ice, and 10 µL of Dynabead Lysis Buffer 
was added to each tube.  This solution was transferred to pre-equilibrated oligo-dT 
Dynabeads (Invitrogen) and incubated for 5 minutes at room temperature with shaking. 
Supernatant was transferred back to the original embryo tubes for bisulfite mutagenesis as 
previously  described (Market-Velker et al., 2010a).  mRNA-Dynabead complexes were 
processed and a cDNA library was generated as previously described (Market-Velker et 
al., 2010b).  Analysis of imprinted expression of H19 and Snrpn was performed using the 
LightCycler Real Time PCR System (Roche Molecular Biochemicals) as previously 
described (Market-Velker et al., 2010b).
 Following bisulfite mutagenesis, nested PCR, cloning and sequencing was 
performed for H19 and Snrpn ICR as previously  described (Market-Velker et al., 2010b). 
Forty-50 clones per embryo were sequenced.  Each sequence was analyzed for location 
and number of converted and unconverted non-CpG associated cytosines to obtain 
conversion rates (number of converted non-CpG cytosines/total number of non-CpG 
cytosines) as well as total number and location of CpG associated cytosines.  Sequences 
with less than 85% conversion rates were not included.  Identical clones (identical 
location and number of unconverted CpG associated cytosines, and identical location and 
number of unconverted non-CpG associated cytosines) were included only  once. 
Polymorphisms present between B6 and CAST sequences at  each gene analyzed allowed 
discrimination between parental alleles.  Hypermethylation of a DNA strand was defined 
at >50% methylated CpGs on a given strand.
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4.2.5 Sex Determination in Individual Embryos
 The cDNA library generated for each embryo was used for the analysis of embryo 
sex.  Two PCR reactions were performed for each embryo.  The first, a nested PCR for 
the Sry gene, located on the Y chromosome, and second, amplification of Xist, a gene 
located on the X chromosome (Table 4.1).  Samples were visualized with gel 
electrophoresis on a 12% acrylamide gel.  The presence of an Sry and Xist amplicon 
indicated a male embryo, while amplification of Xist alone indicated a female embryo. 
Nested PCR for Sry was performed in duplicate.
4.2.6 Cdkn1c Imprinted Expression Analysis
 The analysis of imprinted Cdkn1c expression was performed using the cDNA 
library generated for each embryo.  PCR primers and parameters can be found in Table 
4.1.  Amplification was tested using SYBR green to allow determination of the range of 
cycles located in log-phase amplification.  PCR on subsequent embryos was performed to 
ensure that amplification was log-phase upon completion of the PCR program.  Following 
amplification embryos were digested with the TaqaI restriction enzyme to determine 
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Table 4.1: Primers and PCR Protocols
Gene Primers PCR Program
Xist Forward:
5’ - TTG CGG GAT TCG CCT TGAT T - 3’
Reverse:
5’ - TGA GCA GCC CTT AAA GCC AC - 3’
95°C 2 min
95°C 15 sec
60°C 10 sec
72°C 20 sec
45 cycles
72°C 5 min
Sry First round:
Forward:
5’ - GTG TGG TCC CGT GGT GAG AG - 3’
Reverse:
5’ - TCC AGT CTT GCC TGT ATG TGA TG - 3’
Second Round:
Forward:
5’ - CCC AGC AGA ATC CCA GCA T - 3’
Reverse:
5’ - CTG TGA CAC TTT AGC CCT CCG - 3’
First round:
94°C 2 min
94°C 30 sec
60°C 30 sec
72°C 40 sec
45 cycles
72°C 5 min
Second round:
95°C 2 min
94°C 20 sec
62°C 20 sec
72°C 30 sec
40 cycles
72°C 5 min
Cdkn1c Forward: 
5’ - GCC AAT GCG AAC GAC TTC - 3’
Reverse:
5’ - TAC ACC TTG GGA CCA GCG TAC TCC - 3’
94°C 2 min
94°C 30 sec
58°C 30 sec
72°C 45 sec
40 cycles
72°C 5 min
Atp1a1 Forward: 
5’ – TTC AGC CCA GAA GGA CGA CAT G – 3’
Reverse: 
5’ – AGG GAA GCC GTA GTA TCC GCC CA – 3’
2nd Strand Synthesis:
94°C 2 min
94 °C 30 sec
56 °C/57 °C (Slc2a1) 30 
sec
72 °C 30 sec
94°C 10 min
qRT-PCR:
95°C 4 min
94°C 30 sec
56°C / 57°C (Slc2a1) 30 
sec
72°C 30 sec
45 cycles
94°C 2 min
30°C 2 min
Melting curve from 55 – 
95 °C, read every 1°C.
Slc2a1 Forward:
5’ – CCC AGA AGG TTA TTG AGG AGT T – 3’
Reverse:
5’ – ACG CTT TGG TCT CTC TCC G – 3’
Mapk14 Forward:
5 ‘- AGG CCA TGG TGC ATG TGT GT – 3’
Reverse:
5’ – AGT AGC TGG AGG AGG AGG AG – 3’
Mrpl1 Forward: 
5’ – TTG GAT ATG CCA AGT GAC CA – 3’
Reverse: 
5’ – GCT TCT GCC GTT TGA GTT TC – 3’
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allelic identity; only the B6 allele is cleaved.  Densitometry was performed using the 
Opticon Monitor Software (Biorad).  
4.2.7 Expression Analysis of Atp1a1, Slc2a1 and Mapk14
 The evaluation of Atp1a1, Slc2a1 and Mapk14 expression was performed using 
the cDNA library generated for each embryo, with mitochondrial ribosomal protein L1 
(Mrpl1) as the internal control.  Primers and PCR parameters can be found in Table 4.1. 
Second strand synthesis was performed using the forward primers of both Mrpl1 and the 
gene of interest, and amplification products were then split into separate reactions for RT-
PCR for Mrpl1 and the gene of interest.  Amplification was performed on biological 
replicates with SYBR green using the BioRad Opticon Monitor Real Time PCR Machine 
and Software. Analysis of RT-PCR was performed using the ΔΔCt method, with the 
GeneEx (BioRad) software.  
4.2.8 Statistical Analysis
 To compare between the four culture groups, and between cultured and in vivo-
derived embryos, a nested two-factor ANOVA was performed using R (The R Foundation 
for Statistical Computing (Team, 2011)).  The five groups of embryos were compared 
with respect to embryo volume; cell number; embryo sex; H19 and Snrpn methylation 
levels; H19, Snrpn and Cdkn1c imprinted expression; and Atp1a1, Slc2a1 and Mapk14 
expression using the “aov” (analysis of variance) command.  Expression of the three 
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metabolic marker genes was normalized for Mrpl1 expression, and analyzed both before 
and after normalization for cell numbers.  This was done to obtain additional information 
about whether the change in expression was attributed to an overall change in expression, 
or a change in levels of expression per cell, respectively.  The effect size of each 
comparison that generated a significant p-value was estimated using the “lm” (linear 
model) function, setting the intercept of the model at zero.  This was used to determine 
which groups were most similar to in vivo-derived embryos.  A p-value less than 0.05 was 
taken to be statistically significant.  
4.3 Results
4.3.1 Effects of Embryo Culture on Blastocyst Cell Number and Volume
 The aim of our study  was to determine whether any correlation existed between 
rates of preimplantation embryo development and loss of genomic imprinting.  To best 
evaluate these effects, experiments were done at the individual embryo level, as we 
previously  reported significant inter-embryo variability  in response to ARTs (Market-
Velker et al., 2010a; Market-Velker et al., 2010b) and because this is the level of 
importance in the human ART clinic.  As such, we have developed a novel method to 
evaluate both imprinted methylation and expression of multiple loci in the same 
individual blastocyst, as well as obtain data about cell numbers, embryo volume, and 
embryo sex.  This is the first study of its kind to evaluate multiple parameters to correlate 
morphological changes with epigenetic changes at the individual embryo level.
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 On the premise that individual embryos develop at different rates in culture, 
embryos were separated into four groups based on their stage of development at two pre-
determined time points during the culture time course (Figure 4.1A).  These time points 
were chosen based on the ability to reproducibly distinguish between “Fast” and “Slow” 
at each separation.  Whitten’s culture medium was used as we determined from previous 
studies that culture in Whitten’s medium produced the most significant perturbations of 
genomic imprinting (Market-Velker et al., 2010b), and it allowed us to obtain sufficient 
embryo numbers in each group for analysis.  Multiple culture time courses were 
completed and a total of 68 embryos were collected for analysis, 24 FF, 10 FS, 19 SF, and 
15 SS.  Of these embryos, 47 (16 FF, 9 FS, 10 SF and 12 SS) were analyzed for each of 
the following parameters: cell counts, embryo volume, embryo sex, imprinted 
methylation and expression of H19 and Snrpn, and imprinted expression of Cdkn1c 
(Figure 4.1B).  For the SS group nearly 40% of embryos arrested and did not reach the 
blastocyst stage (unpublished data). For all groups only embryos that developed to the 
blastocyst stage were analyzed.  
 To determine whether differences existed in the total cell numbers present in each 
of the four culture groups, embryos were stained with Hoechst 33342, Z-stacks were 
taken using confocal microscopy, and cells were counted (Figure 4.1B, 4.2A).  We 
observed that on average the FF group contained 74.3 cells, the FS group 46.8 cells, the 
SF group 33.9 cells, the SS group 25.0, and the in vivo-derived group 28.3 cells, which 
was similar to previous studies (Bowman and McLaren, 1970; Smith and McLaren, 
1977).  To evaluate whether differences in cell number were statistically different between
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Figure 4.1: Embryo Separation and Analysis
(A) Graphical representation of the embryo separation scheme.  Two-cell embryos were 
collected, cultured for 24 hours, at  which time the first separation took place.  “Fast” 
embryos were those that displayed 8 or more cells, while “Slow” embryos were those 
containing less than 8 cells.  After an additional 24 hours, the second separation was 
performed.  From the original “Fast” group, those that  showed a blastocyst cavity  were 
classified as “Fast” in the second separation, while those with no evidence of a blastocyst 
cavity were classified as “Slow”.  From the original “Slow” group, compacted morulae 
were classified as “Fast”, and those that were not  compacted were classified as “Slow”. 
After an additional 24 hours, embryos were individually frozen at -80°C.  (B) Individual 
blastocyst assay for multiple data sets.  Top left: Merge of bright field and Hoechst 33342 
staining used to count cell numbers.  Blastocyst  FF23 contained 48 cells.  Top right: Sry 
expression analysis used for embryo sex determination.  L, ladder; F, Female control; M, 
Male control; FF23, blastocyst FF23; -ve, negative control.  Blastocyst FF23 was a male 
embryo.  Bottom left: Paternal H19 methylation analysis. Filled circles represent 
methylated CpGs dinucleotides while unfilled circles represent unmethylated CpGs. Each 
row represents one DNA strand. Blastocyst FF23 displayed 70% hypermethylation at the 
H19 paternal allele.  Bottom right: LightCycler H19 imprinted expression analysis. 
Blastocyst FF23 displayed biallelic expression of H19, with 81% and 19% expression 
from the maternal and paternal alleles, respectively.
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Figure 4.2: Cell Numbers, Embryo Volume and Embryo Sex
Graphical representation of cell numbers and embryo volumes of the four groups of 
cultured embryos and in vivo-derived embryos.  (A) Left: Cell numbers separated by 
embryo group.  Each diamond represents one embryo, and black bars indicate mean cell 
number of each group.  Right: Mean cell numbers in “Fast” and “Slow” groups based on 
the first separation. * the “Fast” group  had significantly more cells than “Slow” group  and 
the in vivo-derived  group. (B) Left: Embryo volumes separated by embryo group.  Black 
bars indicate mean embryo volume of each group. Right: Mean embryo volume in “Fast” 
and “Slow” groups based on the first separation. * “Fast” embryos had significantly 
larger volumes than the “Slow” embryos and in vivo-derived embryos. ** “Slow” 
embryos displayed significantly fewer cells than in vivo-derived  embryos.  (C) Embryos 
separated by sex. White bars, male embryos; black bars, female embryos. Error bars 
represent standard errors of the mean.
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the “Fast” (FF and FS) and “Slow” (SF and SS) groups at the first separation, and 
between groups (FF versus FS, and SF versus SS) in the second separation, we used a 
nested two-factor ANOVA.  With respect to the first  separation, the number of cells 
present in the “Fast” group  was significantly  greater than those in the “Slow” group.  In 
addition, a statistically significant difference was observed at  the second separation 
(Figure 4.2A).  Therefore, not only were the “Fast” groups morphologically more 
advanced than the “Slow” groups as determined by  embryo stage at the time of 
separation, but the cell cycle progressed more quickly in embryos in the “Fast” group 
compared to those in the “Slow” group as determined by cell numbers.  In vivo-derived 
embryos contained significantly  fewer cells than the “Fast” group, but failed to show a 
difference when compared to the “Slow” group.  Therefore, from both statistical analysis 
and graphical representation (Figure 4.2A), we observed that the embryos clustered into 
three distinct groups.  The FF group contained the most cells.  The FS group contained 
fewer than the FF group.  The SF, SS and in vivo-derived groups contained fewer cells 
than the FS group, but were indistinguishable from one another.  Thus, the SF and SS 
groups most closely resembled the in vivo-derived group.
 The total volume of each embryo was also calculated using measurements of 
length in two dimensions, determining the average of these lengths and using the formula 
for the volume of a sphere for calculations.  Average volumes for the FF group was 
6.7X105 µm3, the FS group 3.8X105 µm3, the SF group 3.3X105 µm3, the SS group 
3.5X105 µm3, and in vivo-derived group 4.9X105 µm3 (Figure 4.2B).  As before, a nested 
two-factor ANOVA was performed to test for differences between embryos in the first and 
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second separations.  As with cell numbers, both groups at the first (FF and FS versus SF 
and SS) and second (FF versus FS, SF versus SS) separations displayed a significant 
difference in cell volume.  In vivo-derived embryos displayed significantly smaller total 
embryo volume than the FF group, but a significantly larger embryo volume than the 
other three groups (Figure 4.2B).  From the statistical analysis, the embryo volumes 
clustered into three separate groups.  The FF embryos displayed the largest embryo 
volume, followed by in vivo-derived embryos, with the three remaining groups displaying 
smaller embryo volumes (FS, SF, SS were not significantly different from one another).
4.3.2 Effects of Embryo Culture on Embryo Sex Ratios
 It has been suggested that male embryos develop faster than their female 
counterparts.  Bovine (Avery et al., 1992) and ovine (Bernardi and Delouis, 1996) male 
embryos reach the blastocyst stage earlier than their female counterparts, with variations 
in the embryo culture type, and protocol affecting sex ratios (Pegoraro et al., 1998; 
Gutierrez-Adan et al., 2001; Iwata et al., 2008). In the mouse, the data are more 
contradictory.  While some studies reported male to female sex ratio differences (Valdivia 
et al., 1993; Peippo and Bredbacka, 1995), another study  reported no difference in 
embryo sex ratios (Byrne et al., 2006).  For human embryos, some studies suggested that 
male embryos contain a greater number of cells than their female counterparts after IVF 
(Ray et al., 1995) while others report that this increase in cell number occurs with ICSI 
and not with IVF alone (Dumoulin et  al., 2005), or vice versa (Dean et al., 2010). 
Moreover, an increase in the number of male offspring was noted following blastocyst 
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stage transfer, (Milki et al., 2003; Luna et  al., 2007; Chang et al., 2009), while other 
groups have shown no sex differences in rates of development (Kausche et al., 2001; 
Richter et al., 2006; Csokmay et al., 2009; Weston et al., 2009).  In light  of the above 
studies, the possibility  existed that rates of development were unrelated to adverse affects 
of culture but  instead were the result  of embryo sex.  To address this potential bias, a 
nested PCR was performed for Sry, which is only present in male embryos, while Xist, 
located on the X chromosome, was used as a PCR control and was detected in both male 
and female embryos (Figure 4.1B).  While we did observe more male embryos in the 
overall FF group (10 male, 6 female), and more female embryos in the SS group (6 males, 
8 females), this result was not statistically significant (Figure 4.2C).  Thus, different 
developmental rates were unrelated to embryo sex in our study.  Furthermore, no 
correlation was found between embryo sex and the other parameters examined in this 
study.
4.3.3 Effects of Embryo Culture on H19 and Snrpn Imprinting 
 To test our hypothesis that  slower developing embryos will possess greater 
imprinting defects, we evaluated the ability  of embryos to maintain genomic imprinting 
by examining two key loci, H19 and Snrpn, in the four groups of cultured embryos.  From 
our previous study (Market-Velker et al., 2010a), we showed that imprinted 
hypermethylation on the H19 paternal ICR in in vivo-derived embryos was around 80%. 
Embryos with hypermethylation levels below 80% were therefore considered to exhibit 
“loss of methylation”.  At least five embryos from each group were analyzed.  The FF
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Figure 4.3: Imprinted Methylation of H19 in FF and FS Groups
Imprinted methylation analysis of the paternal H19 allele in “Fast/Fast” and “Fast/Slow” 
groups.  Each group of circles represents one embryo, with the embryo name indicated in 
the top  left.  Percent hypermethylation indicated in the top  middle.  Each row represents 
one DNA strand.  Filled circles represent methylated CpGs dinucleotides while unfilled 
circles represent unmethylated CpGs.
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group displayed a loss of methylation in 3 of 5 embryos (hypermethylation levels 100%, 
90%, 67%, 36% and 33%), with an average methylation of 65%, while the FS group 
displayed loss of methylation at only 2 of 5 embryos (hypermethylation levels 93%, 81%, 
80%, 70% and 53%) with an average methylation of 75% (Figure 4.3).  Two of six 
embryos in the SF group displayed loss of methylation (100%, 94%, 91%, 88%, 75%, and 
75%), and 2 of 5 embryos in the SS group displayed loss of methylation (100%, 100%, 
83%, 78%, and 75%) with an average methylation for both the SF and SS group of 87% 
(Figure 4.4).  Therefore, the overall “Fast” groups displayed an average methylation of 
71%, while the average of the “Slow” groups was much higher at 87%, a statistically 
significant difference (p < 0.05) (Figure 4.5).  In addition, while the “Fast” embryos 
displayed lower levels of methylation than in vivo-derived controls, no difference was 
observed between the “Slow” group and in vivo-derived embryos.  This indicates that the 
slower developing embryos were better able to maintain H19 imprinted methylation than 
their fast developing counterparts.
 A similar result was also observed at the Snrpn ICR.  From our previous study 
(Market-Velker et al., 2010a), we determined the threshold of methylation on the Snrpn 
maternal ICR to be 70% hypermethylation.  The FF group displayed loss of methylation 
in 5 of 6 embryos (75%, 63%, 47%, 45%, 42%, and 36%) with an average methylation of 
51%, and the FS group displayed a loss of methylation in 3 of 5 embryos (80%, 75%, 
67%, 47%, and 43%) with an average methylation of 62% (Figure 4.6).  The SF group 
displayed loss of methylation in 0 of the 5 embryos tested (100%, 90%, 88%, 78%, and 
70%) with an average methylation of 85%, while the SS group displayed a loss of 
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Figure 4.4: Imprinted Methylation of H19 in SF and SS Groups
Imprinted methylation analysis of the paternal H19 allele in “Slow/Fast” and “Slow/
Slow” groups. See Figure 4.3 for details.
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Figure 4.5:  Graphical Representation of Levels of H19 and Snrpn Hypermethylation 
Top: Paternal H19 hypermethylation levels.  Bottom: Maternal Snrpn hypermethylation 
levels.  Each diamond represents one embryo, and black bars represent mean 
hypermethylation levels in each group.
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Figure 4.6:  Imprinted Methylation of Snrpn in FF and FS Groups
Imprinted methylation of the maternal Snrpn allele in “Fast/Fast” and “Fast/Slow” 
groups. See Figure 4.3 for details.
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Figure 4.7:  Imprinted Methylation of Snrpn in SF and SS Groups
Imprinted methylation of the maternal Snrpn allele in “Slow/Fast” and “Slow/Slow” 
groups.  See Figure 4.3 for details.
170
methylation at 3 of the 5 embryos (100%, 100%, 65%, 62%, and 50%) with an average 
methylation of 75% (Figure 4.7). Overall, “Slow” embryos (SF and SS) displayed higher 
levels of methylation than the “Fast” group  (FF and FS) (p < 0.05).  No difference was 
observed at the second separation.  Thus, the “Slow” group was best able to maintain 
imprinted methylation.
 Next, we analyzed H19 and Snrpn imprinted expression in the in vitro cultured 
and in vivo-derived embryos.  From our previous study, we have shown that in our mouse 
model H19 is expressed from only a small number of in vivo-derived blastocysts 
(approximately 1 in 9) (Market-Velker et al, 2010b).  For embryos displaying H19 
expression, this expression was solely  from the maternal allele.  Analysis of imprinted 
H19 expression revealed that 12 out of 16 embryos exhibited H19 expression in the FF 
group with only 4 of these embryos maintaining monoallelic H19 expression from the 
maternal CAST allele (Figure 4.8).  In addition, a significant number of embryos in the 
FF group displayed a “switched” expression pattern, where monoallelic expression 
occurred erroneously from the paternal allele.  This was improved in the FS group, where 
7 of 9 embryos exhibited H19 expression with 5 maintaining imprinted expression, and 
further improved in the SF group, where all embryos displaying H19 expression (6 of 10) 
did so exclusively from the maternal allele.  H19 expression in the SS group was most 
similar to in vivo-derived controls, with 1 of 12 embryos displaying H19 expression, with 
the sole embryo expressing H19 exclusively  from the maternal CAST allele.  Overall, 
“Fast” embryos from the first separation expressed H19 in significantly more embryos 
than the “Slow” group.  No difference was observed at the second separation for FF 
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Figure 4.8: H19, Snrpn and Cdkn1c Imprinted Expression 
Imprinted Expression in the four groups of cultured embryos.  Red bars indicate percent 
expression from the maternal allele, and blue bars indicate percent expression from the 
paternal allele.  Top: H19 imprinted expression analysis. Middle: Cdkn1c imprinted 
expression analysis. Embryo names are indicated on the X-axis.
Bottom: Developmental Cdkn1c imprinted expression in in vivo-derived embryos. 
Embryo stage indicated on the X-axis. 4-cell, n=2, 12 pooled embryos each; 8-cell, n=2, 6 
pooled embryos each; Early M, early morula, n=2, 3 pooled embryos each; Late M, late 
morula, n=2, 1 embryo each; Mid-BL, mid blastocyst; n=7, 1 embryo each; Late BL, late 
blastocyst; n=3, 1 embryo each.
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versus FS groups.  However, within the slow group, more embryos in the SF group 
expressed H19 than the SS group.  Furthermore, as with imprinted H19 methylation, the 
overall “Fast” embryos showed a significantly greater loss of imprinted H19 expression 
than “Slow” and in vivo-derived embryos. By  comparison, “Slow” embryos were more 
similar to in vivo-derived controls at maintaining imprinted H19 expression.  FF embryos 
showed significantly greater loss of imprinted H19 expression compared with the other 
groups.  Similar to previous experiments (Mann et al., 2004; Market-Velker et al., 2010b), 
no effect on Snrpn imprinted expression was observed; all embryos displayed paternal-
specific Snrpn expression (data not shown).
4.3.4 Effects of Embryo Culture on Cdkn1c Imprinted Expression
 We predicted that embryos with biallelic Cdkn1c expression would exhibit slower 
rates of preimplantation development.  To assess this, imprinted Cdkn1c expression was 
evaluated in the four groups of cultured embryos (Figure 4.8), as well as in in vivo-
derived controls.  All embryos in the FF group showed monoallelic expression, except 
one embryo, which lacked Cdkn1c expression.  Two embryos in the FS group expressed 
Cdkn1c from both the parental alleles, while no embryos exhibited biallelic expression in 
the SF group.  Two embryos in the SS group displayed biallelic expression, and three 
embryos showed Cdkn1c expression exclusively  from the normally-silent paternal allele. 
Overall, no significant difference in imprinted expression was observed at the first 
separation between “Fast” and “Slow” groups.  However, a significantly  greater number 
of “Slow” embryos from the second separation, FS and SS, displayed biallelic Cdkn1c 
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expression compared with the “Fast” FF and SF groups, which were not statistically 
different from in vivo-derived controls.  This result  appeared contradictory  to the H19 
imprinted expression pattern, leading us to question whether the observed data were 
related to developmental regulation of imprinted Cdkn1c expression rather than 
misregulation of Cdkn1c imprinting.  As the time course of Cdkn1c imprinted expression 
had not been fully elucidated in preimplantation embryo stages, we evaluated imprinted 
Cdkn1c expression in pools of 4-cell, 8-cell and early morula, as well as individual late 
morula, and blastocyst stage embryos.  Over this developmental time course, we observed 
an overall decrease in B6 expression, with 4- and 8-cell embryos displaying nearly equal 
levels of maternal and paternal expression, and late blastocysts displaying expression 
exclusively  from the maternal allele.  This data indicate that cultured embryos in the FS 
and SS groups displaying biallelic Cdkn1c expression were developmentally delayed 
compared with embryos in the FF and SF groups. 
4.3.5 Effects of Embryo Culture on Metabolic Marker Expression
 According to Leese’s “quiet embryo” theory, embryos more affected by 
suboptimal environment will compensate by increasing their metabolic activity  (Leese, 
2002).  We hypothesized that embryos that develop faster and display a more frequent 
loss of imprinting will also show an increase in metabolic activity.  To evaluate this 
hypothesis, we examined expression of three genes involved in early embryo metabolism: 
Atp1a1 encoding the alpha subunit of the Na+/K+ ATPase, Slc2a1 encoding the solute 
carrier family 2, and Mapk14 encoding p38 alpha in 11 FF, 9 FS, 10 SF and 11 SS 
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Figure 4.9: Expression of Genes Involved in Embryo Metabolism
Relative expression of genes involved in embryo metabolism in cultured and in vivo-
derived embryos.  (A): Left panel:  Relative Atp1a1 expression in the four groups of 
cultured embryos and in vivo-derived embryos.  Embryo group  is indicated on the X-axis, 
each diamond represents one embryo, and black bars represent the mean relative 
expression in each group.  Right panel: Mean relative Atp1a1 expression in “Fast” and 
“Slow” groups based on the first separation. * “Fast” embryos displayed significantly 
higher Atp1a1 expression levels than “Slow” embryos.   (B): Left panel: Relative Slc2a1 
expression corrected for cell numbers in the four groups of cultured embryos and in vivo-
derived embryos.  Black bars represent  the mean relative expression corrected for cell 
numbers in each group.  Right panel: Mean relative Slc2a1 expression, corrected for cell 
numbers, in “Fast” and “Slow” groups based on the first separation. * “Fast” embryos 
displayed significantly lower Slc2a1 expression levels than in vivo-derived and “Slow” 
embryos, and ** “Slow” embryos displayed significantly  lower Slc2a1 expression levels 
than in vivo-derived embryos. (C) Left panel: Relative Mapk14 expression in the four 
groups of cultured embryos and in vivo-derived embryos.  Black bars represent the mean 
relative Mapl14 expression in each group.  Right panel: Mean relative Mapl14 expression 
in “Fast” and “Slow” groups based on the first  separation.  No difference in mean relative 
Mapl14 expression was observed between in vivo-derived, “Fast” and “Slow” embryos. 
Error bars represent standard errors of the mean.
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blastocysts, as well as 5 in vivo-derived controls. Atp1a1 expression was significantly 
higher in the “Fast” group than the “Slow” group at  the first  separation (Figure 4.9), while 
no significant difference was observed in mean levels of expression at the second 
separation, between either the FF and FS, or SF and SS groups.  Moreover, a number of 
embryos within the FF group displayed very high expression, while a number of embryos 
within the SS group exhibited very low expression.  Differences of large magnitudes in 
the response of individual embryos to the culture environment, in addition to an overall 
shift in the mean population response supports the idea that each embryo responds 
differently to environmental insult, and that “Fast” embryos are more likely  to show 
abnormally high levels of expression than their “Slow” or in vivo counterparts. 
Comparing in vivo-derived embryos to cultured embryos revealed three distinct 
groups. The FF group displayed significantly higher Atp1a1 expression and the SS group 
significantly lower expression then the FS, SF and in vivo-derived embryos which 
displayed expression levels between the FF and SS groups.  The FS, SF and in vivo-
derived embryos were indistinguishable from one another.  Normalization to cell numbers 
did not reveal any significant differences in expression between groups. 
 Atp1a1 expression was also correlated with H19 imprinted expression.  As stated 
above, in vivo-derived embryos display one of two H19 expression patterns, maternal or 
no expression.  We compared Atp1a1 expression levels between embryos displaying an in 
vivo pattern of H19 expression (maternal CAST or no expression; 32 embryos) to those 
displaying an abnormal pattern (biallelic or abnormal B6 paternal expression; 7 embryos). 
Significantly, embryos with abnormal H19 imprinted expression possessed higher Atp1a1 
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expression levels (2.7 +/-0.4) than those displaying an in vivo pattern of H19 expression 
(1.6 +/-0.2). Thus, we observed a relationship between Atp1a1 expression levels and 
maintenance of H19 imprinted expression. 
 Slc2a1 and Mapk14 expression were also evaluated in these same embryos.  The 
“Slow” group displayed significantly higher levels of Slc2a1 expression than the “Fast” 
group at the first separation (Figure 4.9), following normalization for cell numbers.  No 
difference was observed at the second separation.  In vivo-derived embryos displayed 
significantly higher expression levels than all four cultured groups, both before and after 
correction for cell number.  Overall, the Slc2a1 expression analysis revealed three distinct 
groups, the FF group with the lowest expression, the FS, SF and SS groups with mid-level 
expression that was indistinguishable from one another, and in vivo-derived embryos with 
the highest Slc2a1 expression.  Strikingly, a difference in the dispersion of the samples in 
the five groups is noted, with a decrease in sample variability from in vivo to SS group, 
and further on to FF group, suggestive of a “dose” response.  No relationship was 
observed between Slc2a1 expression and H19 imprinted expression.  For Mapk14, while 
expression levels were higher in the FF compared with in the other culture groups and in 
vivo controls, this difference was not statistically significant.  As well, no difference 
between groups after cell number correction, and no relationship to H19 imprinted 
expression was observed.
4.4 Discussion
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  In this study, we set out to determine whether embryos with different 
developmental rates differed in their ability  to maintain genomic imprinting, with slower 
rates of embryonic development correlating with loss of imprinting.  Notably, we 
identified a subset of in vitro cultured embryos that, according to all parameters evaluated 
in this study, are very similar to in vivo-derived embryos (Figure 4.10).  However, 
contrary to our expectation, we observed that embryos with faster developmental rates 
possessed greater cell numbers and embryo volume, as well as greater perturbations in 
genomic imprinting and metabolic marker expression.  While the slowest developing 
embryos displayed lower cell numbers, smaller embryo volumes, and were better able to 
maintain genomic imprinting, a proportion of these embryos were developmentally 
delayed as determined by Cdkn1c imprinted expression and the presence of  more 
arrested embryos prior to the blastocyst stage in this group.  Instead, embryos with slow 
to moderate development rates (SF embryo group) were most similar to in vivo-derived 
embryos, displaying similar cell numbers, embryo volume, H19 and Snrpn methylation, 
H19 imprinted expression, and Atp1a1 and Slc2a1 expression. 
4.4.1 Relationship between Development Rates and Genomic Imprinting
In this study, we evaluated the differences in the maintenance of genomic 
imprinting at two imprinted loci, H19 and Snrpn, which are involved in the development 
of the imprinting disorders AS and BWS, and correlated this loss of imprinting with rates 
of preimplantation embryo development.  Our data suggests that embryos that develop 
faster do so at the expense of maintaining epigenetic regulation.  It is currently unclear 
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how embryo culture can lead to alterations in imprinting.  One possibility is that culture 
conditions interfere with epigenetic maintenance mechanisms and this in turn deregulates 
the embryo’s growth kinetics.  Interestingly, embryos with only maternal genomes 
(parthenotes) or with only paternal genomes (androgenotes) display developmental 
defects that have been attributed to alterations in cell proliferation and differentiation 
rates (reviewed in Mann, 2005).  We observed that faster developing embryos were more 
advanced morphologically, but had a shorter cell division cycle given the greater number 
of cells.  On the other hand, slow embryos maintained rates of cell division similar to in 
vivo-derived embryos, given similar cell numbers.  Given a possible relationship between 
genomic imprinting, developmental rates and cell cycle progression, we investigated the 
imprinted expression of Cdkn1c, a cell-cycle regulator that acts to inhibit cell cycle 
progression through its interaction with cyclin-CDK complexes (Lee et al., 1995).  We 
demonstrated that Cdkn1c expression is biallelic in early cleavage stages, and becomes 
maternal-specific as preimplantation development progresses.  Interestingly, we observed 
more embryos with biallelic expression in the “Slow” groups (FS and SS) at the second 
separation than those in the “Fast” groups (FF and SF), suggesting that Cdkn1c may play 
a role in regulating progression through the latter phase of preimplantation development. 
Lower levels of expression, in the form of monoallelic expression, may result in less cell 
cycle inhibition and in turn, increase the rate of cell division.  Alternatively, biallelic 
expression may result in an increase in cell cycle inhibition, resulting in increased time 
required to progress through the cell cycle.
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4.4.2 Relationship Between Development Rates and Embryo Volume
During preimplantation development, the total volume of the embryo remains 
relatively constant, while the number of cells increase as development proceeds (Aiken et 
al., 2004).  With respect to embryo volume, the effect size of the difference between FF 
and in vivo-derived embryos was larger than that between in vivo controls and the other 
three groups, again indicating that slower embryos were more similar to in vivo-derived 
controls.  This raises the question as to what mechanisms could lead to a difference in 
embryo volume for the FF group.  Two possible explanations for the differences observed 
in embryo volume between cultured and in vivo-derived controls are an increase in 
overall cell volume, or an increase in volume of the blastocoel cavity.  An increase in cell 
volume may be due to increased transcription, translation and protein processing 
necessary to support higher metabolism in response to cell stress as well as changes in the 
cell’s ability to regulate intracellular osmotic pressure (Baltz and Tartia, 2010). One 
mediator of environmental stress is MAPK14, which regulates embryonic adaptations to 
culture such as variations in culture medium osmolarity (Bradham and McClay, 2006; 
Fong et al., 2007; Bell et al., 2009).  Treatment with MAPK14 inhibitors has 
demonstrated a requirement for MAPK14 in early cleavage division embryos (Natale et 
al., 2004).  As larger FF embryos may respond to environmental stress via MAPK14 with 
the end result of producing larger cells, we investigated Mapk14 expression in the five 
embryo groups.  Our analysis showed no difference in Mapk14 expression between the 
four culture groups and in vivo controls, indicating that variations in cell volume do not 
likely account for overall variations in blastocyst volume that we observed.  MAPK14 
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levels and its posttranslationally-modified forms need to be investigated to confirm this 
observation. 
Alternatively, larger FF embryo volumes may be a result of larger cavity volumes. 
Trophectoderm (TE) cells produce a blastocoel cavity through the use of the Na+/K+ 
ATPase, which generates an ionic gradient across the trophectoderm, facilitating 
movement of water from the outside environment to the inside of the embryo (Watson 
and Barcroft, 2001; Barcroft et al., 2003).  Embryos that contain more TE cells will have 
greater levels of the Na+/K+ ATPase, resulting in a greater influx of water into the 
blastocoel cavity.  This would result in faster production of a larger cavity and therefore a 
more morphologically advanced embryo.  Our results favour the latter hypothesis, where 
an increase in TE cells generates a larger blastocoel cavity via increased Na+/K+ ATPase.  
Examination of Atp1a1 expression, the alpha subunit of the Na+/K+ ATPase, revealed 
higher levels of expression in the “Fast” group when compared to the “Slow” group.  In 
addition, as predicted by the above model, this increase in Atp1a1 expression was a 
function of cell number, as no difference in expression was observed when corrected for 
cell number.  Interestingly, we also observed that increased Atp1a1 expression levels 
correlated with loss of H19 imprinted expression.  Thus, this provides a link between 
genomic imprinting and developmental rates.
4.4.3 Relationship between Development Rates and Embryo Metabolism
 Changes in Atp1a1 expression in the faster developing embryos suggest that the 
metabolism of these embryos is altered compared to in vivo-derived controls.  To further 
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investigate this, we examined Slc2a1 expression.  SLC2A1 is one of the primary glucose 
transporters in the preimplantation embryo.  In early cleavage division embryos, SLC2A1 
is primarily localized to the nucleoli and nuclear membranes.  Post-compaction, Slc2a1 
expression increases dramatically  (Morita et al., 1994; Uechi et al., 1997) and SLC2A1 
translocates to the basolateral membrane of TE cells and the plasma membrane of ICM 
cells (Pantaleon et al., 2001), permitting shuttling of glucose from the blastocoel cavity to 
ICM cells.  This differential localization of SLC2A1 coincides with the switch of energy 
preferences in the developing embryo, from pre-compaction utilization of pyruvate to 
post-compaction utilization of glucose.  Before the switch, a transient pulse of glucose is 
required.  A complete absence of glucose during the early stages of preimplantation 
development results in delay  or impaired development to the blastocyst  stage (Martin and 
Leese, 1995; Pantaleon et al., 2008).  Importantly, multiple groups have shown that 
Slc2a1 mRNA expression and protein levels are significantly higher in in vivo-derived 
compared to in vitro cultured embryos (Morita et al., 1994; Uechi et al., 1997; Leppens-
Luisier et al., 2001; Balasubramanian et al., 2007).  In our study, we also found much 
higher levels of Slc2a1 expression in in vivo-derived compared to cultured embryos. 
Interestingly, “Slow” embryos expressed Slc2a1 at significantly  higher levels than their 
“Fast” counterparts when corrected for cell number, again demonstrating that the “Slow” 
group is more similar to controls.  No significant difference was observed at the second 
separation. 
As both Slc2a1 mRNA and protein levels increase at compaction in response to 
the increased need for glucose utilization, we hypothesize that the “Fast” embryos are 
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unable to adequately upregulate Slc2a1, while the “Slow” embryos respond appropriately 
and have levels of Slc2a1 more similar to in vivo-derived embryos.  In the “Fast” 
embryos, a lack of appropriate increase in Slc2a1 expression would result in decreased 
availability of glucose.  To maintain their intrinsic rates of development, and support 
blastocyst formation as well as all other cellular activities, these embryos would be 
required to switch their metabolism to utilize alternate means of ATP generation such as 
amino acid catabolism (for glugoneogenesis) and beta oxidation of fatty acids (Sturmey et 
al., 2009b).  Interestingly, differential uptake of glucogenic and non-glucogenic amino 
acids has been noted between developmentally competent and incompetent embryos 
cultured in vitro (Houghton et al., 2002; Stokes et al., 2007; Lehninger et al., 2005). In 
addition, a large proportion of the ATP generated in the developing blastocyst is utilized 
by the Na+/K+ ATPase, for which we demonstrated higher Atp1a1 expression levels in 
“Fast” developing embryos (Leese et al., 2007), thereby further reducing the pool of ATP 
available for other cellular activities in these embryos.  Persistent inadequate ATP 
generation, would lead to compromised cellular functions including epigenetic regulation 
of genomic imprinting (Hargreaves and Crabtree, 2011).  Perhaps this is not surprising as 
all known chromatin-remodeling complexes are powered by an ATPase subunit 
(Hargreaves and Crabtree, 2011).  Interestingly, we observed that increased Atp1a1 
expression levels correlated with loss of H19 imprinted expression, lending support to the 
attractive idea that culture-induced epigenetic effects may act at the interface of a Na+/K+ 
ATPase.  This study provides a link between genomic imprinting, developmental rates 
and metabolism, with increased metabolism of alternate energy sources representing a 
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compensation for the maladaptation of the embryo to the suboptimal culture environment. 
Thus, future studies should be directed towards the analysis of ATP-driven metabolic 
factors and epigenetic regulators in “Fast” and “Slow” developing embryos over their 
period of development in culture.
Taken all together, our data indicate that “Slow” embryos maintain a baseline 
level of metabolic activity similar to in vivo-derived embryos, while “Fast” embryos 
adapt and compensate by increasing the activity of other metabolic pathways, 
compromising cellular processes to maintain continued embryo growth and survival. 
Moreover, imprinting defects in “Fast” embryos indicate altered epigenetic 
reprogramming in response to suboptimal embryo culture, while “Slow” developing 
embryos exhibit more in vivo-like reprogramming.  Thus, our data lend support to the 
quiet embryo hypothesis espoused by Leese and colleagues.  This hypothesis suggests 
that the most viable embryos are “quiet”, exhibiting lower levels of metabolic activity, 
expending less energy repairing damage caused by the suboptimal culture environment, 
and possessing slower cell division cycles (Leese, 2002; Baumann et al., 2007; Leese et 
al., 2007; Sturmey et al., 2009a).  In contrast, embryos that actively adapt to culture will 
possess higher metabolic levels and faster cell cycle divisions.  Our study is the first to 
demonstrate a link between embryo culture, development rates, imprint maintenance and 
metabolism. 
4.4.4 The Best Embryos for Transfer
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 The term assisted reproductive technologies encompasses many techniques used 
to treat human infertility.  However, all involve the manipulation of human gametes and 
preimplantation embryos, and many involve embryo culture during preimplantation 
development.  While the optimal time and number of embryos to transfer after 
fertilization and culture has been a source of debate, all are in agreement that only the 
“best” or “healthiest” embryos should be transferred (Kallen et al., 2010; Min et al., 2010; 
Porat et al., 2010; Sills and Palermo, 2010; Wang et al., 2010).  Many algorithms have 
attempted to determine the parameters that most accurately  predict successful embryo 
transfer resulting in implantation and pregnancy (Elizur et al., 2005; Lesourd et al., 2006). 
Currently, morphological characteristics and stage of embryo development at a given time 
point are the most commonly  used criteria for identifying “healthy” embryos that should 
be transferred to patients in IVF clinics (Shoukir et al., 1997; Van Montfoort et al., 2004). 
Multiple studies have suggested that those embryos attaining the 4-cell stage (cleavage-
stage transfer) or the blastocyst stage (blastocyst transfer) the fastest are most suitable for 
embryo transfer (Claman et al., 1987; Windt et  al., 2004; Biezinova et al., 2006; Wang et 
al., 2010). However, other studies have suggested that embryos progressing at  a moderate 
pace are those that should be used, and have cautioned against the use of embryos with 
very fast or very slow development (Cummins et al., 1986; Alikani et al., 2000; Weitzman 
et al., 2010).  It  is important to know whether slower developing embryos are indeed 
suitable for transfer to patients, especially in situations where a choice between which 
embryo(s) 
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Figure 4.10: Summary of Multiple Parameter Analysis at the Individual Embryo 
Level
Dotted lines indicate significance. The FF group was most different from in vivo controls 
in all assays. Embryos in the “Slow” group (specifically SF) were more similar to in vivo-
derived embryos.
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to transfer can be made.  Previously, the relevance of these criteria to the maintenance of 
genomic imprinting was unknown.
Results from this study support the transfer of embryos displaying slow to 
moderate rates of development.  We argue that embryos in the SF group are most suitable 
for embryo transfer.  These embryos displayed imprinted methylation and expression, cell 
numbers, embryo volume, and metabolic marker expression most similar and in some 
cases indistinguishable from in vivo-derived embryos (Figure 4.10).  Our data also argue 
against transfer of the fastest developing embryos.  The FF group was most different from 
in vivo controls in all assays, and most importantly, showed the highest number of 
embryos with loss of imprinted H19 and Snrpn ICR methylation.  While the FS group 
was more similar to controls than the FF group with respect to embryo volume and H19 
imprinted expression, this group still displayed lower levels of H19 and Snrpn imprinted 
methylation, greater perturbations of Cdkn1c imprinted expression, greater expression of 
Atp1a1 and lower expression of Slc2a1 than controls.  By comparison, the slowest (SS) 
group displayed levels indistinguishable from controls with respect to cell number, 
embryo volume, and H19 imprinted expression.  However, the SS group showed levels of 
Cdkn1c imprinted expression indicative of delayed development, and lower levels of H19 
and Snrpn imprinted methylation than in vivo-derived control embryos.  In addition, 40% 
of embryos in the slowest (SS) group failed to develop to the blastocyst stage after 3 days 
of culture.  As such, the SF group is likely the most suitable for embryo transfer in the 
human clinic. 
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Our group and others have previously reported that the response of 
preimplantation embryos to in vitro culture with respect to genomic imprinting is 
stochastic (Doherty et al., 2000; Mann et al., 2004; Market-Velker et al., 2010b; Lim et 
al., 2009; Rossignol et al., 2006).  Here, we show that this can partly be attributed to a 
differential response of embryos to culture, with the fastest developing embryos acquiring 
the greatest perturbations in imprinted gene regulation and metabolic gene expression.  
We propose that embryos that undergo reprogramming to counter the stresses of 
suboptimal culture are the least healthy for embryo transfer.  Therefore, selecting embryos 
with slow rates of development is one step towards choosing a more “healthy” embryo. 
Determining the differences between slowest, slow to moderate and fast developing 
embryos, and developing non-invasive methods to more easily identify them in the 
human clinic will be critical to choosing the “best” or “healthiest” embryos for transfer, 
thereby maximizing pregnancy rates.
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Chapter 5 - The Effects of Superovulation and Embryo Culture at the Peg1/Mest 
Locus
The work in this chapter originates from the following manuscript:
Market Velker, B. A., Denomme, M. M., Mann, M. R. ‘A comprehensive evaluation of 
the effects of superovulation and embryo culture on the acquisition and maintenance of 
genomic imprinting of Peg1/Mest’ submitted for publication in the journal Biology of 
Reproduction, in June 2011.
5.1 Introduction
 Genomic imprinting is an epigenetic phenomenon where gene expression is 
regulated according to parent-of-origin; one parental allele is expressed while the other is 
repressed (Reik and Walter, 2001; Rodenhiser and Mann, 2006).  To date, approximately 
150 genes have been identified whose expression is regulated in such a manner (http://
www.har.mrc.ac.uk/research/genomic_imprinting/maps.html) (Morison et al., 2005).  
Many of these imprinted genes play critical roles in the development of the embryo and 
placenta, or influence behaviour after birth (Ono et al., 2006; Varrault et al., 2006; 
Wilkinson et al., 2007; Bressan et al., 2009; Broad et al., 2009), and their dysregulation 
has been linked to a group of human diseases called imprinting disorders.  Two important 
time periods have been identified with respect to genomic imprinting: acquisition (during 
gametogenesis) and maintenance (during preimplantation development).  Numerous 
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assisted reproductive technologies take place during these two critical periods, and as 
such have the potential to disrupt acquisition and/or maintenance of genomic imprinting.
 The development and increased use of assisted reproductive technologies (ARTs) 
for the treatment of infertility/subfertility, led to the observation that genomic imprinting 
may be affected by ex vivo manipulation of the early embryo.  In addition to BWS and 
AS, studies have suggested a relationship between Silver-Russell Syndrome (SRS), and 
dysregulation of imprinted genes by ARTs.  SRS is an imprinting disorder characterized 
by intrauterine and post-natal growth retardation (Wollmann et al., 1995).  Up to 44% of 
SRS cases are associated with hypomethylation of the H19 ICR within the 11p15 region 
(Eggermann et al., 2010), which harbours the imprinted genes H19 and Igf2, while 
maternal uniparental disomy of chromosome 7 has been implicated in approximately 5% 
of cases of SRS (Kotzot et al., 1995; Eggermann et al., 2010), a region that contains the 
Peg1/Mest gene.  
 Peg1/Mest has been proposed as one of the causative agents of SRS (Hannula et 
al., 2001; Chou et al., 2004; Kagami et al., 2007).  Paternal inheritance of a targeted Peg1/
Mest allele results in severe IUGR in the offspring, while maternal inheritance of the 
deleted allele does not (Lefebvre et al., 1998).  On the other hand, high levels of Peg1/
Mest expression has been found in adipocytes from obese mice, and transgenic 
overexpression of Peg1/Mest results in enlargement of adipocytes (Takahashi et al., 
2005).  This suggests a key role for Peg1/Mest in regulating fetal growth.  
 Genomic imprinting of Peg1/Mest, which is located on mouse chromosome 6 and 
human chromosome 7, was identified through subtractive hybridization comparing 
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normal and parthenogenetic mouse embryos (Kaneko-Ishino et al., 1995).  Paternal 
monoallelic expression of Peg1/Mest has been confirmed in adult tissues (Reule et al., 
1998), and in a number of other species including humans (Kobayashi et al., 1997; 
Riesewijk et al., 1997), tammar wallaby (Suzuki et al., 2005), and sheep (Feil et al., 
1998).  A CpG island spanning the putative promoter region and exon 1 is methylated in a 
parent-of-origin specific manner: the maternal allele is methylated while the paternal 
allele is unmethylated (Riesewijk et al., 1997; Nishita et al., 1999).  Acquisition of 
imprinted DNA methylation at the maternal differentially methylated region (DMR) 
occurs at the tertiary/early antral follicle stage, after the majority of other imprinted genes 
have already acquired their methylation (Obata and Kono, 2002; Hiura et al., 2006), and 
continues after ovulation (Imamura et al., 2005).  This has led to suggestions that the 
Peg1/Mest imprint may be more vulnerable to perturbation by environmental insult 
(Anckaert et al., 2010).  A number of studies have demonstrated differences in the 
response of Peg1/Mest to various environmental insults during oocyte development, 
including superovulation and in vitro maturation when compared to other imprinted 
genes, such as H19 and Snrpn (Khosla et al., 2001; Liang et al., 2008; Tveden-Nyborg et 
al., 2008; Anckaert et al., 2010).   
 In this study, we characterize the effects of two commonly used procedures in 
ART, superovulation and embryo culture, on the acquisition and maintenance of genomic 
imprinting at the Peg1/Mest locus.  Superovulation, also known as ovarian 
hyperstimulation, is used to recover large numbers of mature oocytes, while embryo 
culture facilitates the development of embryos through preimplantation stages.  To 
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provide a comprehensive allelic analysis of the response of the Peg1/Mest locus to these 
procedures, and to avoid confounding factors that have prevented detailed analysis in 
other studies such as intrinsic patient subfertility, and the use of pooled oocytes/embryos, 
our analysis was performed using a mouse model on individual oocytes and blastocyst 
stage embryos.  We demonstrate that DNA methylation at the maternal Peg1/Mest DMR 
is maintained in ovulated metaphase II (MII) oocytes following low or high dose 
superovulation, indicating that acquisition of Peg1/Mest imprinted methylation in the 
developing oocyte is not affected by hormonal stimulation.  However, a significant loss of 
maternal methylation at the Peg1/Mest DMR was observed at the blastocyst stage 
following superovulation or embryo culture, indicating that maintenance of genomic 
imprinting was disrupted by these interventions, although no correlation to rates of 
preimplantation development was observed.  
5.2 Methods
5.2.1 B6(CAST7p6)  Mouse Model
 Previous studies from our lab utilized a mouse model ideally suited for imprinting 
analyses, C57BL/6(CAST7) (B6(CAST7) that contain two Mus musculus casteneus 
chromosome 7s on a B6 background. Polymorphisms between B6(CAST7) and C57BL/6 
(B6) mice allow for subsequent identification of maternal and paternal alleles.  
Investigation of Peg1/Mest was not possible using this model, as Peg1/Mest is located on 
chromosome 6 in the mouse.  To identify C57BL6(CAST7partial6) [B6(CAST7p6)] 
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mice, we screened our original B6(CAST7) colony by microsatellite marker mapping and 
found a subset of mice that harboured the same partial region of M.m. castaneus 
chromosome 6. Using microsatellite markers, D6Mit140 and D6Mit34, as well as allelic 
PCR-restriction digest of published polymorphisms, crossover events were mapped to 
22.8-23.7 and 31.02-32.05 MB, a 9.25 MB region that contained the entire Peg1/Mest 
imprinted domain (Figure 5.1).  The proximal crossover was mapped to between SNP#4 
(rs3090864) and SNP #5 (rs3088527).  The PCR primers for SNP#4 were F: 5’-
GTGCCAGATTGTCTTCCC-3’, and R: 5’-ACCCTCAGGACAGTTCG-3’, and for 
SNP#5 were F: 5’-ATGCCTCATTTGGAGTCTG-3’, and R: 5’-
AGCATCCTCTGGGAGTGTA-3’.  For SNP#4, a polymorphic A/G restriction site 
between B6 (A) and CAST (G) distinguished the parental alleles, as the CAST (G) allele 
is cleaved by the HpyCH4III restriction enzyme (B6: 181 and 12 bp, CAST: 101, 80 and 
12 bp).  For SNP#5, a polymorphic A/C restriction site between B6 (C) and CAST (A) 
distinguished parental alleles, with the CAST allele cleaved by the restriction enzyme 
CviKI-1 (B6: 74, 54, and 38 bp, CAST: 112 and 54 bp).  The distal crossover was mapped 
to a region between the MapPairs D6Mit341 and D6Mit140.  To determine if the Peg1/
Mest imprinted domain was within the CAST region, another polymorphism, SNP#10 
(rs6183467), outside the domain was investigated using the following primers F: 5’-
CAGGATGGGTCTGGAGTGA-3’ and R: 5’-CTTAGTAGCAACTGGGTGGTG-3’.  A 
polymorphic T/G restriction site between B6 (T) and CAST (G) was observed, and 
restriction digest with the enzyme HincII resulted in cleavage of the CAST allele.  All 
polymorphisms were confirmed by sequencing of the PCR products.  SNP#4 was used for 
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Figure 5.1:  Crossover Sites in the B6(CAST7p6) Mouse Model
Graphical representation of chromosome 6 in our B6(CAST7p6) mouse model.  Genes in 
red are located within the known M. m. castaneus region, genes in blue are located within 
the known B6 region, and genes in purple fall within the crossover region.  Green boxes 
represent MapPairs that  were used to genotype the mice.  Yellow boxes represent sites of 
single nucleotide polymorphisms (SNPs) that were used as restriction sites to determine 
genotypes.  The Peg1/Mest imprinted domain was found to reside within the M. m. 
castaneus region.
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the allelic PCR-restriction digestion genotyping assay to identify B6(CAST7p6) mice. 
B6(CAST7p6 intercrosses were used to generate a B6(CAST7p6) mouse colony.  This 
B6(CAST7p6) mouse model was used for all subsequent experiments.
5.2.2 Oocyte and Embryo Collection and Culture
 Ovulated oocytes were collected from B6(CAST7p6)xB6 F1 females following 
superovulation, or spontaneous ovulation for controls.  F1 females have one CAST 
chromosome 7 and a partial CAST chromosome 6 on a B6 background inherited from the 
mother, and a B6 chromosome set inherited from the father, allowing for identification of 
grandparental inheritance at the Peg1/Mest locus within the oocyte following meiosis. 
 Superovulated females were injected with either 6.25 IU or 10 IU Pregnant 
Mare’s Serum Gonadotropin (PMSG, Intervet Canada) followed 40-44 hours later by the 
same dose of human Chorionic Gonadotropin (hCG, Intervet Canada).  Oocyte-cumulus 
cell complexes were flushed from the oviducts at approximately 12 PM the following day 
(22 hours post-hCG) into M2 media (Sigma). MII stage oocytes were dissociated from 
surrounding cumulus cells using 0.3 mg/ml Hyaluronidase (Sigma) and were washed 
three times in 30 µl of M2 media.  Diameter and volume measurements were recorded for 
each individual oocyte using the Olympus IX81 microscope.  Oocytes were treated with 
Acidic Tyrode’s solution (Sigma) at room temperature for removal of the zona pellucida, 
washed twice more in M2 media, and individually placed on a glass slide in minimal 
media.  Oocytes were gently mixed with a small amount of 2:1 agarose:lysis solution [20 
µl 3% low melting point agarose (Sigma)], 8 µl Dynabead lysis buffer (see below), 1µl 2 
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mg/ml proteinase K (Sigma), 1 µl 10% IPEGAL (Sigma) at 70ºC, embedded in 10 µl of 
this solution and placed in an eppendorf tube containing 300 µl of mineral oil. Following 
a 10 minute incubation on ice to allow the agarose bead to harden, mineral oil was 
removed and 500 µl of Dynabead lysis buffer was added [100 mM Tris–HCl pH 7.5 
(Bioshop), 500 mM LiCl (Sigma), 10 mM EDTA pH 8.0 (Sigma), 1% LiDS (Bioshop), 5 
mM DTT (Sigma)]. Individual samples were incubated overnight in a 50ºC waterbath.
The following morning (~20 hours later), Dynabead lysis buffer was removed and 
300 µl mineral oil was again added to the bead. Samples were incubated at 90ºC for 2.5 
minutes (Proteinase K inactivation), and were then placed on ice for 10 minutes. Bisulfite 
mutagenesis was performed as described (Market-Velker et al., 2010a) with the following 
exception: each oocyte sample was directly added as a solid agarose bead to a ready-to-go 
PCR bead (GE) containing Peg1/Mest specific primers and 1 µl of 240 ng/ml tRNA in a 
15 µl solution, with 25 µl mineral oil overlay.  Negative controls (agarose bead without 
oocyte) were processed alongside each sample.  The first round nested PCR was 
performed with an annealing temperature of 50ºC.  For the second round, 5 µl of first 
round product was added to a second 25 µl ready-to-go PCR bead, with Peg1/Mest 
specific primers but without tRNA, with 25 µl mineral oil overlay.  The second round 
nested PCR was performed using an annealing temperature of 54ºC.
 Embryos were obtained from B6(CAST7p6) females crossed with B6 males 
(Charles River, St Constant, Canada).  For in vivo-derived embryos, female 
B6(CAST7p6) mice were checked for estrus, and mated with B6 males. For the 
superovulated group, females were injected with either 6.25 or 10 IU of PMSG, followed 
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by the same dose of hCG, 40-44 hours later.  Females were mated with B6 males the 
same day as hCG injection.  In both groups, pregnancy was determined by the presence of 
a vaginal plug at 0.5 days postcoitum (dpc).  F1 hybrid 2-cell embryos were flushed from 
the oviducts of B6(CAST7p6) females at 1.5 dpc, washed twice and cultured in Whitten’s 
medium (made in-house) (Whitten, 1971).  Embryo culture drops were prepared prior to 9 
AM the morning of embryo collection or embryo separation, and allowed to equilibrate. 
Embryos were cultured in either 10, 15 of 20 µL drops, with filter-sterilized mineral oil 
overlay (Sigma), at a concentration of 1 embryo per microliter.  Embryos were separated 
into four groups based on rates of development over the course of the 3 day culture period 
as described in Chapter 4.
 Control blastocyst stage embryos were flushed from uteri of B6(CAST7p6) 
females in M2 Medium (Sigma) at 3.5 dpc (~96 hours post-hCG).  Cultured embryos and 
embryos collected at the blastocyst stage were frozen in individual tubes, snap frozen on 
dry ice and stored at -80˚C.
5.2.3 Analysis of Peg1/Mest Imprinted Methylation and Expression
 The combined analysis of imprinted methylation and expression in individual 
blastocysts was performed as previously described using the cDNA library generated for 
each embryo (Market-Velker et al., 2010b).  The following primers were used for the 
analysis of imprinted expression of Peg1/Mest (NM_008590; 1380-1920): Forward 5’-
CACATTGGTGAACAAACTACAGG-3’(1PG2), Reverse 5’-
AGAGTGCTGGGAACTGAACC-3’(1PG5).  Amplification of a 541 bp fragment 
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containing an allelic polymorphism between B6 (C) and CAST (A) (position 1679, 
NM_008590) was tested using SYBR green to allow determination of the range of cycles 
located in log-phase amplification.  PCR on subsequent embryos was performed to ensure 
that amplification was log-phase upon completion of the PCR program.  Following 
amplification using ready-to-go PCR Beads, embryos were digested with the BsiHKA1 
restriction enzyme to determine allelic identity; the B6 allele is cleaved into 270 and 271 
bp fragments, while the CAST allele is uncut.  Densitometry was performed using the 
Opticon Monitor Software.    
 For imprinted methylation, bisulfite mutagenesis, nested PCR, cloning and 
sequencing was performed as described previously (Chapter 3) (Market-Velker et al., 
2010b).  Analysis of 15 CpGs in the Peg1/Mest DMR (AF017994; 1309-1651) was 
performed using the following primers: outer primers; Peg1B 5’-
TTTTAGATTTTGAGGGTTTTAGGTTG-3’, and Peg1E 5’-
TCATTAAAAACACAAACCTCCTTTAC-3’, 50˚C annealing temperature; inner 
primers; Peg1C 5’-GGTGTTGGTATTTTTAGTGTTAGTTG-3’, and Peg1D 5’-
AATCCCTTAAAAATCATCTTTCACAC-3’, 57.5˚C annealing temperature.  Primers 
were designed within the region described by Anckaert et al (Anckaert et al., 2010).  At 
least 40 clones per embryo were sequenced, and each sequence was analyzed as described 
previously (Chapter 3) (Market-Velker et al., 2010b).  Hypermethylation of a DNA strand 
was defined as > 50% methylated CpGs on a given strand. 
 For each oocyte, 5 clones were sequenced.  Since individual oocytes are expected 
to have a single strand of DNA amplified, any samples having more than one methylation 
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pattern were excluded from analysis, due to implied cumulus cell contamination. 
Sequences with conversion rates < 85% were not included. 
5.2.4 Statistical Analysis
 Statistical analysis was performed comparing loss of methylation between in vivo-
derived embryos, superovulated embryos (6.25 IU and 10 IU) and in vitro cultured 
embryos.  The Fisher’s exact test was used to compute the significance of non-random 
association between these groups of embryos.  A one-sided test was utilized as 
methylation changes were anticipated to be only in one direction.  P-values less than 0.05 
were considered to be significant, and were calculated using the following online 
software: http://faculty.vassar.edu/lowry/fisher.html
5.3 Results
5.3.1 Effects of Superovulation on Peg1/Mest Imprinted Methylation in Oocytes
 In this study, we set out to determine the effects of superovulation on Peg1/Mest 
imprinted methylation in ovulated oocytes.  Furthermore, we wanted to determine 
whether the original maternal and paternal Peg1/Mest alleles displayed differential 
sensitivity to hormone treatment.  During oogenesis, imprinted methylation acquisition 
may occur differentially between the parental alleles as evidence indicates that 
methylation of the Snrpn grand-maternal allele is established prior to that on the 
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grandpaternal allele (Lucifero et al., 2004). By using B6(CAST7p6) F1 females, we can 
distinguish between the Peg1/Mest grandmaternal (CAST7p6) and grandpaternal (B6) 
alleles within individual oocytes.
To assess effects of superovulation on imprinted methylation, our recently 
developed single cell bisulfite mutagenesis assay was used to determine the methylation 
status of 15 CpGs located in the Peg1/Mest DMR.  Amplification was successful in 36% 
of individual oocytes (10/28) from spontaneously ovulating B6(CAST7p6) females, all of 
which displayed 100% hypermethylation (Figure 5.2). 
 To investigate the effects of superovulation on the acquisition of genomic imprints 
at the Peg1/Mest DMR, we analyzed oocytes from B6(CAST7p6)XB6 females 
superovulated with either 6.25 IU or 10 IU hormone treatment.  Following bisulfite 
mutagenesis amplification was successful for 38% of 6.25 IU individual oocytes (17/45) 
and 40% of 10 IU individual oocytes (20/50).  Following exclusion of samples with 
cumulus cell contamination (1/16 6.25 IU, 5/20 10 IU oocytes), all individual oocytes 
from hormone-treated females showed 100% Peg1/Mest DMR hypermethylation (Figure 
5.2).  Thus, we conclude that superovulation does not alter acquisition of genomic 
imprinting at the Peg1/Mest DMR, even at higher hormone treatment levels.  In addition, 
as both grandmaternal (CAST7p6) and grandpaternal (B6) alleles displayed similar 
hypermethylation patterns, our results do not demonstrate differential allelic susceptibility 
of maternal imprint acquisition to perturbations by superovulation, at this point of 
analysis.  Analysis of oocyte diameter and volume revealed no difference between 
oocytes derived from spontaneously and superovulated females (data not shown).
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Figure 5.2. Methylation of Peg1/Mest in Oocytes
Methylation of the Peg1/Mest DMR in individual oocytes derived from spontaneously 
ovulated and superovulated B6(CAST7p6)xB6 F1 females (6.25 and 10 IU). 
Unmethylated CpGs are represented as empty circles while methylated CpGs are depicted 
as filled circles.  Each line denotes an individual strand of DNA from a single oocyte. 
Oocyte designations are indicated on the left of each DNA strand, allele is indicated on 
the right of each strand (B-B6, C-CAST).  All oocytes displayed 100% hypermethylation. 
Hypermethylated DNA strands were those displaying >50% methylated CpGs.
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5.3.2 In Vivo Patterns of Imprinted Methylation at the Peg1/Mest DMR in 
Blastocysts
 Methylation patterns of in vivo-derived embryos have not been described at the 
Peg1/Mest DMR in blastocyst stage embryos.  As such, prior to our investigation of 
superovulated or cultured embryos, we set out to determine the imprinted Peg1/Mest 
DNA methylation pattern in in vivo-derived blastocyst stage embryos in our mouse 
model.  Using a modified bisulfite mutagenesis protocol to obtain information for 
individual blastocysts (Chapter 4), we determined the Peg1/Mest imprinted methylation 
patterns for 10 in vivo-derived B6(CAST7p6)xB6 embryos.  We observed that 7 of the 10 
embryos displayed high hypermethylations levels at the maternal Peg1/Mest DMR (E011 
70%; E023 100%; E010 92%; E033 86%; E076%; E090%; E031 80%) while the 
remaining three embryos displayed lower levels of hypermethylation (E018 30%; E020 
40%; E014 67%) (Figure 5.3).  Using data from these embryos, we set our threshold for 
loss of methylation at 70% (74% average hypermethylation of the maternal allele), 
similar to Snrpn (Chapter 2; Market-Velker et al., 2010a).  In our previous analysis of 
H19, Kcnq1ot1 and Peg3 methylation (Chapter 2; Market-Velker et al., 2010a), we 
observed that 10-20% of in vivo-derived blastocysts exhibited a loss of imprinted 
methylation (as evidenced by levels of methylation below our set thresholds).  Notably 
for Peg1/Mest, three embryos show this pattern of hypermethylation.  As Peg1/Mest has 
been reported to acquire methylation later in oocyte development, perhaps its methylation 
is more labile.
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Figure 5.3: Methylation of the Peg1/Mest DMR in Embryos derived from 
Spontaneously Ovulating Females.
Methylation of the paternal Peg1/Mest DMR in B6(CAST7p6)xB6 F1 embryos derived 
from spontaneously vulated females.  Each group of DNA strands represents one 
blastocyst.  Unmethylated CpGs are represented as empty circles while methylated CpGs 
are depicted as filled circles.  Each line denotes an individual strand of DNA, and each 
group of strands denotes an individual blastocyst.  Blastocyst designations are indicated at 
the top left of each group, and % hypermethylation is indicated at the top center of each 
group.  Percentages were calculated as the number of hypermethylated DNA strands/total 
number of DNA strands.  Hypermethylated DNA strands were those displaying >50% 
methylated CpGs.
212
5.3.3 Effects of Superovulation on Imprinted Methylation at the Peg1/Mest DMR in 
Blastocysts
 To determine the effects of superovulation on Peg1/Mest imprinted methylation in 
embryos, we investigated methylation at the Peg1/Mest DMR in blastocysts from 
superovulated females treated with either 6.25 IU (low dose) or 10 IU (high dose).  In the 
low dose hormone group, using 70% hypermethylation as our threshold, 5/9 embryos 
displayed loss of methylation  (E62 38%; E63 13%; E617 40%; E626 50%; E624 50%), 
with a mean maternal hypermethylation level 56% (Figure 5.4).  At the high hormone 
dosage, loss of methylation was observed in 9/11 embryos (E102 33%; E1018 0%, E1031 
63%; E1034 58%; E101 67%; E1033 70%; E1032 20%; E105 63%; E104 13%), with a 
mean maternal hypermethylation level of 51% (Figure 5.5).  Overall, an increase in the 
number of embryos displaying loss of methylation was observed in the low hormone 
treatment group compared to in vivo-derived controls, with a further increase observed in 
the high hormone treatment group, which was statistically significant (p = 0.02).  This is 
consistent with the behaviour of other imprinted loci in response to superovulation 
(Chapter 2; Market-Velker et al., 2010a).
5.3.4 Effects of Embryo Culture on Imprinted Methylation at the Peg1/Mest DMR in 
Blastocysts
 Embryo culture is another technique commonly used in the treatment of infertility.  
To evaluate the effects of embryo culture on imprinted methylation at the Peg1/Mest 
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Figure 5.4: Methylation of the Peg1/Mest DMR in Embryos derived from 
Superovulated (6.25 IU) Females
Methylation of the paternal Peg1/Mest DMR in B6(CAST7p6)xB6 F1 embryos derived 
from superovulated (6.25 IU) females.  See Figure 5.3 for additional information. 
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Saturday, April 16, 2011Figure 5.5: Methylation of the Peg1/Mest DMR in Embryos derived from 
Superovulated (10 IU) Females
Methylation of the paternal Peg1/Mest DMR in B6(CAST7p6)xB6 F1 embryos derived 
from superovulated (10 IU) females.  See Figure 5.3 for additional information.
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DMR, we analyzed 23 individual embryos cultured from the 2-cell to the blastocyst stage 
in Whitten’s medium (Figures 5.6-5.9).  Embryos were separated based on rate of 
preimplantation development, as described in Chapter 4.  In the FF group 7/8 embryos 
displayed loss of imprinting methylation (68%, 67%, 61%, 50%, 44%, 42%, 35%), 3/5 in 
the FS group (70%, 56%, 38%), 5/6 in the SF group (64%, 57%, 50%, 50%, 33%) and 3/5 
in the SS group (56%, 50%, 43%).  The average hypermethylation in each group were as 
follows: 56% FF, 63% FS, 55% SF, and 61% SS.  Overall, the “Fast” group displayed loss 
of methylation in 10/13 embryos, corresponding to an average hypermethylation of 58%, 
and the “Slow” group displayed a loss of methylation in 8/11 embryos, also 
corresponding to an average hypermethylation of 58%.  Unlike our previous study 
showing more severe loss of methylation in “Fast” developing embryos than the “Slow” 
group at the H19 and Snrpn ICRs, no statistical difference was observed between the 
embryo culture groups at the Peg1/Mest DMR.  In addition, no difference was observed 
when comparing embryos at the second separation (FF and SF vs FS and SS).  Overall, 
significantly more cultured embryos (18/24) displayed levels of imprinted methylation 
below the 70% threshold (p = 0.02), compared to the in vivo group (3/10).
5.3.5 Effects of Superovulation and Embryo Culture on Peg1/Mest Imprinted 
Expression
 We also analyzed imprinted expression of Peg1/Mest in the same in vivo-derived 
embryos used for methylation analysis, using our technique for combined imprinted 
methylation and expression analysis in individual embryos (Market-Velker et al., 2010b).
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Figure X:  Imprinted methylation for Peg1 from the Fast/Fast embryo group.  
Embryo number is indicated in the top-left of each sample, % hypermethylated strands is indicated to 
the right, imprinted expression is indicated to the right in orange.
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Figure 5.6: Methylation of the Peg1/Mest DMR in Blastocysts From the FF Group
Methylation of the aternal Peg1/Mest DMR in B6(CAST7p6)xB6 F1 embryos from the 
Fast/Fast group, cultured in Whitten’s medium.  See Figure 5.3 for additional information. 
Imprinted expression in each embryo is indicated in orange next to each group.
217
Figure 5.7: Methylation of the Peg1/Mest DMR in Blastocysts From the FS Group
Methylation of the paternal Peg1/Mest DMR in B6(CAST7p6)xB6 F1 embryos from the 
Fast/Slow group, cultured in Whitten’s medium.  See Figure 5.3 and 5.6 for additional 
information.
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Figure 5.8: Methylation of the Peg1/Mest DMR in Blastocysts From the SF Group
Methylation of the paternal Peg1/Mest DMR in B6(CAST7p6)XB6 F1 embryos from the 
Slow/Fast group, cultured in Whitten’s medium.  See Figure 5.3 and 5.6 for additional 
information.  
Figure X:  Imprinted methylation for Peg1 from the Slow/Fast embryo group.  
Embryo number is indicated in the top-left of each sample, % hypermethylated strands is indicated to 
the right, imprinted expression is indicated to the right in orange.
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Figure 5.9: Methylation of the Peg1/Mest DMR in Blastocysts From the SS Group
Methylation of the paternal Peg1/Mest DMR in B6(CAST7p6) X B6 F1 embryos from the 
Slow/Slow group, cultured in Whitten’s medium.  See Figure 5.3 and 5.6 for additional 
information. 
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Figure X:  Imprinted methylation for Peg1 from the Slow/Slow embryo group.  
Embryo number is indicated in the top-left of each sample, % hypermethylated strands is indicated to 
the right, imprinted expression is indicated to the right in orange.
E52 80%
Peg1 2CAST
B6
93.4%18A
97.8%22A
96.7%15A
93.4%1A
93.4%31A
96.3%?
98.9%23A
97.5%?
96.3%?
91.4%?
94.5%24A
94.5%25A
100%2B
98.9%6B
92.3%7A
97.8%2B
93.4%14A
98.9%15A
98.9%8A
update oct 1
Saturday, October 23, 2010
Peg1 1115CAST
B6
96.7%?
96.3%?
98.9%?
97.8%1A
97.5%?
96.3%?
91.4%?
97.5%?
96.3%?
91.4%?
97.5%?
96.3%?
91.4%?
94.5%11A
100%15A
94.5%2A
94.5%7A
95.6%9A
98.9%1B
100%5B
96.7%9B
Thursday, November 11, 2010
E55 78%
Saturday, April 16, 2011
220
  Peg1/Mest was expressed in 12 of 15 (80%) of in vivo-derived embryos, all of which 
displayed monoallelic expression from the paternal B6 allele (Figure 5.10).  Similar to in 
vivo-derived embryos, both the 6.25 IU and 10 IU groups displayed paternal monoallelic 
expression, with 20/21 embryos (95%) showing expression from each of the two groups 
(Figure 5.10).
 Imprinted expression of Peg1/Mest was evaluated in 14 FF, 8 FS, 9 SF and 8 SS 
embryos.  All embryos displayed paternal monoallelic expression with the exception of 
the FF group; three embryos lacked any detectable Peg1/Mest expression (Figure 5.11).  
Expression of Snrpn was also analyzed in all samples as a control for generation of the 
cDNA library, and was monoallelically expressed in all samples.  Thus, similar to 
previous experiments with Snrpn and Peg3 (Mann et al., 2004; Market-Velker et al., 
2010b), no effect was observed on imprinted expression, even through alteration in 
imprinted methylation were present in these same embryos.
5.4 Discussion
 In this study, we present a comprehensive evaluation of the effects of 
superovulation and in vitro culture on genomic imprinting at Peg1/Mest.  Superovulation 
resulted in disruption of imprinted methylation at the blastocyst stage, in a dose-
dependent manner, similar to other loci previously examined (Chapter 2; Market-Velker et 
al., 2010a).  Our analysis of individual oocytes provides evidence that this disruption was 
not due to a failure of imprint acquisition during oogenesis, as superovulated oocytes 
displayed methylation patterns identical to their in vivo-derived counterparts.  With 
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Figure 5.10:  Imprinted Expression of Peg1/Mest in Spontaneous and Superovulated 
Blastocysts
Imprinted expression of Peg1/Mest in blastocysts derived from spontaneously ovulated 
and superovulated females.  Green represents the paternal B6 allele, and blue represents 
the maternal CAST allele.  Biallelic expression was classified as > 10% expression from 
the maternal allele.  Embryo designations and groups are indicated on the bottom.
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Figure 5.11:  Imprinted Expression of Peg1/Mest in Cultured Embryos
Imprinted expression of Peg1/Mest in blastocysts cultured in Whitten’s medium.  Green 
represents the paternal B6 allele, and blue represents the maternal CAST allele.  Biallelic 
expression was classified as > 10% expression from the maternal allele.  Embryo 
designations and groups are indicated at the bottom.
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respect to embryo culture, no difference was observed in Peg1/Mest imprinted 
methylation between “Fast” and “Slow” embryos, while a significant loss of methylation 
was observed when compared to in vivo-derived controls.  This suggests that mechanisms 
regulating maintenance of genomic imprinting during the early preimplantation stages at 
the Peg1/Mest DMR were not affected by rates of embryo development.  
5.4.1 Maintenance, Not Acquisition, is Affected by Superovulation
 We have previously shown that, at the blastocyst stage, superovulation results in 
loss of imprinted methylation on the repressed maternal allele of Snrpn, Peg3, and 
Kcnq1ot1, and a gain of methylation on the active maternal H19 allele.  Loss of 
methylation on the paternal H19 allele was also observed, which first led us to speculate 
that superovulation may disrupt maintenance of genomic imprinting, rather than, or in 
addition to, acquisition.  Here, we show that acquisition of genomic imprinting at the 
Peg1/Mest locus was not affected by superovulation, consistent with another study 
demonstrating normal imprinted methylation at the Peg1/Mest DMR in the oocyte 
following superovulation (Sato et al., 2007).  Furthermore, greater loss of methylation in 
the high hormone group compared to the low dosage group indicates a dose-dependent 
effect.
 In a previous study, imprinted methylation at the Peg1/Mest DMR was 
investigated in fully grown GV oocytes, freshly ovulated MII oocytes, and MII oocytes 
cultured for either 8 or 24 hours (22 and 42 hours after hCG, respectively), all derived 
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from superovulated females. Peg1/Mest methylation acquisition was completed in MII 
oocytes following culture for 8 hrs (22 hours post-hCG), but not in earlier stages of 
oocyte maturation, indicating that acquisition of methylation at this locus continued after 
ovulation.  Our oocytes were collected at approximately 22 hours post-hCG, and fully 
hypermethylated alleles were observed in both spontaneously and induced ovulated 
oocytes.
 Two theories concerning the effects of superovulation on acquisition of genomic 
imprints have been put forth.  First, hormonal stimulation may lead to rapid oocyte 
maturation, or it may induce ovulation of immature oocytes that have not completely 
acquired their imprints (Paoloni-Giacobino and Chaillet, 2004; Ludwig et al., 2005). As 
we observed no change in oocyte diameter or volume, nor a delay in imprint acquisition, 
our data indicate that immature oocyte were not recovered in this analysis.  Secondly, 
ovarian stimulation may accelerate oocyte maturation (Baerwald et al., 2009), resulting in 
an inability of the oocyte to synthesize and store high enough amounts of these maternal 
factors.  In this case, imprint acquisition would proceed normally but imprint maintenance 
would be compromised during preimplantation development.  Our results support the 
latter hypothesis.
 Studies of human oocytes have suggested that acquisition of imprinted 
methylation is affected by superovulation, however in all of these studies, intrinsic 
subfertility is a confounding factor.  Loss of methylation at the Peg1/Mest locus was 
observed in oocytes collected from infertile women undergoing hormonal stimulation, 
however mouse oocytes from the same study in which intrinsic subfertility is not a 
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confounding factor showed no loss of methylation (Sato et al., 2007).  Subfertility in male 
patients has also been associated with alteration at the Peg1/Mest locus.  The Peg1/Mest 
DMR is unmethylated from fetal spermatogonia to mature spermatozoa (Kerjean et al., 
2000).  Hypermethylation of this region has been associated with idiopathic male 
infertility as well as infertility due to low sperm counts (Poplinski et al., 2010).  
Therefore, although mechanisms in the sperm and in the oocyte vary, alterations of 
acquisition of genomic imprinting observed in human studies at the Peg1/Mest locus may 
be a result of intrinsic subfertility of the patient, and not only a result of hormonal 
stimulation.
 
5.4.2 In Vitro Culture, but not Rates of Early Development Affect Methylation of 
Peg1/Mest
 Embryo culture has been shown to cause perturbation of imprinted methylation 
and expression of a number of imprinted genes (Doherty et al., 2000; Mann et al., 2004; 
Rivera et al., 2008; Market-Velker et al., 2010b).  Consistent with data from the previous 
chapters, here we report loss of imprinted methylation at the Peg1/Mest DMR following 
in vitro culture to the blastocyst stage in Whitten’s medium.  This is in contrast to two 
other studies which show no loss of methylation at the 2-cell or blastocyst stage following 
in vitro culture in M16 medium (Imamura et al., 2005), or M16 medium supplemented 
with serum (Khosla et al., 2001).  However neither of these were performed allelically, or 
on individual embryos. 
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 Moreover, we separated in vitro cultured embryos into groups based on their rates 
of preimplantation development, as previously described in Chapter 4.  Contrary to our 
previous observations, where loss of methylation was more severe in the “Fast” group at 
the H19 and Snrpn ICRs, loss of methylation at the Peg1/Mest DMR was not different 
between “Fast” and “Slow” embryos.  Therefore, unlike Snrpn and H19, methylation at 
the Peg1/Mest DMR does not correlate with rates of early cleavage.
 This difference could be due to a number of factors.  First, the regions of H19 and 
Snrpn analyzed in our previous study were known imprinting control regions (ICRs), 
while the region of Peg1/Mest analyzed in this study consisted of 15 CpGs within the 
known DMR.  Until this DMR is investigated for its ability to regulate domain 
imprinting, it is not certain whether this region represents the Peg1/Mest ICR.  Once 
identified, analysis of the Peg1/Mest ICR may show a similar association with rates of 
embryo development as do Snrpn and H19.  
 Alternatively, many other groups have described a differential response of Peg1/
Mest to environmental insult when compared to other imprinted loci (Khosla et al., 2001; 
Liang et al., 2008; Tveden-Nyborg et al., 2008; Anckaert et al., 2010), suggesting that 
slightly different mechanisms regulate genomic imprinting at this locus.  Different 
mechanisms operating at these imprinted loci during early cleavage stages would explain 
the altered susceptibility of Peg1/Mest to the differences between “Fast” and “Slow” 
embryos at early stages of preimplantation development.  
 Furthermore, the Peg1/Mest locus was not protected from the detrimental effects 
of long term in vitro culture.  We observed a significant increase in the number of cultured 
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embryos displaying loss of imprinted methylation when compared to in vivo-derived 
controls.  Due to the late acquisition of methylation in the oocyte, slow rates of 
development may not confer the same advantage to oocytes’ ability to maintain levels of 
methylation at the Peg1/Mest locus early in preimplantation development, as it had for 
H19 and Snrpn.  Thus, a persistent suboptimal culture environment, together with later 
acquisition of Peg1/Mest methylation, would result in de-regulation of factors necessary 
throughout subsequent cell cycles for maintenance of genomic imprinting.
5.4.4 Imprinted Expression of Peg1/Mest is Unaffected by Superovulation, and 
Embryo Culture
 In addition to imprinted methylation, we examined Peg1/Mest imprinted 
expression in blastocysts derived from superovulated females, as well as those subjected 
to in vitro culture.  Neither procedure affected imprinted expression of Peg1/Mest.  
Previous studies have shown disrupted imprinted expression of H19 following embryo 
manipulation (Doherty et al., 2000; Mann et al., 2004; Market-Velker et al., 2010b), 
however, no change in imprinted expression was observed for Snrpn, and Peg3 under the 
same conditions at the blastocyst stage (Doherty et al., 2000; Market-Velker et al., 
2010b).  Having said this, analysis of imprinted expression at post-implantation stages of 
these same genes revealed biallelic expression, especially in extraembryonic tissues 
(Mann et al., 2004; Rivera et al., 2008).  Thus, we predict that Peg1/Mest will behave in a 
similar manner with disruption of imprint methylation maintenance during 
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preimplantation development resulting in dysregulation of imprinted expression in post-
implantation tissues.
 To date, many groups have attempted to characterize the changes in expression 
(Wang et al., 2005; Zheng et al., 2005; Hamatani et al., 2006; Zheng et al., 2007; 
Giritharan et al., 2010), and in localization of chromatin modifiers (Doherty et al., 2000; 
Ooga et al., 2008; Kim and Ogura, 2009) throughout normal preimplantation 
development, and in response to different ARTs.  These studies, and others specifically 
targeting known regulators of epigenetic phenomena will be invaluable in pinpointing the 
specific factors involved in global maintenance of genomic imprinting during 
preimplantation development.  Our data suggest that investigation of epigenetic factors 
that are produced as maternal effect products may hold the most promise for identifying 
those factors involved in imprinted maintenance during preimplantation development.
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Chapter 6 - Discussion
 Genomic imprinting is a complex process that depends on both the proper 
acquisition and maintenance of imprinting marks throughout preimplantation 
development, and adult life.  Assisted reproductive technologies, namely superovulation 
and embryo culture, take place during the critical periods of imprint acquisition and 
maintenance, providing an window for deregulation of these processes.  To date, our 
ability  to investigate the effects of ARTs on embryos has been limited by our technical 
abilities.  To properly evaluate the effects at a level relevant to the human clinic studies 
must be performed on individual embryos, to obtain information about the degree of 
perturbation in each embryo, as well as the frequency of perturbation under each 
environmental condition.  The methodology  developed (outlined in Appendix 1) 
represents a technical advancement in the field.  Prior to the experiments in this thesis, the 
effects of ARTs were known only  for a select number of imprinted loci, from studies 
using pools of embryos, and investigations of individual embryos at post-implantation 
stages of development.  Here, I provide a comprehensive analysis of ART-induced 
imprinting errors at the single embryo level, in preimplantation embryos.  Experiments 
investigate the effects of superovulation alone and of culture alone in various 
commercially-available media, on both imprinted methylation and expression at key loci. 
In addition, as this has not been previously  investigated, I report the effects of embryo 
culture on Peg3 and Kcnq1ot1 at the blastocyst stage, and comprehensive evaluation of 
the response of the Peg1/Mest locus to ARTs.  
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 In addition, these studies aim to provide some insight into the mechanism of 
imprinting dysregulation.  Much work remains to be done before distinct molecular 
pathways are elucidated, however the work presented in this thesis narrows the search: (1) 
both maternal and paternal imprints are disrupted by superovulation, indicating that 
superovulation perturbs a maternal-effect gene product  required for imprint  maintenance 
during preimplantation development; (2) multiple imprinted loci are affected in the same 
embryo by ARTs, although the misregulated loci vary between embryos, indicating that 
the response to adverse effects of ARTs is stochastic; (3) the use of multiple procedures 
increases the number of affected embryos, suggesting that pathways disrupted by  various 
ARTs are the same, or converge at common point; and (4) faster developing embryos 
exhibited a greater loss of imprinting, greater changes in metabolic activity and are least 
similar to in vivo-derived controls, suggesting that higher metabolic levels and faster cell 
cycle divisions represent maladaptations to the culture environment.
6.1 ARTs Affect Genomic Imprinting
6.1.1  Superovulation
 The timing of superovulation coincides with the development of oocytes from MI 
to arrested MII, when the acquisition of methylation imprints occurs.  Due to this timing, 
we and others have hypothesized that superovulation disrupts the acquisition of genomic 
imprints.  Therefore, any disruption in genomic imprinting that occurred as a result  of 
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superovulation would be evident at the MII stage, and after fertilization and 
preimplantation development, would be present at  blastocyst stage.  As well, only 
maternal imprints should be affected, as the paternal imprint is acquired in developing 
spermatocytes and would not be affected by hormonal treatment used for superovulation.  
 A number of hypotheses attempt to explain how superovulation disrupts imprint 
acquisition.  The first suggests that superovulation rescues subordinate follicles that, 
under normal circumstances, would undergo atresia and not develop  into fully mature 
oocytes (Van der Auwera and D'Hooghe, 2001).  Superovulated oocytes override the 
atretic program, leading to ovulation of oocytes that have not properly  acquired their 
maternal imprints.  Variations on this hypothesis state that superovulation simply results 
in ovulation of immature oocytes that have not had enough time to acquire their genomic 
imprints (Paoloni-Giacobino and Chaillet, 2004; Ludwig et al., 2005).  In both of these 
cases, superovulation does not affect  epigenetic processes in the oocyte, it  simply allows 
continued development of oocytes with aberrant genomic imprinting, or accelerates 
development preventing completion of acquisition prior to ovulation.  The second 
hypothesis suggests that administration of exogenous hormones results in modulation of 
molecular signaling pathways.  These molecular pathways may  result in misregulation of 
genes important for acquisition of genomic imprinting (ex: DNMT and its binding 
partners), perhaps disrupting the ability of the cell to target epigenetic machinery to 
proper locations resulting in lack of de novo methylation at certain loci.  This would result 
in disruption of methylation acquisition at maternally methylated loci, and potentially, in 
a gain of methylation of paternally  methylated (maternally unmethylated) loci if 
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mechanisms blocking methylation at a given locus were also disrupted.  However, this 
hypothesis does not provide an explanation for loss of methylation at paternally-inherited 
loci, that acquire their methylation in male germ cells.  The third hypothesis states that 
superovulation accelerates the growth rate of ovarian follicles, allowing for normal 
maternal imprint acquisition, but instead disrupts one or more maternal-effect  genes or 
gene products.  This maternal-effect gene would play  a key role in maintenance of 
genomic imprinting throughout preimplantation development.  Experiments in this thesis 
support the third hypothesis, as no change in Peg1/Mest imprint acquisition was observed 
following superovulation.  In addition, superovulation resulted in loss of methylation on 
maternal alleles, gain of methylation on maternal alleles, and most  importantly, loss of 
methylation on paternal alleles, in blastocyst stage embryos.
 Further evidence has begun to support the third hypothesis.  Other groups have 
reported no adverse effects of superovulation on maternal imprinted methylation in 
oocytes; fully  methylated alleles are noted at imprinted loci (Sato et al., 2007; Anckaert et 
al., 2009).  Studies from our lab (by M. Denomme) confirm this; following 
superovulation, fully methylated maternal alleles are observed in MII oocytes. 
 Therefore, I propose that superovulation acts to disrupt genomic imprinting 
potentially through acceleration of ovarian follicle growth leading to disruption of one or 
more maternal-effect genes or gene products.  This accelerated growth may  result in a 
decrease in maternal mRNA stores, which are critical for maintenance of genomic 
imprinting.  A decrease in these stores would not affect acquisition of genomic imprinting, 
as the molecular components necessary for this transient act of de novo methylation (and 
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potentially histone modifications, etc...) would be synthesized prior to their function 
during the arrested MI to MII period, and are not required to exhibit long-term activity. 
However, the level of maternal mRNAs necessary for maintenance may  fall below a 
necessary  threshold to maintain imprinting at  certain loci.  As such, maintenance of 
maternal methylation would be affected, causing levels of maternal methylation to 
decline.  In addition, mechanisms that protect paternally  methylated loci from acquiring a 
maternal profile would also be depleted, accounting for the gain of methylation that we 
and others (Borghol et al., 2006; Sato et al., 2007) have observed following 
superovulation.  Finally, it would be expected that these same maternal mRNAs would be 
required to maintain imprinted marks during the drastic epigenetic changes undergone by 
the paternal genome following fertilization.  As such, a deficiency in these factors may 
result in disruption of paternal imprints during the active wave of demethylation after 
fertilization, consistent with our report of loss of paternal methylation at the H19 allele in 
blastocysts following superovulation.  With the model outlined above, loss of methylation 
on the maternal alleles of paternally  expressed genes, gain of methylation on the paternal 
alleles of maternally  expressed genes, as well as loss of methylation on the paternal allele 
of maternally expressed genes is expected, all of which I report  in Chapters 2-5. 
  
6.1.2 Embryo Culture
 The second ART investigated was embryo culture.  Depending on the protocol 
employed, embryo culture takes place from the 1- or 2-cell stage, up  to the 4- to 8-cell, or 
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blastocyst stage.  Many studies have identified ARTs, of which embryo culture is an 
integral component, as a means to disrupt genomic imprinting, however the majority of 
studies did not  evaluate embryo culture alone (Doherty  et al., 2000; Khosla et al., 2001; 
Mann et al., 2004; Li et al., 2005; Fauque et al., 2007).  As such, separating out the effects 
of each individual technique using these studies is nearly  impossible.  Our studies focused 
on embryo culture alone, demonstrating a significant  effect on genomic imprint 
maintenance. 
 Comparisons of studies of embryo culture have proven difficult as type of culture 
media, type of oil overlay, culture volume, oxygen tension, and associated ARTs, to name 
only a few, vary between labs and clinics.  In Chapter 3, I aimed to accurately compare 
multiple embryo culture media currently used in the field and determine if one media was 
superior to another with respect to the maintenance of genomic imprinting.  Contrary to 
my expectations, I did not observe drastic differences between media; all media were 
suboptimal in their ability to maintain genomic imprinting.  However, genomic imprinting 
at certain loci was better maintained in some media than others.  Overall more recently 
developed media (ex: Global) appeared superior to the less optimized types (ex; HTF and 
Whitten’s).  As well, the use of sequential media showed no advantage over non-
sequential media.  These findings lead us to speculate that embryo culture, the act of 
maintaining preimplantation embryos out of the female reproductive tract, is the most 
significant factor.  In addition, as all loci were affected by all media, I speculate that the 
factor(s) that is affected by embryo culture is a universal one, and the mechanism 
underlying the dysregulation is a global mechanism rather than a locus specific binding 
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factor.  Differences in embryo culture media are then due to the degree of perturbation of 
these factors, and to the extent of compensatory mechanisms in each embryo.  
 One candidate through which global methylation may be affected is DNMT1. 
Two isoforms of DMT1 have been described in preimplantation stage embryos, the 
somatic form DNMT1s, and the oocyte-specific form DNMT1o (Ding and Chaillet, 
2002).  During preimplantation development, DNMT1s is localized predominantly to the 
cytoplasm,  (Carlson et al., 1992), while DNMT1o localizes to the nucleus at the 8-cell 
stage (Ding and Chaillet, 2002).  Disruptions in DNMT1 itself are unlikely, as a number 
of imprinted genes in the embryo and placenta do not appear to require DNMT1 for 
monoallelic expression (Li et al., 1993; Caspary et  al., 1998; Lewis et al., 2004), those 
that do vary in their response to reduced levels of DNMT1 (Weaver et al., 2010) and no 
differences in DNMT1 localization or activity have been noted following embryo culture 
(Doherty et al., 2000).  
 The passive demethylation of the maternal genome suggests that  although 
DNMT1 is present in the nucleus during preimplantation stages, its activity  is tightly 
regulated and targeted to DMRs.  Some studies have suggested that  this targeting 
mechanism may involve Zfp57, a DNA binding protein that  recruits the histone methylase 
complex SETDB1, which provides repressive histone marks (Ayyanathan et al., 2003), or 
Stella, another similar histone modification targeting factor (Nakamura et al., 2007). 
Histone methylation may provide binding sites for proteins such as HP1, which in turn 
can recruit DNMTs (Lehnertz et al., 2003).  Disruption in one or many of these targeting 
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mechanisms, or their associated protein complexes, may be cause of the loss of 
methylation that we and others have observed at the blastocyst stage.
 Imprinted loci may not be the only regions disrupted by ARTs.  Many studies have 
shown global changes in epigenetic modifications following embryo culture.  The effect 
of assisted reproduction on DNA methylation was assessed at more than 700 genes in 
placenta and cord blood from children of assisted and unassisted conceptions using a site-
specific CpG methylation assay (Katari et al., 2009).  A significant change in DNA 
methylation was observed with lower mean methylation levels in the placenta, and higher 
mean methylation levels in cord blood from children conceived in vitro when compared 
to children conceived naturally, indicating the broad effects of ART on DNA methylation. 
Global changes in genes involved in glucose metabolism, glucose transporters and insulin 
signaling (Zheng et al., 2007), and changes in genes involved in DNA repair, and cell 
cycle regulation (Zheng et al., 2005) have been shown following embryo culture, again 
indicating that embryo culture has the potential to affect many different cellular systems.
 In addition, we cannot rule out the possibility that mechanisms regulating 
individual loci are also disrupted by ARTs.  As different imprinted loci are regulated 
through different mechanisms (Wan and Bartolomei, 2008; Koerner et  al., 2009), with 
different domain specific proteins involved in their acquisition and maintenance, it is 
possible that a common factor involved in the regulation of some, but not  all, imprinted 
loci, is dysregulated by ARTs.
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6.1.3 Multiple ARTs
 The effects of multiple ARTs is additive, resulting in more embryos with 
disruptions at more imprinted loci.  Examination of different loci did not reveal gene-
specific, nor ART type-specific effects, as one locus was not more likely to show loss of 
methylation in one media type, or following one type of ART than another locus.  This 
suggests that superovulation and genomic imprinting affect the same epigenetic pathways, 
or that their effects converge on a single pathway.  While one technique may results in 
some depletion or overexpression of important factors, the use of multiple ARTs 
exacerbates this effect leading to more affected embryos.  My data indicates that 
superovulation results in depletion of maternal mRNA used for maintenance of genomic 
imprinting.  Embryo culture may result in perturbation of the same oocyte-specific 
mRNA(s) if it  persists through early cleavage division or the same gene(s) if is also 
transcribed from the embryonic genome.  
6.2 Stochastic Effects of ARTs
 The first studies to identify perturbations of genomic imprinting were performed 
on pools of embryos (Sasaki et al., 1995; Doherty et al., 2000).  While these studies were 
integral to uncovering the fact that in vitro culture caused dysregulation of genomic 
imprinting, they  were unable to provide specific information about  the frequency and 
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severity of this dysregulation.  Development and utilization of single embryo protocols 
(Appendix 1) was necessary to obtain this information.  
 One common finding from these experiments is the stochastic nature of imprint 
disruption by superovulation and embryo culture.  In the case of superovulation, some 
embryos were severely affected at a given locus, showing very low levels of imprinted 
methylation, while others showed no loss of methylation at that same locus with levels of 
imprinted methylation comparable to in vivo-derived embryos.  In addition, embryos 
displaying severe loss of imprinted methylation at one locus did not necessarily show loss 
at other imprinted loci, and no consistent patterns emerged.  This indicates that the effects 
of superovulation are not locus specific, supporting the idea that more global epigenetic 
mechanisms are disrupted.
 In the case of embryo culture, the same phenomenon was observed.  Loss of 
methylation was observed in some, but not all embryos, and at some, but not all loci.  In 
those embryos that remained unaffected at all the loci examined, further analysis of 
additional imprinted loci would likely reveal that genomic imprinting is affected in every 
embryo, while the extent of the disruption varies with different embryo manipulations. 
The question then becomes what differentiates those embryos that  better maintain 
genomic imprinting from those that do not.
 To shed light on this phenomenon, I investigated the relationship between rates of 
preimplantation development and genomic imprinting.  We attempted to determine if 
there were non-invasive characteristics that would lead us to predict which embryos 
would be more severely affected by embryo culture, and which were more similar to in 
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vivo-derived control embryos.  This question has significant importance to the selection of 
embryos for transfer in the human clinic.  Often a number of oocytes are fertilized and 
become viable embryos, but how to choose the best embryo(s) to transfer to the patient is 
often unclear.  Morphological staging and assessment are commonly used, with fast 
development most often equated with the healthiest  embryos (Claman et al., 1987; 
Shoukir et al., 1997; Van Montfoort et  al., 2004; Windt et al., 2004; Biezinova et al., 
2006).  Here, I argue against the use of the fastest developing embryos, supporting other 
studies in humans suggesting that a slow to moderate rate of development (neither too 
slow, nor too fast) is a marker of embryo health (Cummins et al., 1986; Alikani et al., 
2000; Weitzman et al., 2010).  
6.3 The Mouse Model and Application to the Human Clinic
 There are many barriers to a thorough evaluation of ARTs, including the ethical 
dilemma of using human embryos and the difficulties with long term follow up, to name a 
few.  As such, our studies were carried out using the mouse model system, as the 
protocols employed for superovulation and embryo retrieval are simple, standardized 
procedures.  In addition, the mouse embryo has been historically used to optimize culture 
conditions for the human embryo and is still used as a quality control assay for every 
batch of embryo culture media.  The mouse is still advocated as the model system of 
choice for studies of early embryo development and its molecular regulation (Quinn and 
Horstman, 1998; Summers and Biggers, 2003).  Studies using the mouse model have been 
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integral in the development and refinement of various ARTs, and in the future, thorough 
evaluation of new techniques in animal model systems such as the mouse should be 
undertaken prior to widespread acceptance and use of these new techniques in humans.  
 While the immediate applicability  of these studies to the human clinic may be 
debated, from the data presented in this thesis I am able to make a number of general 
recommendations with respect  to the manipulation of preimplantation stage embryos. 
First, the number and prolonged use of ARTs should be minimized, as I have shown that 
the effects of multiple ARTs are additive.  Avoidance of superovulation through single 
embryo transfer techniques is one way to minimize ARTs that can be put into practice 
immediately.  Secondly, if multiple embryos are available for transfer, those displaying 
moderate rates of development should be chosen over those with very  fast, or very slow 
rates of development.  Third, as we showed no advantage of sequential media over non-
sequential medium with respect to genomic imprinting, my data advocate the use of non-
sequential media to avoid additional embryo manipulation occurring with transfer of 
embryos to different culture drops.  Fourth, all embryos are affected by manipulation 
during ARTs, however some are affected more than others.  Patients undergoing ART 
should be made aware of this fact, and more patient education outlining the risks of ART 
should be instituted.  Most importantly, findings from these and other studies indicate that 
it is possible to generate blastocysts that appear morphologically normal, but are in reality 
severely epigenetically compromised.  
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6.4 Future Directions
 From these and other studies, it is evident that ARTs, in their many forms, perturb 
genomic imprinting at multiple loci.  The next step is to determine ways to prevent these 
perturbations from occurring, or develop ways to correct them.  These objectives can only 
be carried out once the mechanisms responsible for imprinting acquisition and 
maintenance are known, and how the environmental insult of ARTs affects these 
mechanisms.  Therefore, future studies in the field should focus on elucidating these 
pathways, and developing non-invasive ways to detect these mal-adaptations to 
environmental insult.  In addition, studies should focus on moving the knowledge 
obtained from animal studies to the human clinic.
6.4.1 Superovulation
 To confirm the hypothesis of disruption of the maintenance of genomic 
imprinting, imprinted methylation at  multiple loci (those that acquire methylation early as 
well as those that  acquire it later on in oocyte development) in individual embryos 
throughout the various stages of preimplantation development is required.  These studies 
will determine when loss of methylation occurs, and if the loss is progressive over the 
entire course of preimplantation development.  Pinpointing the stage of preimplantation 
development at which methylation imprints are lost will provide important insight into the 
mechanism of this disruption. 
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 Essential to future studies will be the identification of the maternal-effect gene(s) 
disrupted by superovulation.  Maternal-effect genes are transcribed and accumulate in the 
growing oocyte (Schultz, 1993), and are necessary for the early stages of preimplantation 
development prior to embryonic genome activation (Flach et al., 1982; Conover et al., 
1991; Bellier et al., 1997).  A maternal effect on early  development has been well 
described in Xenopus (Droin, 1992) and Drosophila (Akam, 1987; Morisato and 
Anderson, 1995) and many maternal-effect  genes have also been identified in the mouse, 
including Mater (Tong et al., 2000; Tong et al., 2002), Zar1 (Wu et al., 2003), Hsf1 
(Christians et al., 2000), Gdf9 (Dong et al., 1996), Ces5 (Tashiro et al., 2010) Filia 
(Zheng and Dean, 2009) and Stella (Payer et al., 2003).     
 The maternal-effect gene(s) involved in the effects of superovulation should 
exhibit a number of characteristics.  First, as with other maternal-effect genes, it should be 
transcribed and stored in the developing oocyte.  Mutation or deletion may or may not 
lead to arrest prior to embryonic genome activation, as uniparental embryos (parthenotes, 
androgenotes, gynogenotes), which lack a parental genome complement, are able to 
develop past the 2-cell stage (Markert, 1982; McGrath and Solter, 1984; Surani et  al., 
1984).  This gene should have a known role in epigenetic regulation, and levels, 
localization or post-translational modification of this gene product should be altered by 
superovulation.  
 Therefore, to identify our maternal-effect  gene(s), first, a list of genes expressed 
and stored in the developing oocyte is needed.  From this list, genes involved in 
epigenetic regulation should be identified, generating an list of epigenetic-specific 
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maternal-effect genes.  Final candidates would be those genes displaying differential 
expression, localization or post-translational modification between spontaneous and 
superovulated oocytes.  Attractive candidates are maternal-effect genes whose functions 
in epigenetic regulation are well known such as Stella (Nakamura et al., 2007), and Zpf57 
(Li et al., 2008), indicated above as potential targeting mechanisms for DNMT1 in 
preimplantation embryos (Ayyanathan et al., 2003) (Nakamura et al., 2007).
 Investigation of global levels of transcription in oocytes and preimplantation 
embryos has been performed, and a subset of genes have been identified that demonstrate 
distinct expression patterns (Hamatani et al., 2004; Wang et al., 2004; Zeng et al., 2004; 
Hamatani et al., 2006).  Following embryonic genome activation, maternal mRNAs 
expressed in the oocyte may either persist with no reactivation from the embryonic 
genome, or be degraded.  Those that show degradation of maternal mRNA may (1) be 
reactivated in the embryonic genome, or (2) maternal transcripts may be degraded 
without reactivation.  Genes transcribed in the oocyte may also (3) be degraded early in 
development but be reactivated later, creating a window where no gene product is present 
in the early  embryo.  As I hypothesize that the maternal-effect  gene(s) of interest is likely 
involved in the maintenance of genomic imprinting throughout preimplantation 
development, it is likely that it would be present in the oocyte and in the preimplantation 
embryo.  Arguments can be made as to whether expression originates from the oocyte, 
and maternal mRNAs persist throughout preimplantaion development, or whether 
maternal mRNAs are degraded and reactivated from the embryonic genome.  Both are 
plausible explanations, however as both superovulation and embryo culture appear to 
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affect the same pathway, I hypothesize the the gene(s) of interest do display degradation 
of maternal mRNA and reactivation from the embryonic genome, and therefore follow the 
first pattern of expression.  In the study by Hamatani et al, genes demonstrating 
degradation followed by an early pattern of reactivation of expression include Oct4, E-
cadherin, Dnmt1, Dnmt2, Dnmt3b, Lefty2, Spp1, Mecp2, Cbx1, Morf4l1, Tex20, Fragilis, 
Pelo and Sfrs3 (Hamatani et al., 2004).  Many  of these genes, including Dnmt1, Dnmt2, 
Dnmt3b, Mecp2, Morf4l1, and Cbx1 are known to be involved in epigenetic regulation 
(Aagaard et  al., 1999; Nakao et al., 2001; Pardo et al., 2002; Turek-Plewa and 
Jagodzinski, 2005), and therefore satisfy  two of the three criteria of our maternal-effect 
gene, as outlined above.  Demonstration of differences in the levels, localization or post-
translational modifications of these gene products in spontaneous and superovulated 
embryos would fulfill the additional criterion.  
 Alternatively, the reverse approach could be taken, using genome-wide 
comparison of expression between spontaneous and superovulated oocytes.  Candidates 
could then be narrowed by  identifying genes involved in epigenetic regulation, and 
determining the pattern of expression following fertilization.  Once a candidate list was 
assembled, involvement could be confirmed by analyzing their expression, localization 
and post-translational modifications in spontaneous and superovulated oocytes.  Levels 
more similar to spontaneously ovulated oocytes and embryos would be expected in 
superovulated oocytes and embryos with preserved imprinted methylation, while aberrant 
levels would be expected those that had lost imprinted methylation. 
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 Once the maternal-effect gene products disrupted by superovulation have been 
identified, the next  step will be to determine non-invasive ways to determine which 
oocytes display improper expression, activity or localization of these products, and 
exclude the oocytes from use in the human clinic.  One possible technique is through 
sampling of the polar body, provided that this does not have any negative developmental 
consequences for the oocyte.  Alternatively, indirect methods of evaluating the status of 
the maternal effects genes may prove useful, such as measurements of by-products of the 
pathway involving the maternal-effects gene in the medium used to culture oocytes prior 
to fertilization.
6.4.2 Embryo Culture
 While we hypothesize that maternal-effects gene products are affected by ARTs, 
further investigation of how embryo culture disrupts genomic imprinting should also 
focus on how overall epigenetic mechanisms like DNA methylation and histone 
modifications, which are the marks of genomic imprinting, may be disrupted by the 
culture environment.  For example, S-adenosyl methionine (SAM) is widely known as the 
universal methyl donor, responsible for donating methyl groups for use in DNA 
methylation, histone methylation, and a number of other important cellular processes 
(Loenen, 2006).  A complex pathway results in breakdown and regeneration of SAM, 
involving important molecules such as methionine, glutathione, homocysteine and folate 
(Chiang et al., 1996).  Altered concentrations of these components and/or altered 
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expression of enzymes responsible for their synthesis and degradation may underlie the 
epigenetic defects during embryo culture (Steele et al., 2005).  Investigation of these 
pathways should also be undertaken in cultured and in vivo-derived embryos.
 In addition, continued identification of epigenetic mechanisms, both general and 
specific to each imprinted loci will provide invaluable information.  With respect to 
specific pathways, studies such as those being conducted in our lab by Lauren Magri 
focus on determining the different epigenetic mechanisms at work in embryonic versus 
extraembryonic tissues using siRNA based screening.  Differential effects of ARTs on TE 
and ICM  cells has been observed as evidenced by loss of methylation in extraembryonic, 
but not embryonic tissues at E9.5 (Mann et al., 2004).  An understanding of the different 
regulatory molecules controlling imprint maintenance in these various cell lineages will 
provide additional insight into the identity  of the maternal-effects gene(s) disrupted by 
ARTs and their downstream effectors.  Additional investigations into the specific 
regulatory molecules at each imprinted domain are also needed.  A number of imprinted 
loci are regulated in part by DNA binding proteins such as CTCF or YY1 (Kim et al., 
2007; Kim and Kim, 2008; Li et al., 2008; Kim et al., 2009; Nativio et al., 2009). 
Identification of genes and proteins such as these, necessary for imprint maintenance 
across multiple imprinted domains provide additional candidates for the maternal-effects 
gene(s).  Knowledge of these specific mechanisms will facilitate the development of 
targeted therapies aimed at correcting those pathways disrupted by ARTs.
 With respect  to rates of embryo development and metabolism, the quiet embryo 
hypothesis states that embryos with the greatest developmental potential exhibit a lower 
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level of metabolic activity (Leese, 2002).  A more thorough investigation of the metabolic 
differences between embryos that maintain genomic imprinting and those that do not 
should be undertaken.  Studies evaluating the quiet embryo hypothesis employed a 
technique for profiling metabolic byproducts such as amino acids, pyruvate, and glucose, 
and correlated this with embryo viability.  Similar studies correlating profiles of the above 
metabolic products with genomic imprinting will help to further clarify the relationship 
reported in these studies.  
6.4.3  Application to the Human Clinic
 Strict guidelines for clinical trials, elucidating side effects, toxicity levels and 
safety  in specific patient populations have been put in place for the development of 
medications and medical techniques used to treat human disease, however a rigorous 
examination of techniques used in the treatment of infertility  is lacking.  As different 
human clinics employ a wide variety  of treatment programs including the number and 
dosage of FSH injections, gonadotropin receptor hormone agonists or antagonists, and the 
conditions used for oocyte and embryo culture and in vitro fertilization, standardized 
comparisons between centers and in turn large-scale trials remain difficult.  Significant 
advancements in the field leading to increase safety  and efficacy of ARTs will need to 
come from studies of human embryos.  While prospective studies are likely not morally 
defensible, or practically possible, more detailed record-keeping of protocols employed 
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during fertility treatments will facilitate retrospective studies which have already, and will 
continue to provide invaluable information.  
 Advanced maternal age and intrinsic subfertility  of the couples must  be taken into 
consideration when evaluating fertility  treatment outcomes, including detailed analysis of 
maternal and paternal epigenomes to clarify the role of subfertility  in adverse events 
following ARTs.  Male infertility  has begun to emerge as an important factor with respect 
to epigenetic abnormalities following ART.  Loss of imprinting at certain key loci was 
observed more frequently  in men with oligozoospermia than in those with normal semen 
(Marques et al., 2004), and for some embryos, displaying aberrant genomic imprinting 
following embryo culture, aberrant methylation was present in sperm prior to 
manipulation in culture (Kobayashi et al., 2009).  Moreover, detailed follow up of the 
health of children born through ARTs is necessary moving forward.  This will become 
especially crucial in the upcoming decades, as the first wave of ART-born children 
become older and into the age where conditions such as heart disease, diabetes and cancer 
begin to emerge.
 Since loss of genomic imprinting following embryo culture is stochastic, but not 
random, and distinct  groups of embryos are more likely than others to show severe 
imprinting defects, further investigations should focus on determining additional non-
invasive characteristics that correlate with the epigenetic health of the preimplantation 
embryo.  Correlation of other characteristics routinely  evaluated in the embryo such as 
degree of fragmentation and blastomere size (Graham et al., 2000; Scott et al., 2000; 
Nagy et al., 2003; Borini et al., 2005) with genomic imprinting in cleavage stage embryos 
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and blastocysts may  reveal additional ways to identify embryos with preserved genomic 
imprints.  
 Lastly, in the human clinic, the measure of a successful ART cycle is a clinical 
pregnancy, and correlation of imprinting status with implantation and pregnancy rates has 
not been done.  Studies such as these are necessary to solidify the importance of the 
epigenetic status of the embryo with respect to clinical practice.
6.5 Conclusions
 Assisted reproductive technologies are important medical treatments that have 
enabled previously  infertile couples to achieve successful pregnancies, and produce 
biological children.  However, while these techniques are, on the whole, very safe 
procedures, it is important to realize that the manipulation of gametes and embryos is not 
without risks and potential consequences.  Some of the consequences identified to date 
include an increased incidence of imprinting disorders, along with low birth weight and 
prematurity, and the long term effects on adult  health have yet to be fully  determined. 
The studies presented in this thesis further elucidate the effects of two of the most 
common ARTs, superovulation and embryo culture, on genomic imprinting.  We have 
determined that superovulation alone can have a significant impact on genomic 
imprinting at multiple loci, and that this effect worsens with increased dose of hormones. 
We have also demonstrated that embryo culture, in media used today in the human clinic, 
results in disruption of genomic imprinting at multiple loci.  We also show that the effects 
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of superovulation and genomic imprinting are additive; a greater number of embryos and 
imprinted loci are affected following multiple ARTs than with the use of a single 
intervention, suggesting that both techniques disrupt  the same overall mechanisms. 
Lastly, we show that embryos displaying moderate rates of development are most similar 
to in vivo-derived embryos, a finding that supports the quiet  embryo hypothesis (Leese, 
2002), and that will hopefully  prompt further exploration into correlation of non-invasive 
parameters with the epigenetic health of embryos in the human clinic.  It  will be up to 
those pursuing further research in this field to elucidate the mechanisms by  which 
environmental insult affects the epigenetic health of the embryo, to determine accurate, 
repeatable and non-invasive techniques to detect these compromised embryos, and to 
continue to improve our current techniques to minimize the amount of adaptation that 
embryos will require to survive and grow outside the female reproductive tract.  The 
ultimate goal of these studies is a decreased incidence of disease and improved long-term 
health of children born following ARTs.
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Appendices
Appendix 1: Single Embryo Methodology
Limitations of the blastocyst
 The analysis of the imprinted methylation status of individual blastocysts has proved 
challenging due to the very  small amounts of DNA present.  Mouse blastocysts on 
average contain 64 cells but we have found that this can range from 20-120 cells, Each 
cell contains approximately  6 pg of genomic DNA.  Each blastocyst will therefore contain 
120-720 pg of genomic DNA.  This amount of DNA is a barrier to DNA isolation and 
PCR amplification. Furthermore for methylation analyses, bisulfite treatment of genomic 
DNA is a relatively  harsh technique, during which DNA degradation will occur. To get  an 
accurate picture of the methylation status of an imprinting center, information from 
approximately 10 different alleles of both the maternal and paternal alleles is necessary. 
Thus, methodology for the analysis of DNA methylation in blastocyst-stage embryos 
must overcome all of these challenges. Simply stated, it must protect  the DNA from 
degradation, efficiently isolate DNA, and amplify the small amount of DNA remaining to 
a detectable level while still maintaining enough variation to recover the necessary 
number of maternal and paternal DNA strands. On top of this, our goal is to recover both 
DNA and RNA from individual blastocysts to determine both imprinted methylation and 
expression status in the same embryo.
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Bisulfite Conversion
 The first step  in the development of the technique was to optimize the bisulfite 
conversion i.e. to ensure complete conversion of unmethylated cytosines (>85%) while 
maintaining the integrity and quantity  of DNA. We first employed a pre-released bisulfite 
conversion kit, the EZ-DNA Methylation Kit (Zymo Research), asserting to be the most 
sensitive bisulfite kit.  Multiple conversion times and temperatures were tested, and 
optimized parameters were found to be 50°C and 3.5 hours, respectively.  While 
amplification from all four genes using a nested PCR strategy was possible with this kit, it 
was inconsistent.  We concluded that this kit resulted in insufficient recovery  of DNA to 
consistently recover PCR products for multiple genes.  Our next attempt used a modified 
technique in which DNA was treated with sodium bisulfite while embedded in an agarose 
bead in an effort to protect the DNA from degradation. DNA was then isolated from the 
agarose bead using the Qiagen gel extraction buffer (Buffer QG, Qiagen) followed by 
DNA isolation using the columns provided in the EZ-DNA methylation kit.  Nested PCR 
was performed after bisulfite treatment using this method and it was determined that 
amplification of PCR product from all four genes was repeatable, although too little 
DNA was recovered to allow for amplification of multiple alleles of each imprinting 
center.  Furthermore, an insufficient number of clones were obtained for each imprinting 
center 
 While working on a separate project that used the Methyl Detector Kit (Active 
Motif) for large cell numbers, I performed multiple elutions as less than the expected 
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amount of DNA was recovered. I determined that large amounts of DNA remained in the 
column after the first, second and even the third DNA elution.  This prompted us to 
consider that  DNA recovery  from the EZ-DNA columns was suboptimal.  A new protocol 
was developed in which following bisulfite conversion in the agarose bead, the bead itself 
was split  and added to individual PCR reactions for each gene.  We determined via PCR 
followed by allele- and methylation-specific restriction digest, that this method allowed 
for sufficient DNA recovery for both parental alleles of all imprinting centers of interest 
to be PCR amplified and a sufficient number of clones to be obtained for sequence 
analysis.
PCR Optimization
 Typically following bisulfite mutagenesis, a nested PCR is performed to enrich the 
region of interest and allow for amplification of many  DNA strands of each imprinting 
center.  In the first round, primers are specific for a larger area encompassing a region 
within the imprinting center of interest.  In the second round, primers are designed within 
the enriched sequence to generate a smaller final PCR product.  As a diagnostic, 
following the nested PCR, samples are digested using restriction enzymes that cut  the 
methylated allele but not the unmethylated allele to ensure enough variability in the 
amplified sequences.  It was found that using the agarose bead method followed by 
column DNA extraction, PCR bias was observed for all genes tested; either the majority 
of alleles obtained were methylated or unmethylated.  Subsequent PCR optimization was 
performed.  Parameters that were changed include: multiplex or individual PCR, 
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annealing time, annealing temperatures, extension time, extension temperatures, number 
of cycles, volume and type of elution buffer used in EZ-DNA column, volume of starting 
material added to PCR reactions, primer concentrations, MgCl2 concentrations, presence 
or absence of DMSO, and total PCR reaction volume.  Multiple gradient PCRs were 
performed for individual genes as well as various combinations of multiplexed genes. 
The optimal state of each of the above parameters was obtained. Optimization of the 
nested PCR in combination with the agarose bead bisulfite conversion method produced a 
sufficient numbers of clones for sequencing.
Crossover Events
 Crossover events are thought to occur during PCR amplification when there is a 
high concentration of very similar sequences, and the annealing temperature of the PCR 
reaction is such that these similar sequence can bind to one another.  After receiving 
sequence data for the agarose bead protocol alone, multiple crossover events were 
observed in Snrpn, H19 and Peg3. To alleviate this problem, annealing temperatures were 
increased for first round PCR to increase stringency and prevent binding of similar 
sequences. Increasing the annealing temperature of the first round PCR of Snrpn, H19 
and Peg3 resulted in decreased crossover events and successful recovery of sufficient 
numbers of sequences.
Cloning of PCR Products
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 Once DNA is isolated and PCR amplified, we initially  employed a clean-up step 
prior to cloning.  Following second round PCR, gel extraction of the desired bands was 
performed using the Qiagen Gel Extraction Kit (Qiagen), then the extracted DNA was 
TA-cloned.  Our subsequent analysis determined that gel extraction decreased the 
variability of DNA strands recovered and introduced a bias towards the unmethylated 
alleles.  To resolve this issue, amplified DNA was cloned directly from the 2nd round PCR 
product. 
 One problem arising from the direct cloning of PCR products was a decrease in the 
number of correct inserts recovered. This is due to primer-dimer and non-specific 
amplicon insertion.  To reduce the number of unnecessary  miniplasmid preparations 
(minipreps), a strategy for screening colonies was developed. Individual colonies were 
picked, quickly dipped into the PCR reaction, and put into tubes containing LB/AMP to 
grow up overnight.  M13 forward and reverse primers that flank the insertion site were 
used to amplify the cloned insert then agarose gel analysis was used to assess the size of 
the inserted DNA. Those colonies that did not contain the appropriate size insert were 
discarded while minipreps were performed for colonies with the appropriately  sized 
insert.  This strategy worked well for all genes except Snrpn, whose recovery of correct 
amplicon sizes decreased to <30% due to the lack of gel extraction of DNA. In lieu of 
column purification, PCR reactions were electrophoresed on an agarose gel, and thin 
bands containing the amplicon of interest were excised.  Gel fragments were incubated 
overnight in TE to allow DNA to diffuse from the gel.  The DNA solution was then used 
directly  for ligation and subsequent transformation.  Nearly all clones obtained through 
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this method contained the appropriate sized insert.
 To develop a more high-throughput protocol, we bypassed the minipreps, and 
amplicons obtained from bacterial colonies using M13 primers were sent directly to be 
sequenced. No cross contamination, and good chromatogram results were observed. Thus 
this method is an equally accurate way to obtain sequence information from individual 
colonies. Minipreps are no longer performed before clones were sent for sequencing. 
Instead following nested PCR and gel electrophoresis, DNA isolated via gel diffusion was 
ligated and transformed, bacterial colonies were picked directly into a PCR reaction 
containing M13 primers, then the resulting amplicon was sent directly for sequencing.
Analysis of Methylation and Allele-Specific Expression
 After it was found that enough clones of both methylated and unmethylated alleles 
from all 4 genes could be obtained from individual blastocysts, we developed a protocol 
to analyze both expression and methylation from individual blastocysts.  The protocol 
previously  developed isolated RNA and produced a reusable cDNA-Dynabead library 
(Dynal Biotech).  To combine the protocols for DNA isolation/bisulfite conversion and 
RNA isolation/cDNA-Dynabead library synthesis, I made the following modifications. 
Individual blastocysts were lysed in Dynabead lysis buffer using a decreased volume of 
lysis buffer, an increased time for lysis and annealing of RNA to Dynabeads, and 
modified the lysis procedure by combining vortexing and mixing followed by  gentle 
centrifugation of samples.  Lastly, since the Dynal lysis buffer does not completely and 
consistently break open the nuclear membrane, after lysis and annealing of RNA to 
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Dynabeads as described above, supernatant containing cell debris and nuclei were 
removed to a new tube.  To liberated genomic DNA, Protease K and NP40 (final 
concentration of 0.1%) were added and the samples were incubated for 1 hour at 50°C. 
Bisulfite conversion and cDNA-Dynabead library  synthesis were unchanged for the rest 
of the protocol.  I have determined that there was no difference in data obtained for 
imprinted methylation and expression using this new protocol versus either protocol 
alone.
This protocol was employed for embryo analysis in Chapter 2-5.  The final protocol with 
notes can be found below.
Full Protocol: Single Embryo Analysis of Methylation and Expression 
(A) Pre-Wash Dynabeads
1. Vortex Dynabeads on medium speed to re-suspend. Change gloves.
2. Label one 0.2 mL thin walled PCR tube per sample plus an additional tube for a 
negative control.
3. Transfer 10 µl of Dynabeads to each 0.2 mL thin walled PCR tube.
4. Place into Magnetic Particle Concentrator (MPC). Remove supernatant.
5. Add 100 µl Dynabead Lysis Buffer to each sample.
6. Vortex on low for 5-10 seconds, place on MPC, then remove buffer. Repeat.
(B) Embryo Lysis
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1. Retrieve individually frozen embryos from storage at -80oC (see Note 2).
2. Centrifuge briefly to ensure embryo is at bottom of tube (~5 seconds at 
10,000-13,000 rpm).
3. Add 10 µl of Dynabead lysis buffer to each sample.
4. Prior to adding embryo, place in MPC and remove lysis buffer from pre-washed 
Dynabeads from Step 6 above.
5. Transfer entire contents of lysed embryo sample from Step 3 to pre-washed 
Dynabeads.
6. Mix gently by flicking, then centrifuge briefly at 4000 rpm.
7. Incubate with slow agitation on vortex for 5-10 min at room temperature to allow 
for hybridization of mRNA to Dynabead.
8. Centrifuge briefly at 4000 rpm.
9. Place mRNA-Dynabead tube in MPC. Remove supernatant containing DNA to 
original embryo tubes, taking care not to remove any mRNA-Dynabeads. 
10. Add 200 µL of Dynabead Wash Buffer A to mRNA-Dynabeads. Place in MPC and 
set aside until 3.3 RNA isolation.
11. Centrifuge tubes containing DNA/supernatant for 5-10 seconds at 13,000 rpm to 
remove bubbles.
12. Add 1 µl Protease K (Sigma, Oakville, Canada) and 1 µl of 10% Igepal (see Note 
3) to each DNA/supernatant tube.
13.  Centrifuge briefly at 13,000 rpm to remove any bubbles.
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14. Add 300 µl of DNAse-, RNAse- and protease-free mineral oil (Sigma, Oakville, 
Canada) to each tube (see Note 4).
15.  Lyse embryo by incubating for 1 hour in waterbath at 50oC.
(C) RNA Isolation
1. Retrieve mRNA-Dynabead tube containing 200 µL of Wash Buffer A.
2. Vortex on low speed for approximately 5 seconds. Centrifuge briefly. Place in 
MPC, then remove Wash.
3. Repeat washing step with Wash Buffer A once, and Wash Buffer B three times.
(D) Reverse Transcription and Generation of a Solid-Phase cDNA Library (see Note 5)
1. Prepare reverse transcription by  mixing 2 µl 5x First Strand Buffer, 1 µl 0.1M 
DTT, 0.5 µl 10 mM dNTP, 0.5 µl 40 units/µl RNaseOut (Invitrogen, Burlington, 
Canada), 0.25 µl Superscript II (Invitrogen, Burlington, Canada), 5.75 µl H2O, for 
a 10 µl reaction.
2. Remove all of Wash Buffer B from mRNA-Dynabead tube.
3. Add 10 µl of RT mix to each sample.
4. Mix gently by flicking.
5. Centrifuge briefly. Repeat mixing and spin.
6. Incubate for 1-2 hours at 42oC rotating in hybridization oven. 
(E) Agarose Bead Embedding of DNA
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1. Remove Protease K-treated DNA tubes from waterbath. Place in heating block at 
> 95oC.
2. Add 24 µl 2% LMP agarose (pre-warmed at >95oC) under mineral oil.
3. Mix gently by pipetting. Ensure the bead is well mixed.
4. Incubate for 3 minutes > 95oC to inactivate the Protease K.
5. Incubate for 10 minutes on ice to allow agarose bead to harden. 
(F) Denaturation of DNA
1. Remove oil from chilled, hardened agarose bead.
2. Add 1 mL 0.1 M NaOH to each tube. Invert 5-6 times (see Note 6).
3. Incubate for 15 minutes at 37oC in a waterbath, inverting every 3-4 min.
(G) Bisulfite Treatment of DNA
1. Spin gently (< 4000 rpm) (see Note 7).
2. Remove NaOH solution.
3. Add 500 µl of Bisulfite Solution.
4. Add 300 µl of mineral oil.  Ensure that agarose bead is floating in solution (see 
Note 8).
5. Incubate at 50oC in a waterbath for 3.5 hours (see Note 1).
(H) Clean-up of cDNA-Dynabead Library
1. Remove cDNA-Dynabead samples from hybridization oven.
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2.  Centrifuge briefly then place in MPC.
3. Remove all RT mix.
4. Add 10 µl of ITT Buffer, flick gently  to mix, centrifuge briefly, place in MPC, 
remove ITT Buffer. Repeat.
5. Add 10 µl of ITT Buffer, flick gently to mix, centrifuge briefly.
6. Incubate 1 minute at 95oC in block of pre-warmed PCR machine.
7. Working with one sample at a time, centrifuge briefly, place in MPC, remove ITT 
buffer.
8. Add 100 µl of ITT Buffer, flick gently  to mix, centrifuge briefly, place in MPC, 
remove ITT Buffer. Repeat.
9. Store cDNA-Dynabead Library at 4oC (see Note 9)
(I) Second strand synthesis
1.  Remove cDNA-Dynabead library from storage at 4oC, add 100 µl of ITT Buffer, 
flick gently to mix, centrifuge briefly, place in MPC, remove ITT Buffer. Repeat.
2. Prepare separate forward and reverse reactions according to protocols for your 
gene of interest.
3. Place cDNA-Dynabead library in MPC, remove ITT buffer (make sure all of 
liquid is removed).
4. Add forward reaction, flick gently to mix.  
5. Place reaction in PCR machine, run PCR program for one cycle, according to your 
gene of interest.
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6. Remove samples one at a time, spin down quickly in benchtop centrifuge, place in 
MPC and remove all of 2nd strand product to new tube.
7. Transfer an equivalent amount of forward-2nd strand mix to tubes containing pre-
aliquoted reverse Mix.
8. Run PCR as per your gene of interest.
9. Rehydrate cDNA-Dynabead library by adding 100 µl of ITT Buffer, flick gently  to 
mix, centrifuge briefly, place in MPC, remove ITT Buffer. Repeat.
10. Store cDNA-Dynabead Library at 4oC (see Note 10).
(J) Desulfonation of Bisulfite Treated DNA
1. Remove DNA-agarose tubes from 50oC waterbath.
2. Incubate on ice for 3 minutes.
3. Remove Bisulfite solution and mineral oil.
4. Centrifuge briefly (<4000 rpm).
5. Add 1 mL of TE, invert 1-2 times, centrifuge briefly then remove TE.
6. Add 1 mL 0.3 M NaOH, flick gently to mix, invert 5-6 times.
7. Incubate at 37oC in a waterbath for 15 minutes, inverting every 3-4 minutes.
8. Centrifuge briefly (<4000 rpm).
(K) Washing of Desulfonated DNA
1. Remove NaOH.
2. Add 1 mL of TE.
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3. Incubate for 5-10 minutes at room temperature with shaking.
4. Spin gently, remove TE, repeat wash once more with TE.
5. Repeat wash twice more with H2O.
6. Check pH of washes. The last H2O wash should have approximate pH 5.  If 
solution is more basic, perform two addition washes with H2O.
7. Samples are now ready for amplification of gene(s) of interest with bisulfite-
specific primers (see Note 11). 
Notes
1. BS is light sensitive. Cover Bisulfite solutions, Parts I and II, with foil until ready 
to use. Cover all samples in foil once Bisulfite mixture is added, and keep covered 
until after the 3.5 hour incubation.
2. Embryos should be stored in a minimal amount of culture medium (1-2 µL). 
3. The use of 10% Igepal is to ensure lysis of nuclear membrane as well as cell 
membrane.
4. Mineral oil is used to ensure that solutions do not evaporate and condense on the 
top of the tubes during the procedure.  
5. Generation of a solid-phase library is important as it allows for re-use of 
Dynabeads and amplification of an essentially unlimited number of genes.
6. Invert samples gently.  The agarose bead should be mixed but vigorous shaking 
can cause the agarose bead to break up into pieces.
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7. Centrifugation of the agarose bead should not exceed 4000 rpm to prevent 
breakage of agarose bead.
8. The agarose bead should be floating prior to incubation with the Bisulfite solution 
to ensure that  all sides of the agarose bead are exposed to the Bisulfite solution.  If 
the bead does not float, use a pipette tip to release it from the bottom of the tube.
9. For best results, use cDNA-Dynabead library as soon as possible.  Consistent 
amplification has been obtained for cDNA libraries stored up to 8 months.
10. Caution: Dynabeads can be easily lost  during each washing step; ensure all 
Dynabeads are localized to the magnetic side of the tube before removing any 
supernatant. Also, following repeated heating (multiple second strand syntheses), 
Dynabeads may clump. If this occurs consider performing an additional washing 
step. 
11. Set up PCR reactions. To increase PCR efficiency, add 1 µl 240 ng/ml tRNA as a 
carrier to PCR reaction. At 70oC, add to the 30 µl-agarose bead the required 
amount of water to make up 20 µl per gene(s) of interest (up to 4 genes). Mix 
agarose and water by gently pipetting. Keeping the solution at 60-70oC, mix by 
gently pipetting, then split the PCR reaction in two by  removing 12.5 µl into a 
new 0.2 mL thin walled PCR tube. Add 12.5 µl mineral oil overlay. This allows 
for two independent PCR reactions.  PCR amplification from the agarose bead 
should be performed immediately.  If this is not possible, the agarose bead can be 
stored at 4oC up  to one week. However, efficient amplification will decrease 
dramatically with each day of incubation.
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Appendix 2: Perl Program for Sequencing Analysis
 The following perl program was designed to facilitate the analysis of sequencing 
data obtained through the course of these experiments.  The initial work on the program 
was done during the Bioinformatics graduate course taught by  Dr. G. Gloor and was 
designed to read in and analyze each sequence individually.  The program was then 
expanded to all 5 genes analyzed: H19, Snrpn, Peg3, Kcnq1ot1, and Peg1/Mest.  To 
further increase the efficiency of the analysis I enlisted the help of a colleague, Mr. Robert 
Moreland, a classmate at the Schulich School of Medicine, who made some modifications 
to the program to allow for analysis of all sequences with only  one line of input code 
required, rather than one line of input per sequence.  The file entitled “Market-
Velker_Brenna_A_201106_PhD_appendix.pl”  represents the perl programming currently 
used for sequence analysis.
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Appendix 3: Supplementary Material - Chapter 2
The following figures were presented as supplemental data to the experiments presented 
in Chapter 2, published as: 
Market-Velker, B.A., Zhang, L., Magri, L.S., Bonvissuto, A.C. & Mann, M.R. Dual 
effects of superovulation: loss of maternal and paternal imprinted methylation in a dose-
dependent manner. Hum Mol Genet 19, 36-51 (2010).
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Supplementary Figure 2.1.  Methylation of the Maternal Snrpn ICR in B6(CAST7) 
X B6 F1 Embryos Derived from Spontaneously Ovulated Females.  
Methylation status of individual DNA strands in the Snrpn ICR (maternal, CAST strands 
shown) in blastocysts derived from spontaneously ovulated females as determined by 
bisulfite mutagenesis and sequencing analysis. Unmethylated CpGs are represented as 
empty circles while methylated CpGs are depicted as filled circles.  Each line denotes an 
individual strand of DNA.  Clones with identical methylation patterns and non-CpG 
conversion rates representing the same DNA strand were included once. Each group of 
DNA strands represents data from a single embryo, with the embryo designation indicated 
at the top left.  Percent CpG methylation is indicated above each set of DNA strands, and 
was calculated as the number of methylated CpGs / total number of CpG dinucleotides. 
The region analyzed contains 15 CpGs; a base pair change in the maternal CAST allele 
eliminates CpG dinucleotide 1. 
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Supplementary Figure 2.2.  Methylation of the Maternal Peg3 DMR in B6(CAST7) 
X B6 F1 Embryos Derived from Spontaneously Ovulated Females.  
Methylation status of individual DNA strands in the Peg3 DMR (maternal, CAST strands 
shown) in blastocysts derived from spontaneously ovulated females. The region analyzed 
contains 24 CpGs. Details are as described in Supplementary Figure 2.1. 
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Supplementary Figure 2.3.  Methylation of the Maternal Kcnq1ot1 ICR in 
B6(CAST7) X B6 F1 Embryos Derived from Spontaneously Ovulated Females.  
Methylation status of individual DNA strands in the Kcnq1ot1 ICR (maternal, CAST 
strands shown) in blastocysts derived from spontaneously ovulated females.  Details are 
as described in Supplementary Figure 2.1. 
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Supplementary Figure 2.4.  Methylation of the Maternal H19 ICR in B6(CAST7) X 
B6 F1 Embryos Derived from Spontaneously Ovulated Females.  
Methylation status of individual DNA strands in the H19 ICR in blastocysts derived from 
spontaneously ovulated females. Maternal, CAST strands are shown. The region of the 
maternal CAST H19 allele analyzed contains 17 CpGs. Details are as described in 
Supplementary Figure 2.1.
281
Supplementary Figure 2.5.  Methylation of the Maternal Snrpn ICR in B6 X CAST 
F1 Blastocyst Stage Embryos Derived from Spontaneously Ovulated Females.  
Methylation status of individual DNA strands in the Snrpn ICR (maternal, B6 strands 
shown) in blastocysts derived from spontaneously ovulated females. The region analyzed 
contains 16 CpGs.  Details are as described in Supplementary Figure 2.1.
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Supplementary Figure 2.6.  Methylation of the Maternal Peg3 DMR in B6 X CAST 
F1 Blastocyst Stage Embryos Derived from Spontaneously Ovulated Females.  
Methylation status of individual DNA strands in the Peg3 DMR (maternal, B6 strands 
shown) in blastocysts derived from spontaneously ovulated females. The region analyzed 
contains 23 CpGs; a polymorphism eliminates CpG 22 on the B6 allele.  Details are as 
described in Supplementary Figure 2.1. 
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Supplementary Figure 2.7.  Methylation of the Maternal Kcnq1ot1 ICR in B6 X 
CAST F1 Blastocyst Stage Embryos Derived from Spontaneously Ovulated Females.  
Methylation status of individual DNA strands in the Kcnq1ot1 ICR (maternal, B6 strands 
shown) in blastocysts derived from spontaneously ovulated females.  Details are as 
described in Supplementary Figure 2.1. E83 displayed a reverse pattern of imprinted 
methylation as indicated by the asterisk (*).  
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Supplementary Figure 2.8.  Methylation of the Maternal H19 ICR in B6 X CAST F1 
Blastocyst Stage Embryos Derived from Spontaneously Ovulated Females.  
Methylation status of individual DNA strands in the H19 upstream ICR (maternal, B6 
strands shown) in blastocysts derived from spontaneously ovulated females.  Details are 
as described in Supplementary Figure 2.1.  The region of the maternal B6 H19 allele 
analyzed contains 16 CpGs due to a polymorphism that eliminates CpG 8.
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Supplementary Figure 2.9.  Comparison of CpG Methylation Levels of the Maternal 
Snrpn ICR in Embryos Derived from Spontaneously and Induced Ovulated 
Females.  
Percent methylation at each individual CpG dinucleotide was calculated as the number of 
methylated CpGs / total number of CpG dinucleotides, and is represented graphically; top 
(yellow) embryos derived from spontaneously ovulated females; middle (green) embryos 
from low dosage superovulated females; and bottom (blue) embryos from high dosage 
superovulated females. A reduction in CpG methylation was observed in the hormone 
treatment groups. The region analyzed contains 16 CpGs. A base pair change in the 
maternal CAST allele eliminates CpG dinucleotide 1 in B6(CAST7) X B6 F1 Embryos.
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Supplementary Figure 2.10.  Comparison of CpG Methylation Levels of the 
Maternal Peg3 DMR in Embryos Derived from Spontaneously and Induced 
Ovulated Females.  
Percent methylation at each individual CpG dinucleotide was calculated as the number of 
methylated CpGs / total number of CpG dinucleotides, and is represented graphically; top 
(yellow) embryos derived from spontaneously ovulated females; middle (green) embryos 
from low dosage superovulated females; and bottom (blue) embryos from high dosage 
superovulated females. A shift in CpG methylation was observed with lower methylation 
levels in the hormone treatment groups. The region analyzed contains 23 CpGs; a 
polymorphism eliminates CpG 22 on the maternal B6 allele in B6 X CAST F1 Embryos.
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Supplementary Figure 2.11.  Comparison of CpG Methylation Levels of the 
Maternal Kcnq1ot1 ICR in Embryos Derived from Spontaneously and Induced 
Ovulated Females.  
Percent methylation at each individual CpG dinucleotide was calculated as the number of 
methylated CpGs / total number of CpG dinucleotides, and is represented graphically; top 
(yellow) embryos derived from spontaneously ovulated females; middle (green) embryos 
from low dosage superovulated females; and bottom (blue) embryos from high dosage 
superovulated females. A downward shift in CpG methylation was observed in the 
hormone treatment groups. The region analyzed contains 20 CpGs.
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Supplementary Figure 2.12.  Comparison of CpG Methylation Levels of the 
Maternal H19 ICR in Embryos Derived from Spontaneously and Induced Ovulated 
Females.  
Percent methylation at each individual CpG dinucleotide was calculated as the number of 
methylated CpGs / total number of CpG dinucleotides, and is represented graphically; top 
(yellow) embryos derived from spontaneously ovulated females; middle (green) embryos 
from low dosage superovulated females; and bottom (blue) embryos from high dosage 
superovulated females. A gain in CpG methylation was observed in the hormone 
treatment groups. The region analyzed contains 17 CpGs; a polymorphism eliminates 
CpG 8 on the maternal B6 allele in B6 X CAST F1 Embryos.
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Supplementary Figure 2.13.  Comparison of CpG Methylation Levels of the Paternal 
H19 ICR in Embryos Derived from Spontaneously and Induced Ovulated Females.  
Percent methylation at each individual CpG dinucleotide was calculated as the number of 
methylated CpGs / total number of CpG dinucleotides, and is represented graphically; top 
(yellow) embryos derived from spontaneously ovulated females; middle (green) embryos 
from low dosage superovulated females; and bottom (blue) embryos from high dosage 
superovulated females. A shift in CpG methylation was observed with lower methylation 
levels in the hormone treatment groups. The region analyzed contains 17 CpGs; a 
polymorphism eliminates CpG 8 on the paternal B6 allele in B6(CAST7) X B6 F1 
Embryos.
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Supplementary Figure 2.14.  Methylation of the Paternal H19 ICR in B6(CAST7) X 
B6 F1 Embryos Derived from Spontaneously Ovulated Females.  
Methylation status of individual DNA strands in the H19 upstream ICR (paternal, B6 
strands shown) in blastocysts derived from spontaneously ovulated females.  Details are 
as described in Supplementary Figure 2.1. The region of the paternal B6 H19 allele 
analyzed contains 16 CpGs due to a polymorphism that eliminates CpG 8.
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Supplementary Figure 2.15.  Methylation of the Paternal H19 ICR in B6 X CAST F1 
Embryos Derived from Spontaneously Ovulated Females.  
Methylation status of individual DNA strands in the H19 upstream ICR (paternal, CAST 
strands shown) in blastocysts derived from spontaneously ovulated females.  Details are 
as described in Supplementary Figure 2.1. The region of the paternal CAST H19 allele 
analyzed contains 17 CpGs.
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Supplementary Figure 2.16.  Methylation of the Paternal Snrpn ICR in B6(CAST7) 
X B6 F1 Embryos Derived from Spontaneously Ovulated Females.  
Methylation status of individual DNA strands in the Snrpn ICR (paternal, B6 strands 
shown) in blastocysts derived from spontaneously ovulated females. The region analyzed 
contains 16 CpGs. Details are as described in Supplementary Figure 2.1.
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Supplementary Figure 2.17.  Methylation of the Paternal Snrpn ICR in B6 X CAST 
F1 Embryos Derived from Spontaneously Ovulated Females.  
Methylation status of individual DNA strands in the Snrpn ICR (paternal, CAST strands 
shown) in blastocysts derived from spontaneously ovulated females. The region analyzed 
contains 15 CpGs; a base pair change in the paternal CAST allele eliminates CpG 
dinucleotide 1. Details are as described in Supplementary Figure 2.1.
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Supplementary Figure 2.18.  Methylation of the Paternal Snrpn ICR in B6(CAST7) 
X B6 F1 Embryos Derived from Low Dosage Superovulated Females.  
Methylation status of individual DNA strands in the Snrpn ICR (paternal, B6 strands 
shown) in blastocysts derived from females superovulated with a 6.25 IU hormone 
dosage. The region analyzed contains 16 CpGs. Details are as described in Supplementary 
Figure 2.1.
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Supplementary Figure 2.19.  Methylation of the Paternal Snrpn in B6(CAST7) X B6 
F1 Embryos Derived from High Dosage Superovulated Females.  
Methylation status of individual DNA strands in the Snrpn (paternal, B6 strands shown) 
in blastocysts derived from females superovulated with a 10 IU hormone dosage. The 
region analyzed contains 16 CpGs. Details are as described in Supplementary Figure 2.1.
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Supplementary Figure 2.20. Methylation of the Paternal Peg3 DMR in B6(CAST7) 
X B6 F1 Embryos Derived from Spontaneously Ovulated Females.  
Methylation status of individual DNA strands in the Peg3 DMR (paternal, B6 strands 
shown) in blastocysts derived from spontaneously ovulated females. The region analyzed 
contains 23 CpGs; a polymorphism eliminates CpG 22 on the B6 allele.  Details are as 
described in Supplementary Figure 2.1.
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Supplementary Figure 2.21. Methylation of the Paternal Peg3 DMR in B6 X CAST 
F1 Embryos Derived from Spontaneously Ovulated Females.  
Methylation status of individual DNA strands in the Peg3 DMR (paternal, CAST strands 
shown) in blastocysts derived from spontaneously ovulated females. The region analyzed 
contains 24 CpGs. Details are as described in Supplementary Figure 2.1.
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Supplementary Figure 2.22. Methylation of the Paternal Peg3 DMR in B6(CAST7) 
X B6 F1 Embryos Derived from Low Dosage Superovulated Females.  
Methylation status of individual DNA strands in the Peg3 DMR (paternal, B6 strands 
shown) in blastocysts derived from females superovulated with a 6.25 IU hormone 
dosage. The region analyzed contains 23 CpGs; a polymorphism eliminates CpG 22 on 
the B6 allele. Details are as described in Supplementary Figure 2.1.
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Supplementary Figure 2.23. Methylation of the Paternal Peg3 DMR in B6(CAST7) 
X B6 F1 Embryos Derived from High Dosage Superovulated Females.  
Methylation status of individual DNA strands in the Peg3 DMR (paternal, B6 strands 
shown) in blastocysts derived from females superovulated with a 10 IU hormone dosage. 
The region analyzed contains 23 CpGs; a polymorphism eliminates CpG 22 on the B6 
allele. Details are as described in Supplementary Figure 2.1.
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Supplementary Figure 2.24. Methylation of the Paternal Kcnq1ot1 ICR in 
B6(CAST7) X B6 F1 Embryos Derived from Spontaneously Ovulated Females.  
Methylation status of individual DNA strands in the Kcnq1ot1ICR (paternal, B6 strands 
shown) in blastocysts derived from spontaneously ovulated females. Details are as 
described in Supplementary Figure 2.1.
301
Supplementary Figure 2.25. Methylation of the Paternal Kcnq1ot1 ICR in B6 X 
CAST F1 Embryos Derived from Spontaneously Ovulated Females.  
Methylation status of individual DNA strands in the Kcnq1ot1 ICR (paternal, CAST 
strands shown) in blastocysts derived from spontaneously ovulated females. Details are as 
described in Supplementary Figure 2.1. E83 displayed a reverse pattern of imprinted 
methylation as indicated by the asterisk (*).
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Supplementary Figure 2.26. Methylation of the Paternal Kcnq1ot1 ICR in 
B6(CAST7) X B6 F1 Embryos Derived from Low Dosage Superovulated Females.  
Methylation status of individual DNA strands in the Kcnq1ot1 ICR (paternal, B6 strands 
shown) in blastocysts derived from females superovulated with a 6.25 IU hormone 
dosage. Details are as described in Supplementary Figure 2.1.
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Supplementary Figure 2.27. Methylation of the Paternal Kcnq1ot1 ICR in 
B6(CAST7) X B6 F1 Embryos Derived from High Dosage Superovulated Females. 
Methylation status of individual DNA strands in the Kcnq1ot1 ICR (paternal, B6 strands 
shown) in blastocysts derived from females superovulated with a 10 IU hormone dosage. 
Details are as described in Supplementary Figure 2.1.
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Appendix 4: Supplementary Material - Chapter 3
The following figures were presented as supplementary  data in the following peer-
reviewed article:
Market-Velker, B. A., Fernandes, A. D. and Mann, M. R. Side-by-side comparison of five 
commercial media systems in a mouse model: suboptimal in vitro culture interferes with 
imprint maintenance. Biol Reprod 83(6): 938-50 (2010)
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Supplementary Table 3.1:  Regions and Conditions for PCR Analysis for Imprinted 
Methylation and Expression
 Supplementary Table 1.  Regions and condition for PCR analyses for imprinted methylation and expression. 
Gene Accession Primer
/Probe 
Primer Sequence (5'-3') Annealing 
Temp 
Reference 
Imprinted Methylation Analysis   
H19 U19619 OF GAG TAT TTA GGA GGT ATA AGA ATT 55 Mann et al., 
  OR ATC AAA AAC TAA CAT AAA CCT CT  2004;  
  IF  GTA AGG AGA TTA TGT TTA TTT TTG G  50 Market-Velker 
  IR CCT CAT TAA TCC CAT AAC TAT  et al., 2010 
Snrpn AF081460 OF TAT GTA ATA TGA TAT AGT TTA GAA ATT AG 52 Mann et al., 
  OR AAT AAA CCC AAA TCT AAA ATA TTT TAA TC  2004; 
  IF AAT TTG TGT GAT GTT TGT AAT TAT TTG G 54 Market-Velker 
  IR ATA AAA TAC ACT TTC ACT ACT AAA ATC C  et al., 2010 
Peg3 NT_039413.7 OF TTT TGA TAA GGA GGT GTT T 50 Mann et al., 
  OR ACT CTA ATA TCC ACT ATA ATA A  2004; 
  IF AGT GTG GGT GTA TTA GAT T 53 Market-Velker 
  IR TAA CAA AAC TTC TAC ATC ATC  et al., 2010 
Imprinted Expression Analysis    
H19 AF049091 F CCT CAA GAT GAA AGA AAT GGT 55 Mann et al., 
  R AA CAC TTT ATG ATG GAA CTG C  2004 
  Sensor
a
  CCA CCT GTC GTC CAT CTC C-FL   
  Anchor  LC640-TCT GAG GGC AAC TGG GTG TGG-P   
Snrpn MMSMN F CTC CAC CAG GAA TTA GAG GC 52 Mann et al., 
  R TAT AGT TAA TGC AGT AAG AGG  2004 
  Sensor  GAA GCA TTG TAG GGG AAG AGA A-FL   
  Anchor  LC640-GGC TGA GAT TTA TCA ACT GTA TCT TAG GGT C-P   
Peg3 AF038939 F CAG GAG AAA GTT GAA GAT GCT AC 53 This study 
  R TTC GTG AAC TCT CTG GTG CT   
  Sensor
a
  CCA GAG CAC TTT TTC TCA AAT TCG-FL   
  Anchor  LC640-TGA CGG AGT GGG CAT GAA CTT CAG-P   
OF Outer Forward, OR Outer Reverse, IF Inner Forward, IR Inner Reverse, F Forward, R Reverse, 
a
Sensor and Anchor Probes were 
purchased from TIB MolBiol. 
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Supplementary Table 3.2: Ability of Media System to Support Development to the 
Blastocyst Stage
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
96 48 50 6.25 IU/KSOMaa 
98 53 54 KSOMaa 
96 54 56 Whittens 
92 49 53 P1/MB 
91 51 56 HTF 
97 70 72 Global 
100 44 44 G1.5/G2.5 
Experimental Groupa 2-Cell # Blastocystb % Blastocystc 
6.25 IU/Whittens 50 46 92 
6.25 IU/HTF 38 34 89 
6.25 IU/Global 32 31 97 
6.25 IU/P1/MB 22 19 86 
6.25 IU/G1.5/G2.5 46 44 96 
Supplementary Table 2.  Ability of media systems to support development to the blastocyst stage for 
embryos derived from spontaneously ovulated and superovulated (6.25 IU) females.   
aMultiple culture experiments were performed for each group. Data from each group were pooled.   
bDevelopment to the blastocyst stage was scored before freezing on day 4 (see Figure 1), and was 
defined as the presence of a blastocoel cavity. 
cPercent development to the blastocyst stage was calculated as # embryos developed to blastocyst 
stage / total number of embryos cultured. 
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Supplementary Table 3.3:  Gene and Imprinted Expression Analysis from Embryos 
Derived from Spontaneously Ovulated Females
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gene 
 
# Analyzed 
 
# Expressed 
 
% Expresseda 
 
# LOI 
 
% LOIb 
 
H19 
 
68 
 
9 
 
13 
 
0 
 
0 
 
Snrpn 
 
130 
 
130 
 
100 
 
0 
 
0 
 
Peg3 
 
24 
 
23 
 
96 
 
1 
 
4 
Supplementary Table 3. Gene and imprinted expression analysis for H19, Snrpn and Peg3 from B6(CAST7) X B6 
in vivo-derived embryos from spontaneously ovulated females.   
aPercent expressed was calculated as # embryos with gene expressed / total number of embryos analyzed. 
bPercent LOI was calculated as # embryos with loss of imprinted expression / total number of embryos analyzed. 
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Supplementary Table 3.4: Statistical Analysisa of Imprinted H19 Expression 
 
 
 Superovulatedc 
Spontaneousb  
In Vivo Whittens KSOMaa Global HTF P1/MB G1.5/G2.5 
In Vivo  1.2 x 10-11 1.6 x 10-12 1.6 x 10-12 1.1 x 10-13 9.9 x 10-13 2.1 x 10-10 
Whittens 1.2 x 10-7  0.058 0.52 0.27 0.29 0.37 
KSOMaa 3.5 x 10-11 0.52  0.76 0.51 0.54 0.22 
Global 2.6 x 10-9 0.27 0.26  0.52 0.54 0.22 
HTF 8.0 x 10-5 0.18 0.0043 0.040  1.0 0.08 
P1/MB 6.8 x 10-9 0.30 0.25 0.61 0.049  0.09 
G1.5/G2.5 8.3 x 10-10 0.094 0.64 0.34 0.0096 0.32  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Table 4. Statistical analysis
a
 of imprinted H19 expression between in vivo-derived and cultured 
embryos for spontaneous and superovulated treatment.   
aFisher’s exact test was used to compute the significance in number of embryos with imprinted and nonimprinted H19 
expression between groups. P< 0.05 was considered statistically significant. 
bPurple, bottom left half, Spontaneously ovulated versus spontaneously ovulated treatment. 
cPink, top right half, Superovulated versus superovulated treatment. 
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Supplementary Table 3.4: Statistical Analysisa of H19 ExpressionSupple entary Table 5. Statistical analysisa of imprinted H19 expression between in vivo-derived and  
cultured embryos for spontaneous and superovulated treatment.   
 
 Superovulatedc 
Spontaneousb  
In Vivo Whittens KSOMaa Global HTF P1/MB G1.5/G2.5 
In Vivo  0.00005 0.00005 0.0003 0.00014 0.0001 0.0008 
Whittens 0.029  0.17 0.36 0.5 0.59 0.24 
KSOMaa 0.002 0.65  0.36 0.5 0.59 0.24 
Global 0.009 0.38 0.38  0.5 0.43 0.5 
HTF 0.018 0.48 0.33 0.56  0.57 0.37 
P1/MB 0.007 0.32 0.44 0.56 0.5  0.31 
G1.5/G2.5 0.029 0.6 0.21 0.41 0.52 0.36  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
aFisher’s exact test was used to compute the significance in number of embryos with and without H19 expression 
between groups. P< 0.05 was considered statistically significant. 
bPurple, bottom left half, Spontaneously ovulated versus spontaneously ovulated treatment. 
cPink, top right half, Superovulated versus superovulated treatment. 
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Supplementary Table 3.6:  Comparison of H19 Expression and Imprinted Expression
 
 
Experimental Groups 
 
Total 
 
# Expressed 
 
% Expresseda 
 
# LOI 
 
% LOIb 
 
In Vivo 
 
68 
 
9 
 
13 
 
0 
 
0 
 
Spontaneous 
Ovulation /Culture 
 
147 
 
111 
 
75 
 
52 
 
47 
 
Superovulation/ 
Culture 
 
120 
 
113 
 
94 
 
82 
 
73 
Supplementary Table 6. Comparison of percentage of embryos with H19 expression and with loss of H19 imprinted 
expression in B6(CAST7) X B6 in vivo-derived embryos from spontaneously ovulated females, and from cultured 
embryos derived from spontaneously ovulated or superovulated females. 
aPercent expressed was calculated as # embryos with H19 expression / total number of embryos analyzed. 
bPercent LOI was calculated as # embryos with loss of H19 imprinted expression / total number of embryos analyzed. 
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